Modulation of Carcinogen Metabolism by Benzyl Isothiocyanate. by Arya, Nlin.
Modulation of carcinogen metabolism 
By benzyl isothiocyanate
By
Nlin Arya
Submitted for the Degree of Doctor of Philosophy
Faculty of Health and Medical Sciences 
University of Surrey 
August 2008
ProQuest Number: 27557471
All rights reserved
INFORMATION TO ALL USERS 
The qua lity  of this reproduction  is d e p e n d e n t upon the qua lity  of the copy subm itted.
In the unlikely e ve n t that the au tho r did not send a co m p le te  m anuscrip t 
and there are missing pages, these will be no ted . Also, if m ateria l had to be rem oved,
a no te  will ind ica te  the de le tion .
uest
ProQuest 27557471
Published by ProQuest LLO (2019). C opyrigh t of the Dissertation is held by the Author.
All rights reserved.
This work is protected aga inst unauthorized copying under Title 17, United States C o de
M icroform  Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 4 81 06 - 1346
Abstract
Precision-cut rat liver slices were incubated with various concentrations of benzyl 
isothiocyanate (BITC) (0-25 |liM) for 24 hours. BITC decreased the dealkylation of ethoxy- 
(EROD) and methoxyresorufln (MROD) but increased CYPlAl/2 apoprotein levels; in vitro 
studies confirmed that it is mechanism-based inhibitor. BITC decreased both dealkylation of 
pentoxyresorufin (PROD) and CYP2B1 apoprotein levels but there was no effect on 7- 
benzyloxyquinoline (7-BQ) metabolism and CYP3A apoprotein levels. In the case of Phase II 
enzyme systems, BITC increased epoxide hydrolase and GST activity and a similar rises was 
observed in protein levels, no change was observed in NADPHiquinone oxidoreductase 
(NQOl).
In in vivo studies, rats were fed diets supplemented with BITC, equivalent to doses of 0-50 
mg/kg for 2 weeks. BITC increased EROD, MROD, PROD and 7-BQ metabolism and 
CYPlAl, 1A2, 2B1, and 3A apoprotein levels in the liver but not in the lung. When Phase II 
enzymes were modulated, BITC increased activities and protein levels of epoxide hydrolase 
only in the liver, whereas GST in both the liver and the lung were elevated. NQOl was not 
modulated.
Treatment with BITC failed to influence the metabolism of 2-amino-3-methylimidazo[4,5- 
y]quinoline (IQ) as exemplified by the excretion of mutagens in the urine. The effect of BITC 
on the detoxification pathways of IQ was monitored using LC/MS. Treatment with BITC or 
phenethyl isothiocyanate (PEITC) in the diet for 2 weeks increased IQ 5-0-glucuronide and 
IQ 5-0-sulphate excretion. Treatment with high doses of BITC and PEITC 24 hours prior to 
IQ administration, also increased IQ 5-0-glucuronide and IQ 5-O-sulphate excretion. This 
effect was not observed when using sulforaphane or erucin.
Acknowledgements
I would like to express my sincere gratitude to Dr Derek Stevenson, my supervisor for his 
kindness and advice. I am deeply grateful to Prof. Costas loannides for his excellent guidance and 
support throughout my research work and writing. He always was available when I needed 
advice. I am grateful to Dr. Nicolai Kuhnert for his advice during the first year of my PhD project. 
I would like to express my gratitude to Prof. Michael Clifford for his advise in LC/ion trap MS. I 
wish to express my warm and sincere thank to Dr Joanna Kirkpatrick, who has not only been an 
excellent source of LC/MS knowledge, but also a great advisor and good fnend. Her 
encouragement and support have been of great value to me.
I would like to give my special thank to Nattaya Konsue for being a great fnend and a great 
laboratory partner. I deeply thank Dr Dan Driscoll for his help in HPLC laboratory; Hajo 
Roozendaal for his technical help; Dr Meera Umachandran for teaching me the basics of working 
in the laboratory; Dr. Joanne Neary for her advice on the SPE and LC/ion trap MS; Paul Leahy 
and Dan Fernandez for the servicing and maintenance of the laboratory equipment; EBU staff for 
their expertise and helpfulness in the EBU unit. I would like to thank all my friends but especially 
Dr Lesley Beeton, Nicky Hendrie, Dr Chiraphan Khannapho, and Dr Walaipom 
Rewtrakunphaibon.
My thanks also to the Royal Thai Government for their financial support; staff at the office of 
educational affair, the Royal Thai embassy for their help and advice; all my colleagues at the 
faculty of Veterinary Science, Mahidol University, Thailand. Finally, I would like to express my 
gratitude to my family; my grandmother, aunts, uncles, cousins for their love and support, and 
especially, I would like to express my deep and sincere gratitude to my parents for then- 
supporting inspiration to pursue my PhD.
11
Table of contents
Table of contents
Abstract i
Acknowledgments ii
Table of contents iii
List of Figures xi
List of Tables xvi
Abbreviations xvii
1 Introduction
1.1 Introduction 2
1.2 Isothiocyanates (TTCs) 3
1.2.1 Major dietary source o f specific ITCs • 4
1.2.2 Estimated daily intake o f ITCs 5
1.2.3 Metabolism o f ITCs 8
1.2.4 Effect o f cellular GSH level on the cellula accumulation o f  8
ITCs in cell
1.2.5 Elimination o f ITCs 8
1.3 Chemopreventive effect of ITCs 9
1.3.1 Epidemiological studies 9
1.3.2 Studies in animal models 10
1.3.2.1 Benzyl isothiocyanate (BITC) 11
1.3.2.2 Phenethyl isothiocyanate (PEITC) 12
1.3.2.3 Sulforaphane 13
1.4 Mechanism of the chemopreventive effects of ITCs 14
1.4.1 Influences o f the chemopreventive effects ofITCs 14
1.4.2 Modulation o f Phase II  by ITCs 18
1.4.2.1 Glutathione S-transferase (GST) 19
1.4 .2.2 NADPh.-quinone reductase (NQOl) 19
111
Table of contents
1.4.2.3 UDP-glucuronosyltransferase (UGT) 20
1.4.3 Role o f ITCs in apoptosis and cell cycle arrest 20
1.5 Advert effects of ITC 21
1.6 2-Aniino-3-methylimidazo[4,5-:/]quinoline (IQ) 22
1.6.1 Pharmacokinetic behaviour o f IQ 22
1.6.2 Metabolism o f IQ 23
1.7 Precision-cut liver slices 24
1.8 Objectives of current project 25
22. Materials and methods 27
2.1 Materials 28
2.2 Methods 30
2.2.1 Rodent husbandary 30
2.2.2 Liver slices preparation 3 0
2.2.3 Preparation o f subcellular fractions 31
2.2.4 Protein determination 33
2.2.5 7-Ethoxycoumarin metabolism 34
2.2.5.1 Determination o f free 7-hydroxy coumarin 35
2.2.6 Determination of CYP450 activities 35
2.2.6.1 Determination o f CYPIA and 2B activities 35
2.2.6.2 Determination o f CYP3A activity 36
2.2.6.3 Determination o f total CYP450 37
2.2.7 Determination of Phase II enzyme activities 3 8
2.2.7.1 Determination o f epoxide hydrolase activity 3 8
2.2.7.2 Determination o f Glutathione S-transferase (GST) 3 9
2.2.7.3 Total glutathione 41
2.2.7.4 Determination o f NADPH:quinone 42 
oxidoreductase (NQOl)
2.2.8 Determination of lactate dehydrogenase activity (LDH, 44 
Cytotoxicity Detection)
iv
Table of contents
2.2.9 Western blot analysis 45
2.2.9.1 Preparation o f SDS-polyacrylamide gels 45
2.2.9.2 Sample preparation and gel loading 46
2.2.9.3 Transfer o f protein to nitrocellulose membrane 47
2.2.9.4 Immunodetection and visualisation 49
2.2.9.5 Detection 49
2.2.10 The Ames mutagenicity test 50
2.2.10.1 Stock solution and media 51
2.2.10.2 Histidine requirement 53
2.2.10.3 Crystal violet test 54
2.2.10.4 Presence o f the ampicillin resistance R factor 55
2.2.10.5 Viability o f frozen permanent test 5 5
2.2.11 Statistical analysis 55
3.3 Modulation of CYP450 and Phase II enzyme systems by BITC in 56
precision-cut rat liver slices
3.1 Introduction 57
3.2 Methods 57
3.2.1 Effect o f BITC on CYP450 and Phase I I  enzyme system in 5 7 
precision-cut liver slices.
3.2.2 Function o f BITC as a CYP450 mechanism-based inhibitor. 58
3.3 Results 59
3.3.1 Metabolic viability o f precision-cut liver slices 59
3.3.2 Effect o f BITC on CYP450 activities in precision-cut liver 60 
slice
3.3.3 Inactivation o f CYP450 by BITC metabolite(s) 63
3.3.4 Kinetic analysis o f the BITC-modulated EROD inhibition 66
3.3.5 Effect o f BITC on Phase I I  enzyme activities in precision-cut 70 
rat liver slices
Table of contents
5.3.6 Cell toxicity o f  BITC 73
3.4 Discussion 7 4
3.4.1 Metabolic viability o f precision-cut liver slices 74
3.4.2 The effects o f BITC on CYP450 enzyme activities and 74 
expression in precision-cut liver slices
3.4.2.1 CYPIA subfamily 74
3.4.2.2 CYP2B subfamily 75
3.4.2.3 CYP3A subfamily 76
3.4.3 Kinetics o f cytochrome P450 inhibition by BITC 76
3.4.4 The effects o f BITC on Phase II  enzymes activities and 77 
expressions in precision-cut liver slices
3.4.4.1 Epoxide hydrolase 77
3.4.4.2 Glutathione S-transferase 78
3.4.4.3 Total glutathione 78
3.4.4.4 NADPH:quinone oxidoreductase 79
5.4.5 Toxicity o f BITC to precision-cut liver slices 79
3.5 Conclusion 80
4. In vivo modulation of CYP450 and Phase II activities by BITC 81
4.1 Introduction 82
4.2 Methods 83
4.3 Results 83
4.3.1 Effects o f BITC on food intake and body weight 83
4.3.2 Effects o f dietary intake o f BITC on hepatic carcinogen 84 
metabolising enzymes in rat
4.3.2.1 Cytochrome P450 enzyme activities in rat liver 84
4.3.2.2 Cytochrome P450 enzyme activities in rat lung 85
4.3.3 Effects o f  diets supplement with BITC on Phase II  enzyme 89 
activities in rat
4.3.3.1 Phase II  enzyme activities in rat liver 89
VI
Table of contents
4.3.3.2 Phase II  enzyme activities in rat lung 94
4.3.4 Effects o f  BITC treatment on the bioactivity o f  2-amino-3- 96
methylimidazof 4,5-f]quinoline (IQ)
4.4 Discussion 97
4.4.1 Effects o f BITC on cytochrome P450 activities 98
4.4.2 Effects o f BITC on Phase II  enzyme activities 99
4.4.3 Effects o f BITC-induced hepatic S9 the bioactivation o f IQ  101
4.5 Conclusion 102
5. Method development for the determination of 2-amino-3 103
methylimidazo [4,5-/1 quinoline (IQ) and its metabolites by LC/MS/MS
5.1 Introduction 104
5.1.1 Physical-chimicalproperty o f IQ  104
5.1.2 Formation o f IQ  105
5.1.3 Estimation human daily intake 105
5.1.4 Metabolism o f IQ  105
5.1.5 Analytical techniques fo r  the determination ofIQ  106 
metabolites
5.1.5.1 Sample preparation 106
5.1.5.2 Analytical method 109
5.1.6 Aim o f the study 110
5.2 Synthesis of IQ metabolites 111
5.2.1 Synthesis o f IQ N-glucuronide 111
5.2.2 Synthesis o f  N-acetyl IQ  112
5.3 Instrument conditions 112
5.3.1LC/TOF MS conditions 112
5.3.2 LC/ion trap conditions 113
5.4 HPLC conditions for the determination of 2-amino-3 114
methylimidazo[4,5-/|quinoline
5.4.1 UV condition fo r IQ 114
v i i
Table of contents
5.4.2 Stationary phase 114
5.4.3 Mobile phase conditions 114
5.4.3.1 Concentration o f ammonium acetate 115
5.4.3.2 Isocratic V5 gradient 116
5.5 Lower limit of detection 121
5.6 Linear of standard curve 121 v
5.7 Sample preparation 122
5.7.1 Liquid-liquid extraction (LLE) o f IQ  122
5.7.2 Solid phase extraction (SPE) fo r IQ and its metabolite 122
5.7.2.1 Type o f SPE cartridge 123
5.7.2.2 The selection o f SPE cartridge 123
5.7.2.3 Elution solvent selection 126
5.7.3 Validation o f the method for the determination ofIQ  and its 126 
metabolites
5.7.3.1 Recovery and precision o f the SPE assay 126
5.7.3.2 Limit o f detection 131
5.8 Mass spectrometric detection of IQ and its metabolites 131
5.9 Metabolism of IQ by rat liver slices 132
5.9.1 Time-dependent disappearance ofIQ  from the culture 132 
media
5.9.2 Time-dependent generation o f IQ metabolites 136
. 5.9.3 Metabolism ofIQ  by liver slices from f-naphthoflavone- 138
induced rats
5.10 Application of the SPE/LC/MS method to study the in vivo 138 
metabolism of IQ in rats
5.10.1 Precision and accuracy 138
5.10.2 Limit o f detection 141
5.10.3 In vivo metabolism o f IQ by rats 141
5.11 Discussion 144
/
V lll
Table of contents
5.12 Conclusion 144
6. Modulation of 2-amino-3-methylimidazo[4,5-fj quinoline (IQ) metabolism 145
by isothiocyanates
6.1 Introduction 146
6.2 Methods 147
6.2.1 Effects o f BITC on the mutagenicity ofIQ  147
6.2.1.1 Preliminary study 147
6.2.1.2 Experimental study 147
6.2.2 Effects of BITC on IQ metabolism in liver slices 148
6.2.3 Effects o f ITCs on the metabolism ofIQ  in rats 148
6.2.3.1 Effects o f long-term ITC treatment on IQ  148 
metabolism
6.6.3.2 Effects o f short-term treatment on IQ metabolism 149
6.2.4 Sample preparation and analysis 149
6.2.4 Statistic analysis 149
6.3 Results 150
6.3.1 Effects o f BITC on the mutagenicity o f IQ  150
6.3.1.1 Preliminary study 150
6.3.1.2 Effects o f BITC on the urinary excretion o f  151 
promutagen in rats treated with IQ
6.3.2 Effects o f  BITC on IQ metabolism by liver slices 152
6.3.3 Effects o f  ITC on the metabolism o f IQ in rats 154
6.3.3.1 Effects o f long-term BITC treatment on IQ  154 
metabolism in rats.
6.3.3.2 Effects o f long term PEITC treatment on IQ  159 
metabolism in rats.
6.3.3.3 Effects o f short-term BITC treatment on IQ  159 
metabolism in rats.
6.3.3.4 Effects o f short-term PEITC treatment on IQ  168 
metabolism in rats.
IX
Table of contents
6.3.3.5 Effects o f short-term sulforaphane and erucin 168
treatment on IQ metabolism in rats.
6.4 Discussion 177
6.4.1 Effects o f BITC on urinary mutagen and promutagen 177 
excretion in rats treated with IQ
6.4.2 Detoxification pathway o f IQ  179
6.4.3 Effect o f BITC on IQ metabolism in precision-cut liver slice 179 
model
6.4.4 Effects o f long-term treatment with ITCs on IQ metabolism 180 
in rats
6.4.5 Effects o f short-term treatment ofITCs on IQ metabolism in 182 
rats
6.5 Conclusion 184
7 Discussion 185
7.1 Effect of BITC on CYP450 and Phase II enzyme systems 186
7.2 Effect of BITC on carcinogen metabolism 188
7.3 Are ITCs responsible for the chemopreventive effects of cruciferous 189 
vegetables?
7.4 Can ITCs be used as dietary supplements? 191
7.5 Can ITCs be used as drug? 194
7.6 Conclusion 195
8. Bibliography 197
X
List of Figure
List of figures
Chapter 1
Figure 1.1 Metabolism of glucosinolates to isothiocyanates and related reactions. 4
Figure 1.2 Chemical structure of isothiocyanates^ 4
Figure 1.3 Proposed reaction scheme for the formation of the BITC reactive 17
intermediate catalysed by P450 2B1.
Figure 1.4 Principal pathway of IQ metabolism in animal models and humans 24
Chapter 2
Figure 2.1 The Krumdieck tissue sheer. 31
Figure 2.2 Schematic representation of the slicing technique. 33
Figure 2.3 The reaction of the reduced (GSH) and oxidised (GSSG) glutathione in the 41 
cytosolic fractions.
Figure 2.4 Principal of the assay of NADPH:quinone oxidoreductase. 43
Figure 2.5 Scheme of LDH assay. 44
Figure 2.6 Schematic representation of gel stacking procedure. 48
Figure 2.7 Histidine requirement. 54
Figure 2.8 Crystal violet test. 54
Figure 2.9 Presence of the ampicillin resistance R factor. 55
Chapter 3
Figure 3.1 Metabolism of 7-ethoxycoumarin by rat hepatic slices. 59
Figure 3.2 Homogenate protein content of rat hepatic slices during incubation. 60
Figure 3.3 Effect of BITC on CYP450 activities in precision-cut live slices. 61
Figure 3.4 Effect of BITC on CYP450 apoprotein levels in precision-cut liver slices. 62
Figure 3.5 Effect of BITC on EROD activity. 64
Figure 3.6 Effect of BITC incubation time on EROD activity. 64
Figure 3.7 Effect of BITC concentration on metabolite-modulated inhibition of EROD 65
activity.
Figure 3.8 Effect o f BITC incubation time on metabolite-modulated CYP450 65
content.
XI
 __________________     List of Figure
Figure 3.9 Effect of BITC concentration on the metabolite-modulated CYP450 66
content.
Figure 3.10 The inhibition of EROD activity by BITC. 67
Figure 3.11 Lineweaver-Burk plot of EROD activity in the presence of BITC. 68
Figure 3.12 The inhibition of EROD activity by BITC metabolite(s). 69
Figure 3.13 Lineweaver-Burk plot of EROD activity in the presence of BITC 69
following pre-incubation with NADPH.
Figure 3.14 Effect of BITC on Phase II enzyme activities in precision-cut liver slices. 71
Figure 3.15 Effect of BITC on Phase II enzymes on protein level in precision-cut liver 72
slices.
Figure 3.16 Effect o f  BITC on cellular total glutathione in precision-cut liver 73
slices
Figure 3.17 Release of LDH from liver slices cultured in the presence of BITC after 73
24 hour of incubation.
Chapter 4
Figure 4.1 The effects of BITC intake on rat body weight. 84
Figure 4.2 Effects of BITC on cytochrome P450 activity in rat liver 85
Figure 4.3 Effects of BITC on cytochrome P450 apoprotein levels in rat liver. 86
Figure 4.4 Effects of BITC on EROD, PROD and 7-BQ dealkylation activity in rat 87
lung.
Figure 4.5 Effects of BITC on cytochrome P450 apoprotein levels in rat lung. 88
Figure 4.6 Effects of BITC on Phase II enzyme activities in rat liver. 90
Figure 4.7 Effects of BITC on Phase II enzymes protein levels in rat liver. 91
Figure 4.8 Effects of BITC on glutathione iS-transferase (GST) activities in rat liver. 92
Figure 4.9 Effects of BITC on glutathione 5-transferase protein level in rat liver. 93
Figure 4.10 Effect o f BITC on glutathione contents in rat liver. 93
Figure 4.11 Effects of BITC on Phase II enzyme activities in rat lung. 94
Figure 4.12 Effects of BITC on Phase II enzymes protein levels in rat lung. 95
Figure 4.13 Effect of BITC-induced S9 on mutagenic response of IQ in the Ames test 96
X ll
 ________________________     List of Figure
Chapter 5
Figure 5.1 Metabolism of IQ. 107
Figure 5.2 Schematic of the electrospray ionisation. 110
Figure 5.3 LC/MS ion trap machine. 113
Figure 5.4 UV spectrum of IQ in methanol (10 pM). 115
Figure 5.5 HPLC chromatogram of IQ when using isocratic mobile phase. 117
Figure 5.6 Gradients used to evaluate the optimum mobile phase conditions. 118
Figure 5.7 HPLC chromatogram of IQ when using gradient mobile phase. 120
Figure 5.8 Standard curve of standard IQ solution. 121
Figure5.9 The five step process of SPE. 124
Figure 5.10 Standard curve of IQ (A) and V-acetyl IQ (B) fi*om full scan LC/MS. 129
Figure 5.11 LC/MS chromatogram of IQ and its metabolites. 133
Figure 5.12 Metabolism of IQ by rat liver slices. 136
Figure 5.13 Concentration-dependent metabolism of IQ by precision-cut rat liver 137
slices.
Figure 5.14 Metabolism of IQ by precision-cut liver slices from rats induced with p- 139
naphthofiavone.
Figure 5.15 Standard curve of IQ (A) and V-acetyl IQ (B) using full scan LC/MS. 140
Figure 5.16 Urinary profile of IQ metabolites in rat. 142
Figure 5.17 Effect of treatment with p-naphthoflavone on the metabolism of IQ in rat. 143
Chapter 6
Figure 6.1 The Preliminary pattern of excretion of urinary promutagens in rats treated 150
with IQ.
Figure 6.2 Preliminary study to determine promutagen excretion in rats treated with 151
IQ.
Figure 6.3 The effect of dietary BITC on the excretion of promutagen in the urine of 152
rats treated with IQ.
Figure 6.4 Effect of BITC on IQ metabolism by liver slices. 153
Figure 6.5 Effect of long-term BITC treatment on urinary IQ excretion. 155
Figure 6.6 The effect of long-term BITC treatment on 24-hour urinaiy IQ metabolite 156
excretion.
X lll
List of Figure
Figure 6.7 The effect of long-term BITC treatment on 48-hour urinary IQ metabolite 157
excretion.
Figure 6.8 The effect of long-term BITC treatment on total urinary IQ metabolite 15 8
excretion.
Figure 6.9 The effect of long-term PEITC treatment on urinary IQ excretion. 160
Figure 6.10 The effect of long-term PEITC treatment on 24-hour urinary IQ 161
metabolite excretion.
Figure 6.11 The effect of long-term PEITC treatment on 48-hour urinaiy IQ 162
metabolite excretion.
Figure 6.12 The effect of long-term PEITC treatment on total urinary IQ metabolite 163
excretion.
Figure 6.13 The effect of short-term BITC treatment on urinary IQ excretion 164
Figure 6.14 Effect of short-term BITC treatment on 24-hour urinary IQ metabolite 165
excretion
Figure 6.15 Effect of short-term BITC treatment on 48-hour urinary IQ metabolite 166
excretion.
Figure 6.16 Effect of short-term BITC treatment on total urinary IQ metabolite 167
excretion.
Figure 6.17 The effect of short-term PEITC treatment urinary IQ excretion 169
Figure 6.18 The effect of short-term PEITC treatment on 24-hour urinary IQ 170
metabolite excretion.
Figure 6.19 Effect of short-term PEITC treatment on 48-hour urinary IQ metabolites 171
excretion.
Figure 6.20 Effect of short-term PEITC treatment on total urinary IQ metabolite 172
excretion.
Figure 6.21 Effect of short-term sulforaphane and erucin treatment on urinary IQ 173
excretion.
Figure 6.22 Effect of short term sulforaphane and erucin treatment on 24- hour urinary 174 
IQ metabolites excretion.
Figure 6.23 The effect of short-term sulforaphane and erucin treatment on 48- hour 175
urinary IQ metabolite excretion.
Figure 6.24 The effect of short-term Sulforaphane and erucin treatment on total 176
urinary IQ metabolite excretion.
Figure 6.25 Urinary IQ excretion from rat fed with BITC 181
Figure 6.26 Effect of dietary PEITC on the excretion of promutagen in the urine of 183
rats treated with IQ.
xiv
___________________________   List of Figure
Figure 6.27 Effect of PEITC on MROD activity in rat liver. 184
XV
List of the table
List of tables
Chapter 1
Table 1.1 Total glucosinolate content of cruciferous vegetables. 6
Table 1.2 Daily intake of cruciferous vegetables. 7
Chapter 3
Table 3.1 Kinetic parameters of the effect of BITC on EROD activity. 67
Table 3.2 Kinetic parameters of the effect of BITC on EROD activity following pre- 68
incubation with NADPH.
Chapter 5
Table 5. 1 Properties of IQ. 104
Table 5. 2 The retention time of IQ under different mobile phase gradients. 119
Table 5.3 Gradient protocol used for analysing IQ and its metabolites. 119
Table 5. 4 Optimal SPE condition. 125
Table 5.5 Extraction of IQ by various types of SPE cartridge. 125
Table 5.6 Comparison of 2 types of SPE cartridge. 126
Table 5.7 Comparison of elution solvents for SPE extraction of IQ metabolites. 128
Table 5.8 Percentage recovery of IQ, A-acetyl IQ and IQ A-glucuronide. 129
Table 5.9 SPE protocol for extracted IQ and its metabolite. 130
Table 5.10 Inter- and intra-day variation in the determination of IQ in culture media. 130
Table 5.11 Inter- and intra-day variation of the determination of the A-acetyl IQ in 131
culture media.
Table 5.12 Name, Molecular weight (MW), fragmentation, and structure of IQ 134
metabolites.
Table 5.13 Inter- and intra-day variation in the determination of IQ in rat urine. 140
Table 5.14 Inter- and intra-day variation of determination of W-acetyl IQ in urine. 140
XVI
Abbreviations
Abbreviations
7-BQ 7 -benzyloxyquinoline
7-EFC 7-ethoxy-4-(trifluoromethyl)coumarin
7-HQ 7 -hy droxyquinoline
ACF Aberrant crypt foci
AITC Allyl isothiocyanate
ARE Antioxidant response element
B[a]P Benzo [ajpyrene
BBN A-butyl-A-(4-hydroxybutyl)nitrosamine
BITC Benzyl isothiocyanate
BOP N-nitrosobis (2-oxopropyl)amine
CDNB l-chloro-2,4-dinitrobenzene
CV Coefficient of variation
CYP450 Cytochrome P450
D3IQ 2-Amino-3-trideuteromethyl-3H-imidazo[4,5-/|quinoline
DCNB 1, 2-dichloro-4-nitrobenzene
DMBA 7,12-dimethylbenz[a]anthacene
DMSG Dimethyl sulfoxide
DNA Deoxyribonucleic acid
DTNB 5,5'-Dithio-Bis {2-Nitrobenzoic Acid)
EBSS Earl’s Balance Salt Solution
EBU Experimental Biology Unit
EC Ethoxycoumarin
ELISA Enzyme-Linked ImmunoSorbent Assay
EROD Ethoxyresorufm 0-dealkylase
ESI Electrospray ionization
xvii
Abbreviations
GC/MS Gas chromatography/Mass spectrometry
GSH Reduced glutathione
GSSG Oxidised glutathione
GST Glutathione «S-transferase
HA Heterocyclic aromatic amines
Hb Haemoglobin
HDAC Histone deacetylase
HLB Hydrophylic-lipophilic balance
HPLC High performance liquid chromatography
IgG Immunogloblin G
IQ 2-Amino-3 -methylimidazo [4,5-/] quinoline
ITCs Isothiocyanates
JNK c-jun N-terminal kinase
LC/MS Liquid chromatography/Mass spectrometry
LLE Liquid-liquid extraction
m/z Mass-to-charge ratio
MeAaC 2-Amino-3-methyl-9H-(pyrido(2,5-6)indole
MelQ 2-Amino-3,4-dimethylimidazo[4,5-/lquinoline
MelQx 2-Amino-3,8 -dimethylimidazo [4,5-/] quinoxaline
MOPS 3 -(N-morpholino)propanesulfonic acid
MROD Methoxyresorufln 0-dealkylase
MTT Methylthiazole Tétrazolium
MW Molecular weight
MYR Myrosinase
NAT A-acetyltransferase
NADPH Reduced nicotinamide adenine dinucleotide phosphate
NBD-Cl 4, Chloro-7-nitrobenzofurazan
X V lll
Abbreviations
NDBA AT-nitrosobutylamine
NMBA A-nitrosomethylbenzylamine
NNK 4-(methylnitrosamineo-)-1 -(3 -pyridyl)-1 -butanone
NPIP A-nitrosopiperidine
NQOl NADPH:quinone oxidoreductase
Nrf2 NF-E2-related transcription factor 2
PAH Polycyclic aromatic hydrocarbon
PBS Phosphate buffered saline
PEITC Phenethyl isothiocyanate
PHA Phytohaemagglutinin
PhIP 2-Amino-l -methyl-6-phenylimidazo[4,5-6] pyridine
PROD Pentoxyresorufin 0-dealkylase
ROS Reactive oxygen species
S9 Post-mitochondrial supernatant
SDS Sodium dodecyl sulphate
SEM Standard error of mean
SEN Sulforaphane
SIM Single ion monitoring
SPE Solid phase extraction
SRM Selected reaction monitoring
SULT Sulfotransferase
TCDD 2,3,7,8-tetrachlorodebenzo-p-dioxin
TEMED N,N,N',N'-Tetramethylethylenediamine
TIC Total ion chromatogram
TNB 5 -thio-2-nitrobenzoate
TOE Time of flight
UGT UDP-glucuronosyltransferase
XIX
Abbreviations
UV Ultraviolet
XRE Xenobiotic response element
XX
Chapter 1:
Introduction
Chapter 1: Introduction
1.1 Introduction
Diet plays an important role in cancer development. Food contains both chemopreventive 
substances, such as antioxidants, chlorophyll (de Vogel et al. 2005) and glucosinolates, precursors 
of isothiocyanates (Uhl et al. 2004), and also mutagenic/carcinogenic substances, such as 
mycotoxins, polycyclic aromatic hydrocarbons (PAH) and heterocyclic aromatic amines (HAs) 
(Lynch et al. 1995). Consumption of cruciferous vegetables such as broccoli, cauliflower, 
Brussels sprouts, water cress and cabbage, appears to be inversely associated with cancer risk 
incidence (Ambrosone et al. 2004; Joseph et al. 2004; Tang et al. 2008). However, the 
mechanisms of the protective effects of these vegetables are multiple and incompletely 
understood. In recent years, research has been focussed on glucosinolates, which are contained in 
cruciferous vegetables and their breakdown products, such as isothiocyanates (ITCs) and indoles. 
Three possible protective mechanisms of isothiocyanates against carcinogenesis have been 
implicated: 1) inhibition of Phase I enzymes activities 2) induction of Phase II enzymes activities, 
and 3) induction of cell cycle arrest and apoptosis.
To study the modulation of carcinogen metabolism by BITC (a breakdown product of 
glucotropaeolin), 2-amino-3 -methylimidazo[4,5-f]quinoline (IQ), which is a potent rodent 
carcinogen found in cooked meat/fish, was selected to be used in this study. The reasons why IQ 
was selected are: 1) both BITC and IQ are commonly found in the diet; 2) both bioactivation and 
detoxification pathways of IQ involve cytochrome P450 (CYP450) and Phase II enzymes which 
may be either induced or inhibited by BITC; 3) there is experimental evidence that ingestion of 
cruciferous vegetables can reduce genotoxicity/carcinogenicity induced by IQ (Humblot et al. 
2004; Kassie et al. 2002; Uhl et al. 2004).
1.2 Isothiocyanates (ITCs)
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Isothiocyanates (ITCs) comprise a class of small molecules which are present as glucosinolates in 
many edible plants, especially cruciferous vegetables. These are generated when the precursors, 
glucosinolates, are degraded during cutting, chopping or chewing. Glucosinolates have a common 
structure comprising a yg-D-thioglucose group, a sulphonate oxime moiety, and variable side 
chains derived from methionine, tryptophan and phenylalanine. Glucosinolates can be hydrolysed 
by the enzyme myrosinase (^-thioglucosidase glucohydrolase; EC 3.2.3.1; MYR) yielding 
breakdown products such as isothiocyanates and nitrile (Hecht et al. 2000; Thomalley 2002). 
Plant myrosinase is physically separated from the glucosinolate in plant cells but rupture of the 
cell results in exposure of the glucosinolate to the enzyme myrosinase (Mithen et al 2000; 
Rodman et al. 1998). Plant myrosinase loses it activity during cooking process. Glucosinolates 
that are not hydrolysed by plant myrosinase could be degraded by microflora myrosinase (Shapiro 
et al. 1998; Getahun and Chung 1999). Bheemreddy and co-workers (2007) studied the fate of 
glucoraphanin, precursor of sulforaphane, in rats. They compared the urinary ITC profile after 
either ingestion or intraperitoneal injection of glucoraphanin. After a single glucoraphanin 
treatment, intraperitoneal-treated rats excreted significantly less of the A-acetylcysteine conjugate 
of sulforaphane. Moreover, urinary intact glucoraphanin excretion was significantly higher in 
intraperitoneal-treated rats. This data indicated that in the absence of plant myrosinase, 
glucosinolates could be hydrolysed by the microflora but not in the mammals. An enzyme general 
scheme of the hydrolysis of glucosinolate is presented in Figure 1.1.
ITCs are not only responsible for the pungent taste and odour of cruciferous vegetables, but also 
have a variety of pharmacological and toxic properties. ITCs are believed to be responsible for the 
chemopreventive effects of the cruciferous vegetables. The estimated daily consumption of ITCs 
by humans ranges between few to several hundred micromoles (Seow et al. 1998; Shapiro et al. 
1998).
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Figure 1.1 Metabolism of glucosinolates to isothiocyanates and related reactions (Song et al. 
2005)
1.2.1 Major dietary source o f specific ITCs
While over 90 different ITCs have been described, only about six occur frequently in the diet. For 
example: benzyl isothiocyanate (BITC) is found mainly in garden cress {Lepidium spp.) 
(Vermeulen et al. 2006) and also papaya seed (Nakamura et al. 2000); sulforaphane (SFN) is the 
predominant ITC found in broccoli {B.oleracea var.italic) but is also found in rocket {Eruca 
sativa), cabbage (B. oleracea var. capitata) and Brussels sprouts {B.oleracea var gemmiferd) 
(Vermeulen et al. 2006); phenethyl isothiocyanate (PEITC) is obtained from water cress 
{Rorippa spp.) and to a lesser extent from root crops such as turnip {Brassica rapa) (Vermeulen et 
al. 2006). Their structures are illustrated in Figure 1.2
Benzyl isothiocyanate 
miTO
NCS
o
I I
Phenethyl isothiocyanate 
rPETTC')
^  NCS
Sulforaphane (SFN)
Figure 1.2 Chemical structure of the major isothiocyanates.
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The glucosinolate contents in cruciferous vegetables are summarised in Tables 1.1, and are 
essential for estimating human exposure in epidemiological studies. The glucosinolate levels in 
vegetables ranges from 29.1 to 123.7 mg/100 g fresh vegetable weight (Sones et a l, 1984a). The 
ITC levels in vegetables ranges from 4.9 pmol/100 g in cooked Bok choi {Brassica chinensis) to
81.3 pmol/100 g in cooked water cress {Nasturtium officinale) (Shapiro et a l, 1998). Factors that 
affect the bioavailability of ITCs are; 1) type of vegetable; 2) environmental factors, which can 
influence overall amount of isothiocyanate produced by plants; 3) post-harvest storage conditions 
and cooking process, and 4) the thioglucosidase activity of the intestinal microflora.
1.2.2 Estimated daily intake o f  ITC as glucosinolate
Estimated daily intake of isothiocyanate as glucosinolates is based on either food questionnaires 
or measurement of urinary ITC levels. In early studies, the dietary intake of ITC was estimated by 
measuring the glucosinolate content of vegetables before consumption, combined with dietary 
questionnaires to evaluate daily consumption of cruciferous vegetables. The existing databases on 
consumption of cruciferous vegetables (Table 1.2) and glucosinolate content (Table 1.1) may be 
considered adequate to provide a basis for such estimation. For example. Song and Thomalley 
(2005) reported the total glucosinolate found in broccoli was 67 pmol/ 100 g fresh weight. If the 
consumption of vegetable is 40 g/day (Seow et al., 1998), and an average human body weight is 
80 kg, it can be estimated that the average glucosinolate consumption is 0.3pmol/kg/day. Hecht et 
al. (1995 and 1999) estimated that isothiocyanates in cruciferous vegetables represent about 
0.02% of the vegetable mass. Assuming an average molecular mass for isothiocyanates as 170, 
and a portion size of daily consumption of cruciferous vegetable is 100 g, this would indicate that 
about 20 mg of isothiocyanate, or 100 pmol, would be consumed per day (Kirlin et al. 1999). 
Spitz and co-workers (2000) calculated ITC as glucosinolate intake from semiquantitative food 
questionnaires, and estimated that the mean total ITC intake in lung cancer patients was estimated 
to be 0.47 ± 0.51 mg/1000 kcal for the cases and 0.58 ± 0.84 mg/1000 kcal for the controls.
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Table 1.1 Total glucosinolate content of cruciferous vegetables.
Cruciferous vegetable Total glucosinolate content References
Brussels sprouts 59.7-254.2 mg/lOOg fresh weight Sones et al. 1984a
2.3 mmol/kg fresh weight Vermeulen et al. 2006
17.3 pmol/100 g fresh weight Song et al. 2005
Cabbage 31.5-165.1 mg/lOOg fresh weight Sones et al. 1984a
1.0 pmol/g fresh weight Shapiro et al. 1998
10.4 pmol/lOO g fresh weight Song et al. 2005
Cauliflower 9.4-111.1 mg/lOOg fresh weight Sones et al. 1984a
0.6 mmol/kg fresh weight Vermeulen et al. 2006
13.6 pmol/lOO g fresh weight Song et al. 2005
Broccoli 2.0 pmol/g fresh weight Shapiro et al. 1998
1.0 mmol/kg fresh weight Vermeulen et al. 2006
66.8 pmol/lOO g fresh weight Song et al. 2005
Kale 1.1 pmol/g fresh weight Shapiro et al. 1998
The use of dietary questionnaires is a subjective and inaccurate method because the amount of 
cruciferous vegetables in a whole meal is difficult to estimate. Additionally, there are wide 
variables that affect the glucosinolate content and the subsequence conversion of glucosinolates to 
ITCs. As a result, assessment of ITC exposure by measuring urinary ITCs and their metabolites 
was developed in several laboratories. Controlled metabolic studies established that urinary ITC 
equivalents assayed by the cyelocondensation technique reflect the amount of cruciferous 
vegetables consumed (Shapiro et al. 1998; Chung et al. 1998; Seow et al. 1998). Since the 
cyelocondensation reaction is not specific only to ITCs, but also includes dithiocarbamates and
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related thiocarbonyl compounds, some laboratories developed LC/MS techniques which are 
capable of characterising individual ITCs. By using an LC/MS technique, Vermeulen et al. (2003) 
showed that the peak of ITC excretion occurs between 3-6 hours after ingestion, and that most of 
ITCs, which are eaten in the average meal, are excreted within 24 hours. Fowke et al. (2001) 
reported that urinary ITC levels can be used as biomarkers to predict daily intake of cruciferous 
vegetables when average consumption is about lOOg/day, but at higher consumption levels a 
weaker and non-significant association was found. One of the responsible factors could be the 
cooking process. Vermeulen et al. (2006) reported that bioavailability of ITCs was 61% for raw 
vegetables but dropped to 10% for cooked vegetables. Inter-individual variations such as 
chewing, absorption, colonic degradation etc. could play a part as well. However, urinary ITCs 
and their mereapturie metabolites can be used as biomarkers to reflect the active dose of ITCs 
absorbed.
Table 1.2 Daily intakes of cruciferous vegetables.
Region Cruciferous vegetable intake 
(g/person/day)
Reference
China > 100 Chiu et al. 2003
Europe 10-30 Bosetti et al. 2002; Terry et 
al. 2002
North America 25^0 Pacin et al. 1999
Other 40-80 Bosetti et al. 2002; Memon et 
al. 2002; Seow et al. 2002; 
Shannon et al. 2002
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1.2.3 Metabolism o f  ITCs
The —N=C=S group of most isothiocyanates is electrophilic and can react readily with various 
nucleophiles, including thiols. Studies in both humans and experimental animals have established 
that ITCs are metabolised in vivo to various dithiocarbamates, principally by the mereapturie acid 
pathway. Other minor metabolites of ITCs with an alkyl or aryl moiety have also been identified 
in animals (lARC 2004).
1.2.4 Effect o f cellular GSH levels on the cellular accumulation o f ITCs in cells
Cellular GSH levels are responsible for the initial cellular accumulation of ITCs. Previous studies 
have shown that lowering cellular GSH level by inhibiting GSH synthesis leads to diminished 
ITC accumulation in Hepa lc7c cells (Zhang and Talalay. 1998), whereas a rise in cellular GSH 
levels enhanced the accumulation (Zhang 2001). However, the effect of GSH on ITC 
accumulation was much less, or even undetectable after longer periods of incubation (Zhang and 
Talalay 1998). The underlying mechanism of this phenomenon is not yet fully understood.
1.2.5 Elimination o f  ITCs
ITC elimination varies with the nature of the compound and the animal species involved. In rats, 
BITC and PEITC were metabolised mainly via the mereapturie acid pathway and the major 
urinary metabolite was BITC or PEITC -V-acetylcysteine. Guinea-pigs and rabbits excrete BITC 
as the mercaptopyruvate conjugate 4-hydroxy-4-carboxy-3-benzythiozolidine-2-thione (lARC 
2004).
In rats, sulforaphane was excreted as the V-acetylcysteine conjugate and erucin, a reduction 
sulphur analogue of sulforaphane (Kassahun et al. 1997). Moreover, when erucin was
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administered to rats, 7V-acetylcysteine conjugates of sulforaphane and erucin were found in urine 
indicating oxidative metabolism of erucin.
1.3 Chemopreventive effects of ITCs
Previous studies on the chemopreventive effects of ITCs against carcinogenesis/mutagenic have 
generated inconsistent results. These inconsistencies may be attributed to the different 
experimental designs employed; especially dosage and stage of carcinogenesis at which ITCs 
were administered, animal species and target organs. This review will focus on the 
chemopreventive effects of BITC, PEITC, and sulforaphane which are the most abundant ITCs 
present in cruciferous vegetables.
1.3.1 Epidemiogical studies
The effects of cruciferous vegetable intake on cancer risk are still controversial and likely to 
depend on race, gender and target organ. Prospective cohort studies in Dutch men and women 
(Voorrips et al. 2000), US women (Feskanich et al. 2000) and Finnish men (Neuhouser et al. 
2003) indicated that higher intake of cruciferous vegetables was associated with significant 
reduction in lung cancer risk, but prospective studies in US men (Feskanich et al. 2000) and 
European men and women (lARC 2004) showed no such association. The prospective study of 
Dutch adults also revealed inverse relationship between higher intake of cruciferous vegetables 
and colon cancer, however, in the same study, higher intake of cruciferous vegetables showed 
positive associated with increase of risk of rectal cancer in women (Voorrips et al. 2000). the 
breast cancer survivors in USA showed a strong inverse association of cancer recurrence and 
cruciferous consumption (Thomson et al. 2007).
One of the possible reasons for the inconsistent relationship between cruciferous vegetable 
consumption and cancer risk is GST polymorphism (Moore et al. 2007). To eliminate ITC the
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body has to conjugate it with glutathione, and the process is catalysed by GST. Among the four 
classes of GST, ITCs have been reported to be a good substrate for GSTPl-1 and GST Ml-1 
(Zhang et al. 1995). Lack of this enzyme could lead to accumulation of TTC in the body, which 
allows ITC more time to induce target enzymes. Studies in humans revealed links between GST 
genotype and cancer risk. Lin and co-workers (1998) reported that high broccoli intake with the 
GSTMl-null genotype led to the lowest adenoma prevalence. However the relationship between 
GST genotype and urinary excretion of ITC was inconsistent. Seow et al (1998) reported that 
urinary excretion of ITCs was higher in GSTTl positive compared with GSTTl-null person, 
whereas, in contrast, Fowke et al (2003) found that the urinary ITC level was higher in the 
GSTTl-null person. A study conducted in Central and Western Europe showed that cruciferous 
vegetable consumption had an inverse association with kidney cancer risk and this association 
could be modified by GSTTl and GSTMl/Tl genotypes. However GSTTl and GSTMl/Tl 
genotypes did not have any effect in medium and high consumption of cruciferous vegetables 
(Moore et al. 2007).
1.3.2 Studies in animals models
Numerous studies have been carried out to evaluate the effect of cruciferous vegetables against 
the carcinogenicity/genotoxicity of chemicals. For example, Brussels sprouts showed an ability to 
reduce the DNA damage induced by 2-nitropropane and heterocyclic amines in rats (Deng et al. 
1998; Humblot et al. 2004). Garden cress {Lepidium sativum', 0.8 ml/rat) inhibited the IQ-induced 
genotoxic and preneoplastic lesion in rat colon (Kassie et al. 2002). This effect correlated with the 
induction of hepatic UDP-glucuronosyltransferase (UGT) activity, which is a detoxification 
enzyme in the metabolism of heterocyclic amines. Further studies carried out by the same group 
demonstrated that garden cress (0.25-2.0 pl/ml) and water cress juices (0.25-2.0 pl/ml) decreased 
benzo[a]pyrene-induced DNA damage in HepG2 cells (Kassie et al. 2003).
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The prevention of cancer by isothiocyanates in animals was first reported by Lopez and Mazzanti 
(1955) who studied the a-naphthyl-ITC-induced bile-duct hyperplasia. They observed no liver 
cancer presented in the treated rats. Later, Sasaki (1963) and Sidransky et al. (1966) demonstrated 
the inhibitory effects of a-naphthyl-ITC on liver cancer induced by various regimens. After these 
early observations, different ITCs, such as BITC, PEITC, and sulforaphane etc., were tested for 
chemopreventive activity in various organs in laboratoiy animals.
1.3.2.1 Benzyl isothiocyanate (BITC)
The effect of BITC on tumorigenesis depends on species, target organ and time of administration. 
In mice, it was reported that BITC inhibited lung tumour incidence in A/J mice when given 15 
minutes prior to benzo[a]pyrene administration (Wattengberg, 1987). BITC also decreased lung 
tumour multiplicity in mice by approximately 50% when given by gavage 15 minutes before 
giving benzo[a]pyrene (Lin et al. 1993). When tested with other PAH compounds, 5- 
methylchrysene and dibenzo[a,h]anthracene, BITC (6.7 and 13.4 pmol/rat) decreased lung tumour 
multiplicity but not tumour incidence in mice (Hecht et al. 2002). The effect of BITC on 
tumorigenesis and multiplicity in other organs in mice was also studied. Wattemberg (1987) 
reported that administration of BITC orally 15 minutes before intubation with N- 
nitrosodiethylamine reduced both the incidence of forestomach tumorgenicity and number of 
tumours per mouse; more importantly, the incidence of carcinoma was completely abolished. 
However, BITC (6.7 and 13.4 pmol/rat) had no effect on lung tumorigenesis induced by N- 
nitrosodiethylamine, and to forestomach tumorigenesis induced by benzo[a]pyrene (Hecht et al. 
2002).
The effect of BITC on chemical carcinogenesis has also been studied in rats. In 1981, Wattenberg 
demonstrated that BITC inhibited DMBA-induced mammary tumour formation in female 
Sprague-Dawley rats; it reduced incidence by 37% and multiplicity by 59%. Pre-treatment of
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F344 rats with BITC (70 mg/kg) for three consecutive days was also reported to cause a marked 
reduction in heterocyclic amine-induced DNA damage in colon and liver cells (Kassie et al. 
2002). However, the same workers noted that BITC (0.6 pM) showed an unexpected synergistic 
effect with benzo[a]pyrene inducing DNA damage (Kassie et al. 2003), although BITC itself did 
not cause DNA damage.
In a study conducted on male Syrian hamsters, animals were given a single dose of A-nitrosobis 
(2-oxopropyl)amine (BOP) by subcutaneous injection and maintained diets supplemented with 80 
ppm BITC, 80 ppm SFN or 10 ppm resveratrol during the initiation or post-initiation stage. It was 
noted that the multiplicity of combined pancreatic lesions, including atypical hyperplasia and 
adenocarcinomas, was significantly decreased by BITC and SFN when given to the animals 
during the initiation period but not during the post-initiation period (Kuroiwa et al. 2006). The 
authors suggested that the chemopreventive effects of ITCs are primarily associated with 
inhibition of the metabolic activation of carcinogens by CYP450s, coupled with strong Phase II 
detoxification and cellular defensive enzymes regulated by the transcriptional factor Nrf2.
1.3.2.2 Phenethyl isothiocyanate (PEITC)
The effect PEITC on carcinogenesis was demonstrated by Ketch et al. (2000) in mice. They 
reported that PEITC was an effective inhibitor of lung tumour multiplicity induced by NNK and a 
mixture of NNK and benzo[a]pyrene. However, PEITC (6 pmol/g diet) had no effect on lung 
tumour multiplicity induced by benzo[a]pyrene alone. The same authors studied the effect of 
PEITC plus BITC (3 and 1 pmol/g diet respectively) on tumour multiplicity in the same 
experimental model. They noted that the mixture of these ITCs significantly decreased lung 
tumour multiplicity when given 2 hours prior to gavage with benzo[a]pyrene plus NNK by 37% 
and 29%. Moreover, diets containing PEITC or PEITC plus BITC significantly inhibited lung 
tumour multiplicity. The diet containing BITC alone had no effect on lung tumour multiplicity.
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Boysen et al. (2003) observed a reduction in Hb and pulmonary DNA adducts in rats treated with 
benzo[a]pyrene in the diet and NNK in drinking water, and either PEITC (3 pmol/g diet) or a 
mixture of PEITC and BITC (3 and 1 pmol/g diet, respectively) in the diet. However, the 
reduction was not observed when BITC was administered alone. This observation was consistent 
with the previous studies conducted in mice (Hetch et al. 2000; Sticha et al. 2002). Furthermore, 
this inhibitory effect was evident only in DNA adducts in the lung but not in the liver which is 
consistent with a previous study that showed that chronic treatment of rats with PEITC inhibited 
pulmonary but not hepatic metabolic activation of NNK (Staretz et al. 1997).
Plate et al. (2006) treated groups of rats with five different diets; control, diets supplemented with 
PEITC (3.37 and 0.67 mmol/kg), and diets supplemented with indole-3-carbinol (6.8 and 1.36 
mmol/kg). Diets were fed for 2 weeks before, and 10 weeks after administration of the colon 
carcinogen azoxymethane. Only animals fed with indole-3-carbinol, both at low and high dose, 
showed a significant decrease in aberrant crypt foci (ACE), an early marker of colon cancer. 
There was no effect of PEITC on ACF, mucosal apoptosis, cell proliferation and CYP2E1 enzyme 
activity compared to control animals.
The effect of PEITC on NMBA-induced carcinogenesis in rat oesophagus was studied by Keen et 
al. (2007) who fed rats with diets containing PEITC (5 pmol) for 3 weeks prior to administration 
of 3 consecutive subcutaneous injection of NMBA. NMBA-treated rats developed epithelial 
hyperplasia and dysplasia, while rats fed with PEITC prior to treatment with NMBA did not 
displayed any abnormal lesion.
13.2.3 Sulforaphane
Sulforaphane was reported to inhibit malignant progression of lung adenomas induced by NNK 
and benzo[a]pyrene in A/J mice. Histopathological examination of tumours demonstrated a
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significant reduction in the malignant lung tumour multiplicity in animals that received 
sulforaphane (Conaway et al. 2005). Finally, Zhang et al. (1994) repeated that in rats, 
sulforaphane administered orally 3 hr before receiving a single dose of DMBA reduced 
significantly both incidence and multiplicity of mammary tumours.
1.4 Mechanisms of the chemopreventive effects of ITCs
Mechanistically, chemopreventive agents have been classified as either “blocking” agents or 
“suppressing” agents. Blocking agents act at the initiation stage of carcinogenesis through their 
influence on the metabolism of carcinogens leading to reduced damage to cellular DNA, by either 
inhibiting cytochrome P450 (CYP450) activities or promoting detoxification of procarcinogens. 
Suppressing agents act on the promotion/progression stage of carcinogenesis by influencing cell 
proliferation rates, apoptosis, differentiation, angiogenesis, tissue invasion, etc.
1.4.1 Influence o f  ITCs on CYP450 enzymes
Mammalian CYP450 monooxygenases comprise a superfamily of membrane-bound haem 
proteins, which catalyse the metabolism of a wide variety of endogenous and exogenous 
compounds, including drugs, steroids, and carcinogens. CYP450 is able to incorporate one of two 
atoms of an O2 molecule into a broad variety of substrates with concomitant reduction of the other 
oxygen atom by two electrons to produce H2O. CYP450 catalysed reaction can either lead to 
detoxification pathway or produce reactive intermediates. For example, polycyclic aromatic 
amines, a class of environmental carcinogens, are metabolised by CYP450 to form epoxides 
which are further metabolised by either epoxide hydrolase or GST. Epoxide hydrolase will 
convert epoxides to /ran^-dihydrodiols which may be oxidised by the CYPl family to 
dihydrodiol-epoxides, the ultimate carcinogens, while GST will catalyse the conjugation of 
epoxides with reduced glutathione, which are eventually excreted as mercapturate (loannides and 
Parke 1990). Because CYP450 is responsible for the activation of most carcinogens, inhibition of
14
Chapter 1: Introduction
CYP450 activities would result in decreased reactive carcinogen formation; whereas, increased 
CYP450 activities could either increase risk of DNA adduct formation or enhance detoxication.
ITCs have been shown to modulate CYP450 enzyme activities. A study of structure activity 
relationships in vitro showed that an increase in the alkyl chain length of arylalkyl isothiocyanates 
up to six carbons increased the potency of PROD and EROD inhibition. At longer alkyl chain 
length (8-10 carbons), the inhibitory potency declined (Conaway et al. 1996). Moreno and co­
workers (1999) suggested that BITC was acting as a mechanism-based inactivator of CYP2E1. 
They demonstrated that BITC inhibited 7-ethoxy-4-(trifluoromethyl)coumarin O-deethylation (7- 
EFC) in a time- and dose-dependent, manner and required NADPH. They also observed that the 
significant loss of the activity was not correlated with the minimal loss of CO-binding CYP450, 
which suggested that inactivation occurred primarily due to a modification of apoprotein rather 
than haem. A similar phenomenon has been observed with other CYP450 enzymes; PROD, 
EROD, 2A6-mediated nicotine metabolism, or CYP2A13-mediated NNK metabolism (Goosen et 
al. 2000; Goosen et al. 2001; von Weymam et al. 2006).
The requirement of NADPH indicates that intermediate metabolites of BITC and PEITC were 
responsible for CYP450 inactivation. As already discussed, minimal loss of haem indicated that 
the inactivation occurred as a result of the modulation of CYP450 apoprotein by the reactive 
intermediates. This inference was supported by the separation of CYP2B1 by SDS-PAGE 
electrophoresis followed by autoradiography; in the absence of NADPH, radiolabeled BITC 
bound to all proteins in the reconstituted system and this non specific labelling of protein did not 
cause in any loss of catalytic activity. However, if the sample was incubated with both BITC and 
NADPH, an increase in the radiolabel attached to the CYP450 band was observed (Goosen et al. 
2001). A similar phenomenon was reported by Moreno and co-workers (2001) using BITC and 
CYP2E1.
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In an attempt to identify the nature of the reactive intermediates involved in enzyme inactivation, 
the reactive metabolites were analysed using HPLC and LC/MS (Goosen et al. 2000; Goosen et 
al. 2001; Moreno et al. 2001; von Weymam et al. 2006). Goosen and co-workers (2001) proposed 
a reaction scheme for the metabolism of BITC by purified CYP2B1 Two possible metabolic 
pathways have been noted; one leading to the formation of benzaldehyde and benzoic acid and the 
other leading to the formation of benzylamine and a benzyl isocyanate reactive intermediate 
(Figure 1.3). It is further believed that benzyl isocyanate will form a covalent bond with P450 
apoprotein. This was confirmed by Moreno and co-workers (2001) who studied the inactivation of 
CYP2E1 by BITC, the m/z of BITC- inactivated CYP2E1 protein increased by an average 155 
mass units compared to control sample incubated with BITC in the absence of NADPH. This 
mass difference is consistent with the formulation of a benzyl isocyanate-derived protein adduct 
plus one oxygen atom (134 +16 mass unit) (Moreno et al. 2001). A similar observation was 
reported by Von Weymanr and co-workers (2006) who studied the effects of BITC and PEITC on 
CYP2A6 and CYP2A13 activities.
The inhibition potencies of human CYP450 enzymes by PEITC were investigated using 
microsomes from baculovims-infected insect cells expressing human CYPs (Nakajima et al. 
2001). They demonstrated that PEITC functions as an inhibitor of human CYP1A2, 2A6, 2B6, 
2C9, 2C19, 2D6, 2E1 and 3A4. The effect of ITCs towards EROD and MROD in human 
hepatocytes was studied using sulforaphane. The inhibition was shown to be dose-dependent 
manner and was reversible (Maheo et ah, 1997)
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Figure 1.3 Proposed reaction scheme for the formation of the BITC reactive intermediate 
catalysed by P450 2B1 (Goosen et al. 2001).
The effects of isothiocyanates on CYP450 activities in vivo remain controversial. The 
administration of isothiocyanates to rodents has been reported to either increase or decrease 
CYP450 content and activities. The effect appeared to depend on the experimental conditions, 
type and dose of isothiocyanate, and target organ tissue (Zhang and Talalay 1994). Feeding rats 
with BITC did not cause any change in hepatic MROD activity (Kassie et al. 2002). Yoxall and 
co-workers (2005) studied the effect of sulforaphane at dietary levels of intake, on rat hepatic 
CYP450. They observed that sulforaphane treatment increased CYP1A2 levels, determined 
immunologically, but the dealkylations of ethoxy- and methoxyresorufin were not similarly 
increased. An in vitro study was conducted by the same authors in order to clarify the underlining 
mechanism. Sulforaphane inhibited the 0-dealkylation of ethoxy- and methoxyresorufin in liver
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microsome obtained from y5-naphthoflavone-induced rats and the inhibition was enhanced in the 
presence of NADPH. This indicated that sulforaphane forms a reactive intermediate that 
inactivates CYP450 (Yoxall et al. 2005). Administration of PEITC to male F344 rats 24 hours 
before being killed, caused a suppression of CYP2E1 activity, but, on the other hand, induced 
CYP 2B1 activity (Ishizaki et al. 1990). Smith et al. (1993) reported that feeding mice with diets 
containing PEITC increased hepatic PROD and EROD activities. These authors also determined 
immunologically CYP2B1 levels in the liver and lung. They reported the CYP2B1 level in the 
liver increased which is in agreement with the activity. However, the level of CYP2B1 in the lung 
was slightly decreased. Unfortunately, they could not measure lung PROD activity due to the 
insufficient availability of lung microsomes. Finally, Reen and co-workers (2007) studied the 
effect of PEITC on early molecular events in NMBA-induced carcinogenesis. They reported that 
CYP2A2 and CYP3A13 were up-regulated by 2-fold in the rat oesophagus after treatment with 
subcutaneous injections of NMBA, which was suppressed by treatment with PEITC.
1.4.2 Modulation o f  Phase II  enzymes by ITCs
Phase II metabolism involves enzymes such as glutathione ^'-transferase, NADPH : quinone 
oxidoreductase, uridine diphosphate-glucuronosyl transferase, sulfotransferase and epoxide 
hydrolase, they catalyse reactions that generally lead to a water-soluble product which can be 
excreted from the body. Induction of Phase II enzyme will therefore increase excretion of 
mutagen/carcinogen. Sources of ITCs such as brassica vegetables, garden cress, water cress and 
mustard have been reported to induce Phase II enzymes activities in experimental animals (Kassie 
et al. 2002; Kassie et al. 2003; Lhoste et al. 2004). This section will review the effects of 
isothiocyanates on Phase II enzymes activities. (Kassie et al. 2003; Kassie et al. 2002)
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1.4.2.1 Glutathione S-transferase (GST)
Glutathione ^'-transferase is a Phase II enzyme that catalyses the conjugation of glutathione to 
form hydrophilic compound. It is found in the cytosol of liver, kidney, gut and other organs. ITCs 
have been reported to be good substrates for the GST enzyme system. Among the four classes of 
GST enzymes (a, p, %, and 0), GSTPl-1 and GSTMl-1 were the most efficient catalysts while 
GSTAl-1 was less efficient and GATM2-2 was the least efficient (Zhang et al. 1995). GST is 
very important enzyme in ITC metabolism because ITC will accumulate in glutathione conjugates 
and the levels of isothiocyanates accumulation in Hepa lc lc7  cell were correlated with the Phase 
II enzyme induction potency of the compound (Zhang and Talalay 1998).
Munday and Munday (2004) reported that isothiocyanates such as AITC, sulforaphane enhanced 
GST and NQOl activities in various organs, for example forestomach, duodenum, and urinary 
bladder. In contrast, there was no significant change in these activities observed in liver, heart, 
jejunum, ileum, caecum and colon of rats, thus demonstrating that the effects of ITCs on these 
enzymes are tissue-specific.
1.4.2.2 NADPH: Quinone reductase (NQOl)
NADPH : quinone reductase is a two-electron reductase that leads to deactivation of quinones. 
NQOl is characterised by its capacity for utilising either NADH or NADPH as reducing cofactors 
and its potent inhibition by dicoumarol. NQOl activity can be induced by a wide range of 
chemicals including polycyclic aromatic hydrocarbons, azo dyes etc (Huggins and Fukunishi 
1964; Prochaska and Talalay 1988). The antioxidant response element (ARE) and xenobiotic 
response element (XRE) have been shown to mediate NQOl induction as well as repression in 
many cellular systems (Favreau and Pickett 1995; Nguyen et al. 2003).
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The induction potency of this enzyme by isothiocyanate was correlated with intracellular 
glutathione levels. Misiewicz and colleagues (2004) noted that sulforaphane increased 
intracellular glutathione levels and NQOl activity in human lymphoblastoid cells in a dose- 
dependent manner.
1.4.2.3 UDP-glucuronosyltransferase (UGT)
The UGT protein family is widely distributed in human hepatic and extrahepatic tissues. This 
enzyme contributes to the elimination of xenobiotic compounds by catalysing the conjugation of 
glucuronic acid to acceptor compounds in order to convert them into highly water-soluble 
compounds (Gibson and Skett 2001).
UGT was reported to be induced via the activation of ARE. Treatment of Caco-2 cells with 
sulforaphane for 24 hours caused a dose-dependent induction of UGTlAl mRNA (Svehlikova et 
al. 2004). Immunoblot analysis of protein extracts from Caco-2 cells after treatment of 
sulforaphane confirmed the dose-dependent induction of UGTlAl (Svehlikova et al. 2004). The 
effect of BITC on UGT activity was studied by Kassie et al (2002) who reported that the dose that 
significantly reduced IQ-induced DNA damage also caused an increased in UGT-2 activity which 
however was not statistically significant.
1.4.3 Role o f ITCs in apoptosis and cell cycle arrest
Apart from modulation of carcinogen metabolism, some recent studies suggested that the 
chemopreventive activity of ITCs involves other mechanisms such as induction of cell cycle arrest 
and apoptosis. Cell cycle arrest is a process occurring when DNA damage takes place. If the DNA 
damage is severe beyond repair, apoptosis will be initiated instead of cell cycle arrest. Apoptosis 
is a programmed cell death in multicellular organisms and involves a series of biochemical events. 
Unlike necrosis, which responds to toxin or cellular injury, apoptosis is more involved in cellular
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homeostatic, organ development and cellular damage (Elmore 2007). Excessive apoptosis can 
cause hypotrophy, whereas insufficient functioning results in uncontrolled cell proliferation, such 
as cancer. Apoptosis could be triggered by either extrinsic factors which activate death receptor at 
the cell surface, or the intrinsic factor which increases mitochondrial permeability and cytochrome 
c release. ITC have been shown to induce cell cycle arrest and/or apoptosis in several cell lines for 
example; human colon carcinoma cells (HT29), Jurkat human T-cell leukemia cells, Capan-2 
human pancreatic cancer cells (Gamet-Payrastre et al. 2000; Miyoshi et al. 2004; Zhang et al. 
2006). Effect of ITC on cell cycle arrest and/or apoptosis depends on ITC concentration and cell 
types used. Sulforaphane was found to induce Gq/Gi arrest in FHA-stimulated human 
lymphocytes (Pamaud et al. 2004) and G2/M arrest in the HT29 cell line (Gamet-Payrastre et al. 
2000). BITC was reported to induce G2/M arrest in Jurkat cells and Capan-2 human pancreatic 
cancer cells (Miyoshi et al. 2004; Zhang et al. 2006). Several pathways involved in ITC triggered 
cell cycle arrest and apoptosis have been reported, such as the JNK-dependent pathway in Jurkat 
T-cells (Chen et al. 1998), a p53-dependent pathway found in JB6 epidermal cells (Huang et al. 
1998), a cytochrome c-dependent pathway found in HT29 colon cancer cells (Gamet-Payrastre et 
al. 2000) and a mitochondria cell death pathway in rat liver epithelial cells (Nakamura et al. 
2002).
1.5 Adverse effects of ITCs
Apart fi*om their chemopreventive effects, ITCs were also reported to be able to cause 
genotoxicity in bacterial and mammalian cells. Induction of histidine revertants in bacterial gene 
mutation assay was reported with a number of ITCs (Yamaguchi 1980). Kassie et al (1999a) 
reported that BITC caused a moderate but dose-dependent mutagenic effect in the Ames test using 
TA98 and TAIOO. Exposure to higher doses, however, caused a decline in the mutant frequencies 
in both bacteria strain as a result of toxicity. They also demonstrated that low concentration of 
BITC (1-4 pg/ml) caused a dose-dependent induction in the micronucleus assay with human-
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derived hepatoma. In vivo studies also indicated that high doses of BITC (220 mg/kg) can cause a 
change in the pattern of DNA migration in gastric and colon mucosa (Kassie et al. 1999a).
As far as carcinogenicity is concerned, allyl ITC was reported to induce bladder tumours in rats 
(LARC 1985). Interestingly, BITC demonstrated both chemopreventive and enhancing effects in 
urinary bladder carcinogenesis induced by iV-butyl-A-(4-hydroxybutyl)nitrosamine in rats 
(Okazaki et al. 2003; Okazaki et al. 2002). Similarly, continuous treatment with 0.1% PEITC for 
32 weeks in rat caused urinary bladder carcinoma (Satoshi et al. 2003).
1.6 2-Ammo-3-methylimidazo [4,5-y] quinoline (IQ)
To study the effects of ITCs on carcinogen metabolism, 2-amino-3-methylimidazo[4,5-/lquinoline 
(IQ) was used as the model carcinogen. It is a member of the heterocyclic aromatic amines (HA), 
which are formed in meat/fish cooked at temperatures between 100 to 300°C (thermic HA). IQ 
was first isolated and identified by Kasai et al. (1980), and is classified by the International 
Agency for Research on Cancer (lARC 1993) as probable human carcinogen (Group 2A). It has 
been shown to induce hepatocarcinomas in non-human primates (Adamson et al. 1994) and 
tumours at multiple sites in rodents (Kato et al. 1989; Ohgaki et al. 1986; Takayama et al. 1984).
IQ is generated from creatine, hexose, and amino acid through the Maillard reaction and Strecker 
degradation upon heating. The formation of IQ primarily depends on cooking time, temperature, 
cooking method, pH value and type of meats (Ahn and Grun 2005a).
1.6.1 Pharmacokinetic behaviour o f IQ
The pharmacokinetic characteristics of IQ in rodents were studied using radiolabeled IQ. After 
ingestion, IQ is absorbed rapidly from the small intestine, then metabolised and excreted within
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three days. In rats, 36-49% and 46-68% of the dose was recovered in the urine and faeces, 
respectively (Sjodin and Jagerstad 1984; Kestell et al. 1999).
1.6.2 Metabolism o f  IQ
IQ requires metabolic activation to generate reactive intermediates that form DNA adducts. The 
metabolism of IQ involves CYP450 as well as phase II pathways in both activation and 
detoxification. The principal pathways of IQ metabolism are shown in Figure 1.4. Oxidation of 
the exocyclic amine group to form the A-hydroxy derivative is a reaction mainly catalysed by 
CYP1A2, and is believed to be the initial step in IQ bioactivation (Kato 1986). The A-hydroxy 
derivatives are then further activated by 0-acetylation or 0-sulfonylation to form the highly 
reactive A-acetoxy or A-sulfonyloxy esters which break down spontaneously to form the 
nitrenium ion, the ultimate carcinogen that interacts with DNA initiating the neoplastic process 
(loannides and Lewis 2004; Turesky et al. 2005). The detoxification pathways of IQ in rodents 
involves direct conjugation of the exocyclic amine group, with sulphate through sulfotransferases 
(SULTs), or glucuronic acid through UDP-glucuronosyltransferases (UGT). Another mechanism 
for detoxification is ring oxidation of IQ, which is catalysed by CYP450 followed by sulphation 
or glucuronidation (Figure 1.4) (Alexander et al. 1989; Luks et al. 1989; Turesky et al. 1998).
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CYP 1A2/1A1/1B1 
NIK----------------- ► iV-hydroxy-IQ (DNA adducts)
N *^ril3 sulfamate
^ Ring hydroxylation , , 5-0-sulfate and
' " f
CYPl A1/2? At the 5 position 5-0-glucuronide
Figure 1.4 Principal pathway of IQ metabolism in animal models and humans (Dashwood 
and Xu 2003).
1.7 Precision-cut liver slices
Liver slices as an in vitro model have, been used in scienctific research since 1923. At that time 
liver slices were prepared using hand-held equipment known as Stadie-Riggs microtome (Lerche- 
Langrand and Toutain 2000). In 1980, Krumdieck introduced an automatic tissue sheer capable of 
producing relatively viable thin slices of consistent thickness, which are referred to as precision- 
cut tissue slices
Tissue slices are now accepted as a reliable alternative to cell cultures or in vivo studies. It 
provides advantages of conservation of tissue architecture and cell to cell communication. Many 
developmental studies have been undertaken in order to improve slice survival in culture media 
and maintain metabolism and function (Drahushuk et al. 1996; Fisher et al. 1995; Hashemi et al. 
1999a), for example slice thickness. The optimal thickness in the case of liver is 250-300 pm 
which allows rapid nutrient and gas infusion (Smith et al. 1985). Incubation conditions are also 
important for maintaining slice viability. Hashemi et al. (1999a) compared two incubation 
systems, normally dynamic organ culture and the multiwell system for viability and 
morphological structure by evaluating their ability to metabolise 7-ethoxycourmarin. No marked 
differences were observed but liver slices that were incubated using the multiwell system
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remained viable for longer period of time. The liver slice model has been employed in metabolism 
and toxicity studies by many laboratories. Activity of CYP450 and Phase II enzymes in precision- 
cut liver slices have been assessed in rodent and human tissue (Hashemi et al. 1999b, 2000; 
Olinga et al. 1998; Rekka et al. 2002; Wauthier et al. 2004). Both cytochrome P450 and Phase II 
enzymes activities, mRNA, and protein expression (as measured by Western blot or ELISA) have 
been shown to be inducible by exposure to either Aroclor 1254, y^-naphthoflavone, 
benzo[a]pyrene or TCDD (Drahushuk et al. 1996; Lupp et al. 2001; Pushparajah et al. 2008; 
Pushparajah et al. 2007). Although the tissue slices system can not replace completely the in vivo 
study, it has many practical advantages over in vivo model. It requires less test chemical to 
conduct more effective dose-response relationships, and moreover, it reduces the number of 
animals used.
1.8 Objectives of current project
• Investigate the effect of BITC on CYP450 and Phase II enzyme activities in precision- 
cut rat liver slices.
• Investigate the effect of oral intake of low dose of BITC on CYP450 and Phase II 
enzyme activities in the liver and lung of rats.
• Develop and validate an SPE/LC/MS method to identify the metabolite profile of 2- 
amino-3-methylimidazo[4.5-/jquinoline (IQ) in culture media and in the urine of rat 
treated with the IQ.
• Evaluate whether BITC modulates the metabolism of IQ by precision-cut liver slices.
• Establish whether the oral intake of ITCs modulates the metabolic profile of IQ in the 
urine of rat.
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• Determine whether BITC modulates the excretion of mutagen in the urine of rats 
treated with IQ.
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2.1 Materials
Abeam, Cambridge, UK:
Rat anti-CYP 3A antibody; rat anti-quinone reductase antibody
Alpha diagnostic, Wiltshire, UK:
Rat anti-glutathione-5'-transferase a antibody; rat anti-glutathione-^-transferase n 
antibody; rat anti-glutathione-5-transferase p antibody
Becton, Dickinson and Company, Cambridge, UK:
Rat anti-CYP 2B1 antibody
Biodesign, Main, USA:
Rat anti-CYP lA l antibody; rat anti-CYP 1A2 antibody
BioRad, Hemel Hamstead, UK:
Acrylamide (40%), bis-acrylamide, Bio-Rad dye reagent
GE Healthcare, Amersham, UK:
Hybond ECL nitrocellulose membrane; ECL kit for western blot immunodetection; mini 
camera
Gibco®-Invitrogen, Paisley, UK:
Earle’s balance salt solution (EBSS); foetal calf serum, gentamycin; R PM I1640 
Helena Bioscience, Sunderland, UK:
12 well plates 
Milford Laboratories Ltd. Ipswich, Suffolk UK:
Reduced nicotinamide adenine dinucleotide phosphate (NADPH); NADP 
Molecular probes Invitrogen, Paisley, UK:
Methoxyresorufin
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Oxford Biomedical Research, Oxford, USA:
Rat anti-glutathione-iS-transferase Ya antibody 
Phenomenex, Cheshire, UK:
Synergi Hydro reverse-phase CIS column (150 x 2.1 mm, 4|um,), Gemini Phenyl C6 
(150 X 2.1 mm, 4pm,); strata SPE cartridge, strata SCX SPE cartridge.
Roche Applied Science, West Sussex, UK:
Cytotoxicity detection Kit^^^^
Sigma-Aldrich Company Ltd., Dorset, UK:
1-chloro-2,4-dinitrobenzene (CDNB); l,2-dichloro-4-nitrobenzene (DCNB); 7 
ethoxycoumarin; 7-ethoxyresorufin; 7-hydroxycoumarin; p-naphthoflavone; acetonitrile; 
ammonium acetate; anti rabbit and anti goat secondaiy antibody; bovine serum albumin; 
EDTA; methanol; propan-l-ol; acetic acid; hydrochloric acid; benzyl isothiocyanate; 
pyronin Y; sodium dodecyl sulphate solution (SDS); sulphatase; p-glucuronidase; tris 
base; N,N,N’,N \-  tetramethylethylenediamine; resorufin; hydrocortisone 21- 
hemisuccinate, D-glucose; glucose-6-phosphate
Toronto Research Chemical Ltd., Toronto, Canada:
2-amino,3 -methylimidazo[4,5-/|quinoline; 2-amino-3-(trideuteromethyl)-3H 
imidazol [4,5 -f] -quinoline (IQ)
Waters, Maschester, UK,
Oasis® HLB SPE cartridge 
Dr Michael Arand (University of Zurich, Switzerland) generously gave:
Rat anti epoxide hydrolase primary antibody /
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2.2 Methods
2.2.1 Rodent Husbandry
Male Wistar albino rats (200-250 g) were obtained from Bantin and Kingman Universal Limited 
(Hull, UK). Animals were housed at 22±2 °C, 30-40% relative humidity in an alternating 12 
hours light/dark cycle with light onset at 7.00 am. Rats were allowed to acclimatise for at least 24 
hours before being used. Animals were caged with a minimum of two and a maximum of four 
rats per cage. Water and diet (dry pellet, Bantin and Kingman Universal limited) were provided 
ad libitum. Animals were taken care of by EBU staff. All procedures with animal, such as 
gavaging or intraperitoneal injection, were also carried out by EBU staff.
2.2.2 Liver slice preparation
Rats were sacrificed by cervical dislocation. Livers were immediately removed and placed in 
cold oxygenated EBSS solution containing 25 mM D-glucose, to provide enough energy. Tissue 
cylinders were prepared using an 8 mm diameter tissue coring tool. From the cylinder, 250 pm 
thick liver slices, were produced using a Krumdieck tissue sheer (Alabama Research and 
development Corp., Munford, AL, USA; Figure 2.1). Liver slices were transferred to 12 well 
plastic tissue culture plates in 1.5 ml. of 37°C, fresh RPMI media containing 5% foetal calf 
serum, 0.5 mM L-methionine, IpM insulin, 0.1 mM hydrocortisone-21 -hemisuccinate (H-21-H), 
and 50 pg/ml gentamycin. The plates were placed on a gyratory shaker operated at 90 rpm in a 
37“C, 95% oxygen, 5% carbon dioxide incubator. After initial pre-incubation for 30 minutes, 
liver slices were transferred to the warm, fresh RPMI media containing either dimethyl 
sulphoxide, the vehicle, or the test compound for the desired period of time. This procedure for 
generating liver slices is illustrated in Figure 2.2.
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Figure 2.1 The Krumdieck tissue sheer
2.2.3 Preparation o f subcellular fractions
At the end of incubation period, slices were washed with 0.154M KCl buffer (0.154 M) 
containing Tris-HCl buffer (50 mM; pH 7.4). Slices were then homogenised in the same buffer, 
unless otherwise stated. Homogenates were centrifuged at 9000 x g (10,500 rpm) for 20 minutes 
to remove nuclei, mitochondria etc. The supernatant (S9) was then stored at -80°C until used. To 
obtain microsomal and cytosolic fractions, S9 was thawed on ice and centrifuged at 105,000 x g 
(45,000 rpm) for 45 minutes. The supernatant (cytosolic fraction) was kept at -80°C prior to use 
for determination of Phase II enzyme activity. The microsomal pellet was resuspended in an 
equal volume of buffer and used on the same day for determination of cytochrome P450 
activities.
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Rat liver immersed in ice-cold oxygenated 
EBSS solution.
I! 7
Tissue cylinder prepared using an 8 mm 
diameter tissue-coring tool.
From the cylinder, 250 pm thick liver slices are 
produced using a Krumdieck tissue slicer (Olinga 
1998).
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(Continued)
Liver slices transferred to a 12 well plastic 
tissue culture plate containing 1.5 ml of 
fresh RPMI media at 37°C.
Finally, plates are placed on a gyratory 
shaker which operates at 90 rph at 37°C in 
95% oxygen, 5% carbon dioxide incubator.
Figure 2.2 Schematic representation of the slicing technique.
2.2.4 Protein Determination
Protein was determined by using the Bio-Rad® protein reagent procedure, which is based on the 
dye binding method of Bradford (1976). In this colorimetric assay, a chemical reaction occurs 
between the copper-phenol reagent and tyrosine and tryptophan residues in the protein.
Standard solutions (0-500 pg/ml) were prepared by dilution with sodium hydroxide (0.5 M). 
Hepatic microsomal fractions were diluted 1 in 80 whereas lung microsomal fractions were 
diluted 1 in 50. Finally, microsomal fractions obtained from liver slices (10 slices) were diluted 1
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in 25. Cytosolic fractions from livers and lungs were diluted 1 in 100, whereas cytosolic fractions 
from liver slices (10 slices) were diluted 1 in 50.
In a 96-well plate, aliquots of standard or sample (10 pi) were mixed with 200 pi of BioRad 
reagent dye (diluted 1 to 5 with distilled water). The plate was left for 5 minutes for colour 
development. An ELISA reader was used to measure the absorbance of the sample at 495 nm. All 
samples were analysed in triplicate.
2.2.5 7-Ethoxycoumarin metabolism
The metabolism of 7-ethoxycoumarin allows the simultaneous determination of the metabolic 
viability of both CYP450 and Phase II enzyme in slices incubated for different time periods. 7- 
ethoxycoumarin is initially deethylated by CYP450 to 7-hydroxycoumarin which is subsequently 
conjugated with glucuronide and sulphate by phase II enzyme activities (Steensma et al, 1994). 
This reaction allows the facile determination of the xenobiotic-metabolising enzymes, both Phase 
I and Phase II, following incubation with tissue slices. Metabolism of 7-ethoxycourmarin by liver 
slices was determined as described by Hashemi et al (1999)
Media containing 7-ethoxycoumarin (50 pM) were prepared by using stock 7-ethoxycoumarin in 
DMSO. To prevent toxicity to slices, the final volume of DMSO added to the culture media did 
not exceed 0.5% (v/v). Slices were incubated for various time periods up to 6 hours. Media was 
collected at each time point for extraction and evaluation of the 7-ethoxycoumarin metabolites 
level. Slices were homogenised and total protein content was determined.
To determine the generation of 7-hydroxycoumarin conjugates, aliquots of culture media (200 pi) 
were diluted with sodium acetate (0.5 M; 100 pi) containing either p- glucuronidase (5000 U/ml)
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or sulphatase (250 U/ml) and D-saccharic acid (17 mM). Following incubation, at 37°C for 16 
hours, deconjugated samples were used for measuring 7-hydroxycoumarin.
2.2.5.1 Determination o f free 7-hydroxycoumarin
To determine the free 7-hydroxycoumarin level, an aliquot of culture media (100 pi) was diluted 
with KCl (0.154 M; 900 pi) containing Tris-HCl (50 mM; pH 7.4). Hydrochloric acid (4 M; 250 
pi) was added to each tube. The solutions were extracted with chloroform (6 ml) for about 30 
minutes. The chloroform layer (5 ml.) was extracted with glycine-NaOH buffer (0.5 M pH 10.5; 
6 ml) for a further 30 minutes.
To prepare a standard curve, a stock solution of 7-hydroxycoumarin (1 mM) was prepared and 
diluted with KCl (0.154 M) containing Tris-HCl (50 mM; pH 7.4). A range of standard solutions 
was prepared (0-5 pM) and treated as culture media. All standard and samples were assayed in 
triplicate. Protein was measured in each sample.
Fluorescence of the aqueous phase was determined using a fluorimeter at an excitation 
wavelength of 380 nm and emission wavelength of 452 nm. An excitation and emission slit width 
was set at 5 nm.
2.2.6 Determination of CYP450 activities
2.2.6.1 Determination o f CYPIA and CYP2B activities
The methods employed are principally as described by Burke and Mayer (1974). 
Ethoxyresorufm (EROD), Methoxyresorufm (MROD), and Pentoxyresorufm (PROD) were used 
as a marker for activities of CYPlAl, CYP1A2, and CYP2B1 respectively (Burke et a l, 1994). 
The dealkylation of all the substrates was determined by following production of resorufin.
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The following reagents were added into a cuvette:
Tris -HCl buffer (0. IM, pH 7.8) 1.90 ml
Phase I substrate (EROD, MROD or PROD; 0.53 mM) 0.01 ml
microsomal suspension (25% w/v) * 0.05 ml
* 10 slices were pooled, homogenized, and resuspended. Protein was measured in each sample of 
microsomal suspension.
The reaction was initiated by the addition of NADPH (50 mM in 1% NaHCOg; 0.01 ml) in 1% 
NaHCOs. The increase in fluorescence with time was monitored in a cuvette maintained at 37°C, 
for 1-5 minutes, depending on the activation of the sample. A Perkin-Elmer LS-5 luminescence 
spectrophotometer set at excitation and emission wavelength of 571 and 585 nm respectively, 
with slit width of 5 nm and 5 nm, was used.
A standard curve was produced by adding consecutive aliquots of 0.01 ml of resorufin (10 pM) 
to Tris-HCl buffer (O.IM, pH 7.8; 2ml) in a cuvette.
2.2.6.2 Determination o f CYP3A activity
To determine CYP3A activity, 7-benzyloxyquinoline (7-BQ) was used as a substrate. The 
dealkylation of 7-BQ was determined by following the production of 7-hydroxyquinoline (7-HQ) 
(Stresser 2000).
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The following reagents were added to a cuvette:
Sodium Phosphate buffer (O.IM, pH 7.4) 1.75 ml
Glucose-6 -phosphate (3.3 mM) 0.05 ml
Glucose-6 -phosphate dehydrogenase (0.4 U/ml) 0 .1 0  ml
7-BQ (40 mM) 0 .0 1  ml
Microsomal suspension (25% w/v) * 0 .1 0  ml
* 10 slices were pooled, homogenized, and resuspended. Protein was measured in each sample of 
microsomal suspension.
The reaction was started by adding 0.01 ml of 1.3 mM NADP^. The increase in fluorescence was 
monitored in a cuvette maintained at 37“C for 5 minutes. A Perkin-Elmer LS-5 luminescence 
spectrophotometer set at excitation and emission wavelengths of 410 and 538 nm respectively 
with slit widths of 5 nm, was used.
A standard curve was produced by adding consecutive 0.05 ml amounts of 7-HQ (10 pM) into 2 
ml of sodium phosphate buffer (0.1 M, pH 7.4) in a cuvette
2.2.6.3 Determination o f total CYP450
Characteristic 450 nm absorption maximum of carbon monoxide-bound with reduced cytochrome 
P450 was used to determine total cytochrome P450 in microsomal suspension (Omura 1964).
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The following were added into a test tube to create the reduced form of CYP450:
Sodium phosphate buffer (O.IM, pH 7.0) 2.25 ml
Microsome suspension (25%, w/v) 0.25 ml
Sodium dithionite, solid (fresh) 5-10 mg
The solution was divided into two cuvettes, base line was then obtained between 390-500 nm. 
The test cuvette was bubbled with carbon monoxide for 30 seconds before placing it back into the 
spectrophotometer and a second scan was conducted. The difference in absorbance between 490 
and 450 nm was obtained. Data was presented as the percentage of total CYP450 compared to the 
control CYP450 content. All samples were analysed in triplicate.
2.2.7 Determination of Phase II enzyme activities
2.2.7.1 Determination o f epoxide hydrolase activity
Epoxide hydrolase activity was determined as described by Dansette et al. (1979). The hydrolysis 
of benzo[a]-pyrene 4,5-epoxide to the corresponding dihydrodiol, by the microsomal epoxide 
hydrolase, was measured fluorimetrically.
The following reagents were added to a quartz cuvette:
Tris-HCl buffer (0.015 M, pH8.7, at 37°C) 2.00 ml
Benzo[a]-pyrene 4,5 epoxide in acetonitrile (2 mM) 0.01 ml
Microsomal suspension (25% w/v)* 0.05 ml
* 10 slices were pooled, homogenized, and resuspended. Protein was measured in each sample of 
microsomal suspension.
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The reaction was initiated by the addition of the microsomal suspension. The increase in 
fluorescence over the time was monitored in a cuvette maintained at 37®C, until suitable gradient 
was obtained on the chart recorder (1-2 minutes). A Perkin-Elmer LS-5 luminescence 
spectrophotometer set at excitation and emission wavelength of 310 and 385 nm respectively, 
with slit width of 5.0 nm and 2.5, nm was used.
A standard curve was produced by adding consecutive 2 pi of benzo[a]-pyrene-4,5-fra»j'- 
dihydrodiol (2 mM) into 2 ml of Tris-HCl buffer (0.015 M, pH 8.7).
2.2.7.2 Determination o f Glutathione S-transferase (GST)
Glutathione 5-transferase activity was determined by an adaptation of the method devised by 
Habig (1974). The assay was carried out using 1, 2-dichloro-4-nitrobenzene (DCNB) and 1- 
chloro-2,4-dinitrobenzene (CDNB) as a substrate. 4,chloro-7-nitrobenzofurazan (NBD-Cl) which 
is a selective substrate for the a  class of glutathione S-transferase was also used. The method for 
determining GST using NBD-Cl as a substrate was adapted from that described by Ricci et al 
(1994).
The following reagents were added to a cuvette:
DCNB as substrate
Sodium phosphate buffer pH 7.5 (O.IM) 0.90 ml
DCNB (25 mM in absolute ethanol) 0.05 ml
Reduced glutathione (25 mM) in KCl (0,154 M) 0.25 ml
Cytosolic fraction (25% w/v) * 0.05 ml
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* 10 slices were pooled, homogenized, and centrifuged. Cytosol was collected for further 
analysis. Protein was measured in each sample of cytosolic fraction.
Reaction was initiated by addition of cytosol and the change in spectrum at 345 nm was 
measured using a Kroton spectrophotometer. GST activity was calculated from the initial rate of 
reaction, using the molar extinction coefficient of 8.5 nM'^ cm '\
CDNB as a substrate
Sodium phosphate buffer pH 7.5 (0.1 M) 0.90 ml
CDNB (25 mM in absolute ethanol) 0.05 ml
Reduced glutathione (5 mM) in KCl (0.15 mM) 0.25 ml
Cytosolic fraction (25% w/v) * 0.05 ml
* 10 slices were pooled, homogenized, and centrifuged. Cytosol was collected for further 
analysis. Protein was measured in each sample of cytosolic fraction.
Reaction was initiated by addition of cytosol and the change in spectrum at 340 nm was 
measured using a Kroton spectrophotometer. GST activity was calculated from the initial rate of 
reaction, using the molar extinction coefficient of 9.6 mM'* cm'*.
NBD-Cl as substrate
Sodium phosphate buffer (0.1 M, pH 7.5) 1.22 ml
(containing 5 mM reduced glutathione)
Cytosolic fi-ation (25% w/v) *'** 0.10 ml
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* Cytosol from whole liver was diluted 1:4 with KCl (1.15%); ** 10 slices were pooled,
homogenized, and centrifuged. Cytosol was collected for further analysis. Protein was measured 
in each sample of cytosolic fraction.
Reaction was initiated by addition of NBD-Cl (4 mM in methanol; 0.075 ml) and the change in 
spectrum at 419 nm was measured using a Kroton spectrophotometer. GST activity was 
calculated from the initial rate of reaction, using the molar extinction coefficient of 14.5 mM'* 
cm'*.
2.2.73 Total glutathione
The assay was carried out using an adaptation of the method by Akerboom and Sies (1981). The 
sum of the reduced (GSH) and oxidised (GSSG) glutathione in the cytosolic fraction can be 
determined using an enzyme assay, in which the catalytic amount of GSH or GSSG and 
glutathione reductase bring about the continuous reduction of 5,5’-dithiobis(2-nitrobenzoic acid) 
(DTNB) by NADPH as illustrated in Figure 2.3.
2GSH + DTNB non -  enzymatic GSSG + 2TNB
 ►
GSSG + NADPH + GSSG reductase 2GSH + NADP^
 ►
Figure 2.3 The reactiou of the reduced (GSH) aud oxidised (GSSG) glutathioue iu the 
cytosolic fractiou.
The cytosolic fraction was diluted 1 to 5 with perchloric acid (2M; containing 4 mM EDTA). The 
pH was adjusted to 7.0 by the addition of MOPS (0.3 M; 0.1 ml) in potassium hydroxide (2M). 
Standards containing 0 - 0 . 1  mM oxidised glutathione were treated in the same way as the 
samples.
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The following reagents were added to a cuvette;
Potassium phosphate buffer (O.IM, pH 7.0) 1 .0 ml
containing EDTA (25 mM)
NADPH (4 mg/ml) in NaHCOa (0.1 %) 0.05 ml
Glutathione reductase (6  U/ml) 0.10 ml
Standard/ sample 0.10 ml
The reaction was initiated by adding 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB; 3.8 mM; 0.10 
ml) in 0.1% NaHCOa (0.1%). The rate of formation of 5-thio-2-nitrobenzoate (TNB) was 
detected at 412 nm using a Kroton spectrophotometer.
2.2.7A  Determination o f NADPH: quinone oxidoreductase (NQOl)
The assay was carried out using an adaptation of the method by Prohaska and Santamaria (1988). 
Glucose-6 -phosphate and glucose-6 -phosphate dehydrogenase continually generate NADPH, 
which is used by quinone reductase to transfer electrons to menadione. The menadiol reduces 3- 
(4,5-dimethylthiazo-2-yl)-2-naphthol (MTT) to the blue formazan which can be measured over a 
broad range of wavelengths (550-640) (Figure 2.4).
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G-PHOSPHO- GLUCOSE
GLUCONATE G PHO SPH ATE
DEHYDROGENAS^
NADPH . NADP
REDUCTASE
-----
O  ^ S P O N T A N E O U S ^
REDUCED MTT MTT
(FORMAZAN DYE)
Figure 2.4 Priucipal of the assay of NADPHrquiuoue oxidoreductase (Prochaska and 
Santamaria 1988).
The following reagents were added to a cuvette:
Tris-Tween 20 (0.5 M, pH 7.4) 880 pi
3-(4,5-dimethylthiazenoic acid) (MTT; 100 mM) in ethanol 5 pi
NADPH (50 mM) 5 pi
Cytosol (25% w,v)* 50 pi
* 10 slices were pooled, homogenized, and centrifuged. Cytosol was collected for further 
analysis. Protein was measured in each sample of cytosolic fraction.
The reaction was initiated by adding menadione (10 mM, 5 pi). The reaction was performed at 
610 nm using a Kroton spectrophotometer. NQOl activity was calculated from the initial rate of 
reaction, using the molar extinction coefficient of 11.3 mM'* cm *.
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2.2.8 Determination o f lactate dehydrogenase activity (LDH, Cytotoxicity Detection)
Lactate dehydrogenase activity was determined in an enzymatic test (Decker 1988). In the first 
step NAD^ is reduced to NADH/H^ by the LDH-catalysed conversion of lactate to pyruvate. In 
the second step, 2 hydrogen atoms were transferred from NADH/ET to the tétrazolium salt INT 
(2-[4-iodophenyl]-3-[4-nitrophenyl]-5-phenyltetrazolium) which is reduced to formazan (Figure 
2.5). LDH was measured by using a commercial kit (Roche Diagnostic, Germany) comprising 
catalyst, dye solution and stop solution. An aliquot (50 pi) of culture media or slice homogenate 
were taken and analysed in a microassay using 96-well plate technology.
The foUowing reagents were added to a 96-well plate:
Sample 50 pi
Phosphate buffer (50 mM, pH 7.4) 100 pi
Reaction mixture 50 pi
Following 10 minutes incubation at room temperature, reaction was stopped by adding stop 
solution (25 pi). An ELISA reader was used to determine an absorbance at 492 nm. The results 
are expressed as percentage of total LDH released into the media.
a
tetrazoMmi salt (v^
Figure 2.5 Scheme of LDH assay. In the first step, release lactated dehydrogenase (LDH) 
reduces NAD+ to NADH/H+ by oxidising lactate to pyruvate. In the second step, two hydrogens 
are transferred from NADH/H+ to the red tétrazolium salt INT by catalyst (Decker 1988).
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2.2.9 Western blot analysis
This technique was first described by Towbin et al (1979) and it involves the separation of 
polypeptides on a gel followed by the electrophoretic transfer of the polypeptide onto an 
immobilising nitrocellulose membrane. The membrane is then probed with antisera to identify 
specific polypeptides.
2.2.9.1 Preparation o f SDS-polyacrylamide gels
Western blot equipment that contact with the gel (glass plate and comb) was cleaned by 70% 
ethyl alcohol to eliminate residual grease. Two gels were prepared per kit. The glass sandwiches 
were clipped onto a vertical stand to aid the pouring of gel.
The resolving gel was freshly prepared and consisted of:
Milli Q grade water 5.43 ml
Resolving gel buffer 4.50 ml
Acrylamide 5.62 ml
Bis-acrylamide 2.95 ml
A^AjWW-Tetramethylenediamine (TEMED) 18 pi
Freshly prepared ammonium persulphate solution ( 10% w/v) 180 pi
The resolving gel buffer consisted of Tris-HCl buffer (1.5 M, pH 8 .8) and sodium dodecyl 
sulphate (SDS, 0.4% w/v). The components of the gel were mixed and immediately poured 
between the glass plates to the appropriate height indicated on the equipment. An aliquot of 
MilliQ water was poured on top of the gel to create a smooth surface. Gel was left to solidify at 
room temperature for 30 minutes. Once set, the water was drained off and any excess water
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removed using filter paper. One comb per gel was slotted into the air spaee above the resolving 
gel.
Stacking gel was consisted of:
Milli Q grade water 7.15 ml
Stacking gel buffer 2.50 ml
40% Acrylamide 0.75 ml
Bis-acrylamide 0.40 ml
N,N,N,N-Tetramethylenediamine (TEMED) 10 pi
Freshly prepared ammonium persulphate solution (10%, w/v) 50 pi
The stacking gel buffer consists of Tris-HCl buffer (0.5 M, pH 6 .8) containing SDS (0.4%). The 
stacking gel was mixed and poured on the top of resolving gel until the gel covered the comb. 
The gel was left to solidify at room temperature for at least 30 minutes.
2.2.9.2 Sample preparation and gel loading
Equal volumes of microsome or cytosol from each study group were pooled and protein 
concentrations were determined. Protein was diluted in phosphate buffer saline (PBS; pH 7.5) to 
a final concentration of 1 mg/ml, and was then diluted (1 :1) with freshly prepared loading buffer.
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Loading buffer was kept in a brown bottle following preparation as follows:
Milli Q grade water 4.80 ml
Tris-HCl, (0.5 M, pH 6 .8) 1 .2 0  ml
Glycerol 0.96 ml
SDS (10%, w/v) 1.92 ml
P-Mercaptoethanol 0.48 ml
Pyronin (0.05%, w/v) 0.60 ml
The mixture was heated at 100”C for 5 minute in a heating block. When cool, it was centrifuged 
for 1 minute at 3000 x g.
The gel holder was removed from the stand and attached to the electrode mount which was 
placed into a clean tank filled with running buffer (Tris-HCl buffer (25 mM); glycine (192 mM) 
and 10% w/v SDS).
After carefully removing of the combs from the stacking gel, the protein markers and samples 
were loaded into the wells. The electrophoresis was connected at constant current of 40 mA and 
voltage of 120 V. The gels were run for 90 minutes or until the pink dye of the loading buffer had 
nearly reached the base of the plate.
2.2.93 Transfer o f protein to nitrocellulose membrane
The transfer buffer was prepared from the stock solution (stock transfer buffer (160 ml) + water 
(640 ml) + methanol (200 ml)). Stock transfer buffer (pH 8.3) consists of Tris-HCl (74 mM) and 
glycine (750 mM). Blotting paper and nitrocellulose membrane were cut to the same size as a
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membrane template. Nitrocellulose membrane was pre-wetted with methanol (100%) for 1 
minute before being equilibrated in transfer buffer for at least 10 minutes before blotting. The 
plate sandwich was removed from the gel holder and a spacer was used to split the plates, so that 
the gel was left in the spacer plate. The stacking gel was cut from the resolving gel, after which it 
was placed protein-side down on to the membrane. The scotchbrite, blotting paper, gel and 
membrane were stacked into the cassette as shown in Figure 2.6.
Cassettes were placed in the electrode tank so that the black side of the cassette faced the black 
side of the tank. The tank was then attached to the power supply, which was set at a constant 
current of 100 mA and voltage of 120 V. The protein was transferred from gel to membrane in 
approximately 15 hours.
Black electraode (negative charge)
Scotchbrite pad X 2
Blotting paper X 2
Resolving Gel
Nitrocellulose membrane
Blotting paper X 2
Scotchbrite pad X 2
Figure 2.6 Schematic representation of gel stacking procedure.
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2.2.9.4 Immunodetection and visualisation
After completion of the transfer, membranes were removed from the cassette and placed within a 
25 ml universal bottle, with the protein side inwards. A non-specific binding site was blocked by 
a membrane blocking reagent which comprised of 5% w/v non fat dried milk powder in TBS- 
tween buffer (Tris-HCl buffer (20 mM), NaCl (137 mM), and Tween 20 (10%)) for an hour on an 
orbital shaker. When blocking was completed, membranes were then washed with TBS-tween 
buffer 3 times (10 minutes each time).
Primary antibodies were diluted 1:1000 using non-fat dried milk powder (2%) in TBS-tween 
buffer and the membrane was incubated with the antibody for an hour at room temperature on the 
orbital shaker. Subsequently, the membrane was washed first with TBS-tween buffer for 10 
minutes and then for 3 times (5 minutes each times) with fresh TBS-tween buffer.
Secondary antibody was similarly diluted. The dilution factor has been determined empirically 
for each antibody. The membrane was incubated with a secondary antibody for an hour at room 
temperature on an orbital shaker. The membrane was once again washed as described above.
2.2.9.5 Detection
The detection reagent (ECL Plus Western Blotting Detection Reagents, GE Healthcare, 
Buckinghamshire, UK) was stored at 2-8“C and allowed to equilibrate to room temperature 
before use. Detection solutions A and B were mixed in a ratio of 40:1. The final volume of 
detection reagent required was 0.1 ml/cm^. Excess wash buffer was drained from the washed 
membrane and was placed protein side up on to a clean surface. Detection mixture was pipetted 
on to the membrane and incubated for 5 minutes at room temperature. The excess of detection 
reagent was drained by holding the membrane carefully with forceps and gently dabbing with 
tissue paper. Protein bands were detected using an ECL mini camera kit. The exposure period
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was varied so as to generate a sharp, well defined image on the photograph. The immunoblots 
were quantified by densitometry using GeneTool software (Sungene Corporation, Cambridge, 
UK).
One weakness of the procedure described is an absence of loading controls to check if the lanes 
had been equally loaded. Commonly used loading controls or ‘house keeping’ proteins are beta- 
actin or glyceraldehyde-3-phosphate dehydrogenase. In semi-quantitative studies, the ratio of 
protein of interest to loading control is believed to correct for loading errors or different blot 
transfer (Wagner et al., 2006; Vasudevan et al.,2004) Interpretation of the results of western blot 
in the present study should be aware of this limitation.
2.2.10 The Ames mutagenicity test
The method for detecting mutagens with the salmonella mutagenicity test has been revised by 
Maron and Ames (1983). The bacterium used in the test is a strain of Salmonella spp. that caries 
a defective (mutant) gene making it unable to synthesise the amino acid histidine (His). However, 
this mutation can be reversed with the gene regaining its ability to synthesise histidine, so that 
these revertants are able to grow in a medium lacking histidine.
The assay was performed in a class II hood (BioMAT, microbiological safety cabinet). All 
solutions and equipments were sterilised by autoclave. The bacteria used in the current studies, 
YG1024 strain, were freshly grown, and the frozen permanents routinely tested to ensure that the 
bacteria retained their expected characteristics. The assay was performed in triplicate and always 
incorporated a positive and negative (spontaneous reversion rate) control.
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2.2.10.1 Stock solutions and media 
Top Agar
The top agar containing top agar Nol (0.6%) and NaCl (0.5%) was autoclaved and stored at room 
temperature. Before being used, the agar was placed in a steam bath or microwave oven and 
allowed to melt. Subsequently, a sterile solution of L-histidine (0.5 mM) and biotin (0.5 mM) 
was added (1 0  ml for 100  ml of top agar).
Agar plate Vogel-Bonner medium E (50x VB salt)
Warm distilled water (45®C) 670 ml
Magnesium sulphate (MgS0 4 .7H2 0 ) 10  g
Citric acid monohydrate 10 0  g
Potassium phosphate, dibasic (anhydrous) (K2HPO4) 500 g
Sodium ammonium phosphate (NaNH4HP0 4 .4 H2 0 ) 175 g
Ingredients were added in the order indicated above in a 2 litre beaker and mixed with a magnetic 
stirrer on a hot plate. Each salt was allowed to dissolve completely before adding the next one, 
and the volume was adjusted to 1 litre. Finally it was divided into 2 glass bottles, autoclaved for 
12 minutes at 121®C and was then allowed to cool at room temperature.
Bottom agar
Bacto agar (15 g) was dissolved in water (910 ml) and autoclaved for 20 minutes at 12TC, and 
then stored at room temperature. Before use, it was placed in a steam bath or microwave oven 
and allowed to melt. Finally VB salt (5X, 20 ml) and glucose (40%, 50 ml) were added and then 
poured onto the sterile plate (2 0 ml).
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Nutrient broth
Nutrient broth (25 g) was dissolved in water (1 L). An aliquot (20 ml) was poured into a glass 
bottle and then autoclaved and stored at 4°C. Ampicillin (5mg/ml in 0.02 M NaOH) was added 
before inoculation with the bacteria.
Acivation system
Since IQ itself does not cause mutagenicity, it needs to undergo bioactivation by CYP450 and 
Phase II enzymes to convert it to an electrophilic aryl nitrenium. The presence of a hepatic 
activation system is therefore required for IQ activation. It comprised Aroclor 1254-induced rat 
liver S9 and cofactors to initiate enzyme reactions, buffer to maintain pH, and inorganic salt for 
cell integrity.
The percentage of standard mix is shown below;
Potassium chloride (0.33 M) 10 %
Magnesium chloride (0.08) 10 %
liver S9 (25%, w/v) 10 %
Cofactors (NADP (20pmol/ml); glucose -6 - phosphate(25 pmol/ml)) 20 %
Phosphate buffer (0.2 M) 50 %
Bacteria culture
Ampicillin-containing nutrient broth was inoculated with a frozen culture YG1024. The universal 
bottle was wrapped with foil and was incubated in a shaken water bath at 37°C for 12 hours.
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Test system
In sterile test tubes, the following were added in the order shown:
Top agar at 45 ®C containing biotin (0.5 mM) 2.0 ml
and L-histidine (0.5 mM)
Test compounds 0.1ml
Fresh bacterial suspension 0.1 ml
Activation system 0.5 ml
The agar mixture was immediately poured onto a plate placed on a level surface and then 
incubated in a 37°C oven for about 48 hours. At the end of this period, revertant colonies were 
counted. Spontaneous revertant was determined by replacing the test compound with the 
corresponding volume of vehicle (DMSO). All assays were carried out in triplicate.
2.2.10.2 Histidine requirement
The mutation in the histidine operon was tested by checking for bacteria growth in the presence 
and absence of histidine. The test was carried out by applying 2 ml of top agar containing 100 pi 
of L-histidine (0.1 M) and biotin (0.5 mM) on the bottom agar. Bacterial culture was streaked on 
to the plates with and without L-histidine and biotin, incubated at 37°C for 48 hours. The test was 
performed in duplicate
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(A) (B)
Figure 2.7 Histidine requirement. S.typhimurium strain YG1024 from frozen stock was grown 
in the absence (A) and presence(B) of histidine/biotin.
2.2.10.3 Crystal violet test
This is a test for checking the presence of the deep rough (rfa) mutation and the loss of 
Iipopolysaccharide coat on the bacterial surface. For this test, the bacteria culture (0.1 ml) was 
added into top agar (2.0 ml) containing L-histidine (0.5 mM) and biotin (0.5 mM) and poured 
onto the Petri-dish containing bottom agar. After the agar had solidified, a sterile filter paper disc 
containing crystal violet (1 0  pi of 1 mg/ml) was placed into the middle of the plate, which was 
then incubated at 37°C for 48 hours. A clear zone of inhibition around the disc indicated the 
presence of the rfa mutation. The test was performed in duplicate.
/
Figure 2.8 Crystal violet test. S.typhimurium strain YG1024 from frozen stock was tested for 
crystal violet sensitivity. The clear inhibition zone around the sterile filter paper disc containing 
crystal violet indicated the presence of the deep rough (rfa) mutation and the loss of 
lipopolysaccharide coat on the bacteria surface.
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2.2.10.4 Presence o f the ampicillin resistance R factor
The R-factors strains should be tested routinely for the presence of the ampicllin resistance factor 
because the plasmid is unstable and can be lost from bacteria (Maron, 1983) This test was 
performed by adding bacteria culture (0.1 ml.) into top agar (2.0 ml) containing L-histidine (0.5 
mM) and biotin (0.5 mM). The agar was allowed to solidify and a sterile filter paper disc 
containing lOpl of ampicillin (Bmg/ml) in NaOH (0.02 N) was placed onto the middle of the 
plate and incubated at 37®C for 48 hours. The test was performed in duplicate.
Figure 2.9 Presence of the ampicillin resistance R factor. S.typhimurium strain YG1024 from 
frozen stock grew around a sterile filter paper disc containing ampicillin indicating the presence 
of R factor plasmid (Maron and Ames 1983).
2.2.10.5 Viability o f frozen permanent stock test
To determine the viability of frozen permanent stock, three serial dilutions (1:100 each) of the 
frozen bacteria culture were prepared in nutrient broth and 0.1 ml of final dilution was added to 
the top agar containing L-histidine (0.5 mM) and biotin (0.5 mM). This top agar was added onto 
the bottom agar and incubated at 37”C for 48 hours. This test was performed in duplicate. The 
histidine revertant of the frozen permanent stock is 51 ± 6  colonies.
2.2.11 Statistical analysis
Results are expressed as means ± SEM. Statistical calculation was performed by using the 
Student’s t-test. Statistical significance was accepted if ?<0.05.
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Chapter 3: Modulation of CYP450 and Phase II enzyme systems by BITC in rat liver slices
3.1 Introduction
Benzyl isothiocyanate is a breakdown product of glucotropaeolin which is found in plants such as 
garden cress {Lepidium sativum) and papaya seeds (Carica papaya) (Vanetten et al. 1976; 
Fenwick et al. 1983; Pintao et al. 1995; Kassie et al. 1999b). Numerous reports indicated that 
BITC prevents chemically-induced cancer in various organs of laboratory animals such as urinary 
bladder, lung and pancreas (Hecht et al. 2002; Okazaki et al. 2002; Kuriowa et al. 2006). The 
possible mechanisms by which ITC inhibits tumorigenesis include; 1) inactivation of cytochrome 
P450 enzymes involved in the activation of carcinogens; 2) induction of Phase II enzyme 
activities, including epoxide hydrolase, glutathione ^'-transferase, and NADPH:quinone 
oxidoreductase; 3) induction of apoptosis, a protective mechanism against neoplasm development 
which eliminates genetically damaged or improperly divided cells (Yang et al. 2 0 0 2 ).
The use of precision-cut liver slices to observe chemical response in metabolism and toxicology 
studies has been well documented (Smith et al. 198; Parrish et al. 1995; Pushparajah et al. 2007). 
The advantages of the precision-cut liver slices model are that it maintains liver architecture, cell­
cell interactions and cell-matrix interaction. This model has been reported as having the ability to 
retain cytochrome P450 and Phase II enzyme activities for up to 24 hours (Hashemi et al. 1999b; 
Wauthier et al. 2004) and appears to accurately reflect the in vivo metabolic capability of the liver 
(Berthou et al., 1989). In the present study, the effects of BITC on CYP450 and Phase II enzymes 
activities were determined in rat liver slices.
3.2 Methods
3.2.1 Effect o f BITC on CYP450 and Phase II enzyme system in precision-cut liver slices.
Precision-cut liver slices were prepared as described in section 2.2.1. The metabolism of 7- 
ethoxycoumarin was carried out as described in section 2.2.5, in order to evaluate metabolic 
viability. The effect of BITC (0 - 25 pM) on CYP450 and Phase II enzyme activities was
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investigated following incubation with liver slices for 24 hours. The methodology for monitoring 
CYP450 and Phase II enzyme activities is described in sections 2.2.6 and 2.2.7. Cytotoxicity of 
BITC at various concentrations (0-25 pM) was assessed by determining leakage of LDH into the 
culture media (section 2.2.8). Data are presented as mean ± SEM, and statistical significance of 
data was tested by the Student’s t-test.
3.2.2 Function o f BITC as a CYP450 mechanism-based inhibitor
A  single adult male Wistar albino rat (250 g) was treated with a single intraperitoneal dose of 
Aroclor 1254 (500 mg/ kg BW) in order to induce cytochrome P450 activities. Five days after 
injection, the rat was sacrificed by cervical dislocation. Liver was excised and S9 fraction was 
prepared as described in section 2.2.3 then stored at -80°C until used.
The effect of BITC (0-50 pM) on EROD activity in the presence and absence of NADPH was 
determined in Aroclor 1254-induced microsomes. EROD activity was determined as described in 
section 2.2.6.1. Moreover, the effect of BITC (0 - 25pM) on EROD activity in the presence and 
absence of NADPH was also determined at various concentrations of the substrate 
ethoxyresorufin (0-1.0 pM).
To evaluate the effect of BITC on microsomal P450 content, rat liver microsomes were incubated 
with BITC (1-50 pM) in the presence or absence of NADPH for 30 minutes. At the end of the 
incubation, sodium dithionite was added to the test cuvette, followed by the additional carbon 
monoxide and the CYP450 spectrum was determined (section 2.2.6.3). To study the time- 
dependent effect on microsomal CYP450, rat liver microsomes were incubated with BITC (25 
pM) in the presence and absence of NADPH for various time periods (0-30 minutes).
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3.3 Results
3.3.1 Metabolic viability o f precision-cut liver slices
Incubation of rat liver slices with 7-ethoxycourmarin resulted in a time-dependent metabolism. 
The major metabolite was the sulphate conjugate of 7-hydroxycoumarin, with substantial amount 
of the glucuronide conjugate of 7-hydroxycoumarin and low levels of free 7-hydroxycoumarin 
(Figure 3.1). Homogenate protein levels did not change significantly during the incubation period 
(Figure 3.2)
1 2 3 4 5
Incubation time (hours)
Free 7-hydroxycoumarin -Ar 7-hydroxycoumarin glucuronide
7-hydroxycoumarin sulphate "♦  Total metabolites
Figure 3.1 Metabolism of 7-ethoxycoumarin by rat hepatic slices. Liver slices were incubated 
with 7-ethoxycoumarin (50 pM) for different time periods up to 6  hours. Metabolites of 7- 
ethoxycoumarin were monitored at each time point. Data are presented as mean ± SEM (n=3 
slices).
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Incubation time (hours)
Figure 3.2 Homogenate protein content of rat hepatic slices during incubation. Liver slices 
were incubated for different time periods up to 6  hours. Homogenate protein content is expressed 
as mg/slice. Results are expressed as mean ± SEM (n=3 slices).
3.3.2 Effect o f  BITC on CYP450 activities in precision-cut liver slice
The activities of CYPlAl, 1A2, 2B1 and 3A in liver slice microsomes were determined by 
monitoring the formation of the (9-dealkylation metabolites of EROD, MROD, PROD and 7-BQ 
respectively. The effect of various concentrations of BITC (0-25 pM) after 24 hours of incubation 
on EROD activity is shown in Figure 3.3. At 10 and 25 pM, BITC caused significant reduction in 
EROD activity. In contrast to this activity, the level of CYPlAl apoprotein, determined by 
Western blot analysis, was enhanced ~ 300% at the highest concentration of BITC only (Figure
3.4).
Incubation of precision-cut liver slices with a range of concentrations of BITC (0-25 pM) for 24 
hours resulted in reduction of MROD activity at the two higher doses (Figure 3.3), but statistical 
significance was achieved only at the highest doses (25 pM). In contrast to the aforementioned 
activity, the level of CYP1A2 apoprotein, determined by Western blot analysis, increased in a 
concentration-dependent manner (Figure 3.4).
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The effect of various concentrations of BITC (0-25 jiM) after a 24 hours incubation with 
precision-cut liver slices on PROD is shown in Figure 3.3. BITC impaired PROD activity in a 
dose-dependent fashion, significant inhibition being reached at a concentration of 10 pM. The 
level of CYP2B1 apoprotein, determined by Western blot analysis, decreased similarly (Figure
3.4). There was no effect of BITC (0-25 pM) on 7-BQ metabolism in liver slices (Figure 3.3). 
However, a decrease in CYP3A apoprotein level was noted at all concentrations (Figure 3.4).
0 25
EEC conc^ trËÎoa(|im BITC coActhhmoa (pM)
"BQ dealkÿlation
BITC conceBtrmom(;i
ïë*
tL
BITC concentrai Oft (pM)
Figure 3.3 Effect of BITC on CYP450 activities in precision-cut liver slices. Hepatic slices 
were incubated with BITC at various concentrations (0 - 25 pM) for 24 hours. EROD, MROD, 
PROD and 7-BQ metabolism in the microsomal fraction were determined. Results are presented 
as mean ± SEM (n=6 ), * = p< 0.05.
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CYP 1A2
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CYP 2B1
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Lane 1: no slice incubation; Lane 2: 24-hour incubation in the absence of BITC. Lanes 3-6: 24- 
hour incubation in the presence of BITC at 2.5, 5, 10, and 25 pM, respectively
Figure 3.4 Effect of BITC on CYP450 apoprotein levels in precision-cut liver slices. Hepatic 
slices were incubated with BITC at various concentrations (0-25 pM) for 24 hours. The 
microsomal proteins were separated using gel electrophoresis before being transferred to 
nitrocellulose membrane. The immunoblot was carried out with mouse monoclonal anti-rat 
CYPlAl antibody; mouse monoclonal anti-rat CYP1A2 antibody; goat monoclonal anti-rat 
CYP2B1 antibody and rabbit monoclonal anti-rat CYP3A antibody, respectively, followed by 
peroxidase labelled anti-mouse IgG (CYPlAl and 1A2), peroxidase labelled anti-goat IgG 
(CYP2B1) and peroxidase labelled anti-rabbit IgG (CYP3A), and all lanes were loaded with 20 
pg protein. Figures above the immunoblot present percentage values that have been calculated 
using fluorescence software, where fluorescence from the apoprotein level of control slices 
incubates for 24 hours has been set at 100%.
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3.3.3 Inactivation o f  CYP450 by BITC metabolite(s)
As described in section 3.3.2, EROD and MROD activities in liver slices were inhibited by high 
concentrations of BITC, whereas CYPlAl and CYP1A2 apoprotein were markedly increased. To 
understand the underlying mechanism and evaluate the possibility that BITC acts as mechanism- 
based inactivator, the effects of BITC on EROD activity and P450 content were investigated. The 
effect of BITC on the CYP450 was examined using microsomes from Aroclor 1254-induced rats.
EROD activity was inhibited by BITC in a concentration-dependent manner, the activity being 
halved at the highest BITC concentration (Figure 3.5). In order to determine whether metabolism 
of BITC leads to a more pronounced inhibition, rat liver microsomes were incubated with BITC 
in the presence of NADPH. More marked inhibition was evident, which was both incubation 
time- and concentration-dependent (Figures 3.6 and 3.7).
In contrast to EROD activity, addition of BITC (25 pM) into Aroclor 1254-induced microsomes 
had no effect on total P450 content (data not shown). Following the addition of NADPH into the 
system, a reduction of total P450 was noted in incubation a time- and concentration-dependent 
manner (Figures 3.8 and 3.9). However, the effect of BITC on EROD activity was much greater 
than the loss in P450 content.
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Figure 3.5 Effect of BITC on EROD activity. Aroclor 1254-induced rats liver microsomes were 
incubated with BITC (10-50 p,M) and EROD activity was determined. Data are presented as mean 
± SEM for triplicate determinations, * = P<0.05. The 100% EROD activity was 1.43 
nmol/min/mg microsomal proteins.
* * *
Incubation time (minutes)
Figure 3.6 Effect of BITC incubation time on EROD activity. Aroclor 1254-induced rat liver 
microsomes were incubated with BITC (25 pM) for various periods of time (0- 30 minutes) in the 
presence of NADPH and EROD activity was determined. Data are presented as mean ± SEM, for 
triplicate determination, ** P <0.01; *** P <0.001. The 100% EROD activity was 1.43 
nmol/min/mg protein.
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Figure 3.7 Effect of BITC concentration on metabolite-modulated inhibition of EROD 
activity. Aroclor 1254-induced rats liver microsomes were incubated with BITC (0-50 |xM) for 30 
minutes in the presence of NADPH and EROD activity was determined. Data are presented as 
mean ± SEM, for triplicate determination, ** P <0.01; *** P <0.001. The 100% EROD activity = 
1.43 nmol/min/mg protein.
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Figure 3.8 Effect of BITC incubation time on metabolite-modulated CYP450 content. Rat
microsomes were incubated with BITC (25 pM) for various time periods (0-30 minutes) in the 
presence of NADPH. At the end of incubation, sodium dithionite was added and CYP450 
spectrum was determined following addition of carbon monoxide. Data are presented as mean ± 
SEM (n=3) for triplicate determination, * =P<0.05.
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3.3.4 Kinetic analysis o f the BITC-modulated EROD inhibition
The kinetics for EROD inactivation by BITC were studied by measuring the loss of EROD 
activity. The kinetic parameters of BITC inhibition of EROD activity, determined from 
Lineweaver-Burk plots (double reciprocal plots) are shown in Figure 3.10-3.13. The inhibition of 
0-deethylation of ethoxyresorufin by BITC in the absence of NADPH was a competitive 
inhibition (Table 3.1) and had a Ki = 19.11 ± 4.18 pM. The inhibition of EROD by BITC after 
incubation with NADPH for 30 minutes was non-competitive inhibition (Table 3.2) and had a Ki 
= 2.37 ± 0.17 pM.
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Figure 3.9 Effect of BITC concentration on metabolite-modulated CYP450 content. CYP450 
content was determined after incubation of Aroclor 1254-induced liver microsomes with various 
concentrations of BITC (0-25 pM) and NADPH for 30 minutes. Data are presented as mean ± 
SEM, for triplicate determination. * = P< 0.05; ** = P< 0.01
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Table 3.1 Kinetic parameters of the effect of BITC on EROD activity. The inhibition of 
EROD was determined by using various concentrations of ethoxyresorufin (0-1 pM) and BITC 
(10 and 25 pM).
BITC concentration 0 pM 10 pM 25 pM
V max (nmol/min/mg protein) 1196^=61.4 1096 ±76.3 1167 ±58.0
Km (pM) 0.15 ±0.02 0.19 ±0.04 0.32 ± 0.04
^  1000-
s
800-
Ti T I
0.00 0.25 0.50 0.75
Ethoxyresurofin (pM)
0 |LtM BITC ^ 10 laM BITC ^
1.00
25 |iM BITC
Figure 3.10 Inhibition of EROD activity by BITC. The inhibition was determined by measuring 
EROD activity at the various concentrations of ethoxyresorufin ( 0 - 1  pM) and BITC (10 and 25 
fxM). Curves were generated using non-linear regression analysis. Data are presented as mean ± 
SEM, for triplicate determination.
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Table 3.2 Kinetic parameters of the effect of BITC on EROD activity following pre­
incubation with NADPH. After the incubation of microsomes with various concentrations of 
BITC and NADPH for 30 minutes, the inhibition of EROD was determined.
BITC concentrations 0 pM I pM 10 pM 25 pM
V max (nmol/min/mg protein) 407.5 ± 15.9 287.0 ± 11.3 89.9 ±6.1 25.8 ±0.5
Km (pM) 0.035 ± 0.005 0.041 ± 0.006 0.055 ±0.013 0.053 ± 0.007
0.035i
0.030-
0.025-
43 68 9318-7
1/s (pM"')
0 pM BITC ------ 10 pM BITC  25 pM BITC
Figure 3.11 Lineweaver-Burk plot of EROD activity in the presence of BITC. EROD activity 
was measured over a series of substrate concentrations (0- 1.0 pM), in the present of two 
concentrations of BITC (10 and 25 pM).
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Figure 3.12 The inhibition of EROD activity by BITC metabolite(s). The inhibition of EROD 
was determined by using various concentrations of ethoxyresorufin (0-1 jiM) after incubating 
microsomes with various concentrations of BITC and NADPH for 30 minutes. Curves were 
generated using non-linear regression analysis.
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Figure 3.13 Lineweaver-Burk plot of EROD activity in the presence of BITC following pre­
incubation with NADPH. EROD activity was measured over a series of substrate (0-1 pM) in 
the presence of various concentration of BITC (0-25 pM).
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3.3.5 Effect o f  BITC on Phase II enzyme activities in precision-cut rat liver slices
The effect of BITC on epoxide hydrolase enzyme activity was investigated. Incubation of 
precision-cut liver slices with a range of BITC concentration (0-25 pM) for 24 hours increased 
this enzyme activity. Statistical significance was reached at high concentrations (10 pM) (Figure 
3.14). However Western blot analysis failed to show an increase in protein levels. In fact, marked 
suppression was evident at the highest concentration (25 pM) (Figure 3.15).
Modulation of glutathione 6"-transferase activity in precision-cut liver slice was investigated under 
the same incubation condition. When CDNB was used as a substrate, GST activity increased 
modestly at low concentration and decreased at higher BITC concentrations (Figure 3.14). When 
DCNB was used as substrate, GST activity once again increased significantly at low 
concentrations and decreased when exposed to a higher concentration (Figure 3.14). Analysis 
using the substrate NBD-Cl showed that GST activity was significantly decreased at higher 
concentrations (10 and 25 pM) (Figure 3.14). These findings were supported by immunoblot 
studies using antibodies against GST a and p where a decline in protein level was observed at 
high BITC concentrations (Figure 3.15). Total glutathione levels were significantly decreased at 
all BITC concentration (Figure 3.16).
The effect of BITC on NQOl activity of precision-cut liver slices was evaluated using MTT as 
substrate. Although NQOl activity rose at 5 and 10 pM of BITC, it failed to reach statistical 
significance. No perceptible change was found in the protein levels of NQOl. However, at the 
highest concentration of BITC (25 pM), the protein band was hardly detectable (Figure 3.15)
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Figure 3.14 Effect of BITC on Phase II enzyme activities in precision-cut liver slices. Hepatic 
slices were incubated with BITC at various concentrations (0-25 pM) for 24 hours. Epoxide 
hydrolase, GST activity using CDNB, DCNB and NBD-Cl as substrates, and NQOl activity using 
MTT as substrate were determined. Results presented as mean ± SEM, (n=6), * = p< 0.05; ** = ?  
< 0 .01 .
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Lane 1: no slice incubation; Lane 2: 24-hour incubation in the absence of BITC. Lanes 3-6: 24- 
hour incubation in the presence of BITC at 2.5, 5, 10 and 25 pM, respectively
Figure 3.15 Effect of BITC on Phase II enzymes protein levels in precision-cut liver slices.
Hepatic slices were incubated with BITC at various concentrations (0-25 pM) for 24 hours. The 
microsomal (for epoxide hydrolase) and cytosolic (for GST, and NQOl) proteins were separated 
using gel electrophoresis before being transferred to nitrocellulose membrane. The immunoblot 
was carried out with anti-rat epoxide hydrolase; anti-rat GST a; anti-rat GST p; and anti-rat 
NQOl antibody followed by peroxidase label anti-rabbit IgG, and all lanes were loaded with 5 pg 
protein. Figures above the immunoblot are percentage values that have been calculated using 
fluorescence software, where fluorescence from the protein level of control slices has been set at 
100%.
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Figure 3.16 Effect of BITC on cellular total glutathione in precision-cut liver slices. Hepatic 
slices were incubated with BITC at various concentrations (0-25 pM) for 24 hours, total 
glutathione in the cytosolic fraction was determined. Data are presented as mean ± SEM, (n=6), * 
= p< 0.05; ** = p < 0.01.
3.3.6 Cell toxicity o f  BITC
Release of LDH into the culture media was used to evaluate the cell toxicity of BITC. Liver slices 
were incubated at various concentrations of BITC (0-25 pM) for 24 hours before measuring the 
LDH activity in the media and slice homogenates. A statistically significant increase was noted at 
the higher concentrations of BITC (10 and 25 pM) (Figure 3.17).
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Figure 3.17 Release of LDH from liver slices cultured in the presence of BITC after 24 hours 
incubation. Liver slices were incubated with various concentration of BITC (0-25 pM) for 24 
hours. LDH leakage into culture media was expressed as percentage of total LDH. Data are 
presented as mean ± SEM (n=3 slices); * = P<0.05
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3.4 Discussion
3.4.1 Metabolic viability o f  precision-cut liver slices
Precision-cut liver slices model is an in vitro system employed to study xenobiotic metabolism 
and toxicity as well as the biological activity of chemicals (Lerche-Langrand and Toutain 2000; 
Pushparajah et al, 2008; Rekka et al. 2002). It offers the advantage of conservation of structure 
and cell to cell communication. The metabolism of 7-ethoxycoumarin was used to assess the 
metabolic viability of the slices as it represents both Phase I and II enzyme activities. In rat liver 
slices, 7-ethoxycoumarin initially undergoes dééthylation by CYP450 enzymes to form 7- 
hydroxycoumarin which is then conjugated by Phase II enzymes to form the glucuronide and 
sulphate conjugates. Moreover, 7-hydroxycoumarin can be easily determined fluorimetrically. 
Liver slices metabolised 7-ethoxycoumarin in the time-dependent fashion. The rate of formation 
of metabolites was similar to those reported by Steensma et al. (1994) and Hashemi et al. (1999a), 
indicating the metabolic viability of the prepared liver slices.
3.4.2 The effects o f  BITC on CYP450 enzyme activities and expression in precision-cut liver 
slices
After 24 hours of incubation, all basal P450 enzyme activities and apoprotein levels declined as 
previously reported (Hashemi et al. 2000). O-Dealkylation of ethoxy-, methoxy-, and 
pentoxyresorufin are routine assays employed to evaluate the activities of CYP450, lA l, 1A2, 
and 2B1 respectively (Burke and Mayer 1974; Burke et al. 1994).
3.4.2.1 CYP 1A subfamily
The CYPl family is the dominant CYP450 in the bioactivation of chemicals including 
carcinogens. It is believed to be responsible for the activation of more than 90% of known 
carcinogenic chemicals (loannides and Lewis 2004). CYP1A2 is primarily expressed in the liver 
but the hepatic level of CYPlAl is very low (loannides and Lewis 2004). BITC has already been
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reported to be a competitive substrate as well as a mechanism-based inactivator for CYP450 
activity (Conaway et al. 1996; Goosen et al. 2000; Moreno et al. 1999; von Weymam et al. 2006). 
The effectiveness of achieving cancer prevention with TTCs by inhibiting a specific cytochrome 
P450 has been demonstrated in animal experiments. Sticha and co-workers (2000) reported that 
BITC inhibits the formation of DNA adducts induced by benzo[a]pyrene by blocking production 
of the highly reactive metabolite 7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene.
In the present study, EROD and MROD activities in control liver slices were in the same range as 
previously reported (Hashemi et al., 2000; Pushaparajah et al., 2007). The observations that the 
treatment with BITC decreased the dealkylation of the ethoxy- and methoxyresorufin whereas 
CYPlAl and 1A2 apoprotien levels were elevated indicate that this enzyme is induced but is 
catalytically inactivated due to the presence of a bound BITC metabolite(s). As shown in the 
kinetic studies (section 3.3.4), the cytochrome P450 inhibition mechanism of BITC was NADPH 
dependent.
3.4.2.2 CYP2B subfamily
CYP2B is also involved in the metabolism of chemical carcinogens. Although it generally 
converts carcinogens into their inactive metabolites (loannides and Lewis 2004), it also appeared 
to catalyze bioactivation of some nitrosamines (Mori et al. 2002 and 2006). In this current study, 
after incubation for 24 hours with BITC, PROD activity in liver slices decreased in a 
concentration-dependent manner. This result is consistent with the previous reports that BITC is a 
mechanism-based inactivator for PROD activity (Goosen et al. 2000).
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3.4.2.3 CYP3A  subfamily
CYP3A is a broad specificity enzyme, responsible for the metabolism of most medical drugs such 
as macrolide antibiotics etc. (loannides and Lewis, 2004). CYP3A is inducible in rat and human 
in several in vitro models including precision-cut liver slices (McCune et al. 2000; Cui et al. 
2005). However, in this particular study, there was no effect of BITC on 7-BQ metabolism, a 
selective marker for CYP3A (Stresser et al. 2000).
3.4.3 Kinetics o f cytochrome P450 inhibition by BITC
The present study demonstrated that inhibition of EROD activity by BITC is time- and 
concentration dependent. Without the addition of NADPH, BITC appeared to inhibit 
competitively EROD activity only at the high concentration (>10 pM). Incubation with NADPH 
prior to the addition of the substrate potentiated inhibition effect which was now non-competitive 
in nature. Goosen et al. (2000) reported a similar observation, where PEITC showed a time-, 
concentration-, and NADPH- dependent inactivation of CYP2B1. They also reported that at a 
high concentration, PEITC (5-1 OpM) also caused inhibition in the absence of NADPH.
The requirement for NADPH indicates that microsomal metabolism of BITC formed an 
unidentified metabolite(s) with inhibitory activity. Moreno et al. (2001) studied the metabolism of 
BITC by CYP2E1. They identified three metabolites of BITC produced by CYP2E1 namely 
benzaldehyde, benzoic acid, and benzylisocyanate. Similar finding was reported by Goosen et al. 
(2001). They suggested that BITC was metabolised by CYP2B1. The study by LC/MS showed an 
increase in molecular mass of CYP2E1 of approximately 155 Da, consistent with a benzyl 
isocyanate adduct containing one oxygen (Moreno et al. 2001).
There are three possible pathways to explain the mechanism of inactivation of hepatic microsomal 
P450; 1) formation of a reactive intermediate that covalently modifies the haem moiety, 2)
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destruction of the haem with cross linking to the apoprotein or 3) covalent modification of 
apoprotein. The magnitude of the reduced -CO difference spectrum of P450 decreased by 
approximate 29% following the inactivation by BITC and NADPH and did not correlate with the 
83% loss in EROD activity. This implied that the inactivation of P450 enzyme activity by BITC 
may be due to modification of the apoprotein with little haem loss. Moreover, radiolabeled BITC 
bound to the P450 protein following SDS-PAGE separation and autoradiography was reported, 
indicating a covalent modification of apoprotein by the metabolite(s) of BITC (Goosen et al. 
2001; Moreno et al. 2001).
3.4.4 The effects o f  BITC on Phase II  enzymes activities and expressions in precision-cut liver 
slices
Phase II enzymes play an important role in the detoxification of xenobiotic compounds. The 
induction of these enzymes protects animals against the toxic and neoplastic effects of 
carcinogens. Although BITC has been shown to be a potent Phase II inducer on several in vitro 
experiments (Nakamura et al. 2000), this is the first time it has been demonstrated in the 
precision-cut liver slice model. Nevertheless, exposure to high concentration of BITC (25 pM) 
could also lead to toxicity as evident by an increase in LDH leakage in the media.
3.4.4.1 Epoxide hydrolase
Hepatic epoxide hydrolase is an important enzyme in the metabolism of aromatic compounds, 
since it converts the intermediate arene oxides formed by the mixed-function oxidase system to 
the corresponding dihydrodiols, which are non toxic (Gibson and Skett 2001). The hydrolysis of 
benzo[a]pyrene 4,5 epoxide to the corresponding dihydrodiol, by microsomal epoxide hydolase is 
widely used for the evaluation of epoxide hydolase activity. Pushparajah et al. (2007) 
demonstrated that precision-cut liver slices could be used to assess induction of epoxide hydrolase 
activity following exposure to chemicals. Activity levels in control liver slices in the present study
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were in the same range as reported elsewhere (Pushparahah et. al. 2007). BITC induced epoxide 
hydrolase activity in dose-dependent manner, reaching statistical significance at the concentration 
of 10 pM.
3.4.4.2 Glutathione S-transferase
Modulation of GST by BITC was investigated in precision-cut slices at the activity and protein 
level. In control liver slices, GST activity expression was in the same range as previously reported 
(Hashemi et al. 1999b; Pushparajah et al. 2007). To evaluate the specificity of the effect of BITC 
on GST class in precision-cut liver slices, three substrates were used. When using CDNB and 
DCNB, which were broad spectrum and M l specific substrates, respectively (Habig et al. 1974), 
GST activity was induced by BITC in a dose-dependent manner. This was similar to previous 
observations in hepatic cell line, human colon carcinoma cells etc (Kirlin et al. 1999; Nakamura et 
al. 2000). At the higher concentrations of BITC, the activities were decreased, possibly a 
consequence of cytotoxicity of BITC. However, when NBD-Cl, which is a  class specific (Ricci et 
al. 1994), was employed as substrate, there was no significant change.
3.4.4.3 Total glutathione content
In this thesis, cellular GSH levels significantly dropped after 24 hours incubation with various 
concentrations of BITC (0-25 pM). ITC appears to penetrate cells by diffusion. The ITC is rapidly 
conjugated with intracellular thiols, mainly GSH. As a consequence, the level of GSH dropped in 
a dose-dependent manner (Zhang et al., 2000). There is evidence indicating that exposure to a low 
concentration of ITC for longer periods of time (>24 hours) activated GSH synthesis (Spamins et 
al., 1982). A similar explanation of a decreased cellular concentration of GSH was proposed by 
Xu and Thomally (2001), who studied the effect of PEITC on glutathione metabolism in human 
leukemia cells. They proposed that 5'-(2V-phenethylthocabamoyl)glutathione, formed by the 
reaction of glutathione and PEITC, was exported from the cell by a GSH conjugate transporter,
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resulting in glutathione depletion. Moreover, the exposure to BITC could lead to a increase in 
cellular reactive oxygen intermediates further leading to the membrane leakage (Nakamura et al. 
2000) that caused the lower GSH contents found in this present study.
3.4.4.4 NADPH: Quinone oxidoreductase (NQOl)
NQOl is a Phase II enzyme that promotes obligatory two-electron reduction of quinones, 
preventing their participation in oxidative damage and the depletion of intracellular GSH (Prestera 
et al. 1993). BITC was reported to be a potent NQOl inducer in the hepatocytes (Zhang et al. 
1998). In this study, although the activity of NQOl increased in a dose-dependent manner, no 
statistical significant was achieved.
3.4.5 Toxicity o f  BITC to precision-cut liver slice
To determine whether the BITC, at the concentrations used in the present study was toxic to the 
hepatocytes, LDH leakage level was monitored. LDH is one of a number of biomarkers used to 
assess slice viability. With a 40% leakage after 24 hours incubation, it raises a question if 
precision-cut liver slices would be an acceptable experimental method. The answer depends on 
what is the parameter of interest, which in this thesis is activities and protein expression of 
CYP450 and Phase II enzyme systems. The 7-ethoxycourmarin metabolism study indicated the 
metabolic viability of this model. Moreover, Hashemi and co-workers (1999b and 2000) 
demonstrated that the precision-cut liver slice model could maintain activities and protein 
expression of CYP450s and Phase II enzyme systems following 24 hours incubation. The 
percentage leakage of LDH in control liver slices in this thesis was also in agreement with that 
reported by Fisher et al. (1995) and Hashemi et al (1999a).
BITC has been reported to be a potent cytotoxic compound in HepG2 cells (Kassie et al. 1999a). 
In a study using HT 29, colon carcinoma cells, it was demonstrated that BITC at a concentration
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of 25 pM caused a significant increase in the number of detached cells from culture plates after a 
20-hours of incubation (Kirlin et al. 1999). In the current study, percentage leakage of LDH after 
incubation with the higher doses of BITC (10 and 25 pM) rose to 60%. Literpretation of the 
effects of BITC on cytochrome P450 and Phase II enzyme activities should take into 
consideration its toxicity at the high levels of exposure.
3.5 Conclusion
This chapter describes the abilities of BITC to modulate cytochrome P450 and Phase II enzyme 
activities in precision-cut liver slices and consider the underlying mechanisms. The inhibition of 
CYP450 activities by BITC is substrate-specific. It was clearly demonstrated that EROD activity 
was inhibited by both BITC and its reactive metabolite. In the case of Phase II enzymes, BITC 
elevated epoxide hydrolase and glutathione iS-transferase activity. This ability was limited by the 
cytoxicity of BITC at the high concentration. In conclusion, this study provides evidence that 
supports the chemoprotective effect of BITC.
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4.1 Introduction
Numerous epidemiological studies indicate that the consumption of diets with a high cruciferous 
vegetable content protects against a number of cancers (Bueno de Mesquita et al. 1991; Brown et 
al. 1995; Ji et al. 1998; Voorrips et al. 2000; lARC 2004). For example, Terry et al (2001) 
reported an inverse association between Brassica vegetable consumption and breast cancer in post 
menopausal women, and subsequent studies repeated similar findings (Fowke et al. 2003; 
Ambrosone et al. 2004). The chemoprotective activity of cruciferous vegetable may be due to 
their non-nutrient bioactive compounds, glucosinolates, and their breakdown products, 
isothiocyanates and indoles. These compounds were found to modulate carcinogen- metabolising 
enzymes in cell cultures and rodent tissues (Zang and Talalay 1998; Munday and Munday 2002; 
Von Weymam et al. 2006).
Among isothiocyanates, benzyl isothiocyanate (BITC) is one of the most intensively studied in 
laboratory animals and was found to be a promising chemopreventive agent towards different 
classes of carcinogens in various organs, for example urinary bladder, lung and pancreas (Hecht et 
al. 2002; Okazaki et al. 2002; Kuriowa et al. 2006). The mechanisms of this chemoprotective 
effects is not entirely understood but have been linked to the abilities of this compound to 
influence CYP450 and Phase II enzyme activities and, moreover, induce apoptosis in tumour cells 
(Nakamura et al. 2000; Conaway et al. 2002).
The present study investigated the effects of BITC towards CYP450 and Phase II enzyme 
activities using doses that reflect human intake. Although many studies supported a 
chemopreventive role of BITC through modulation of these enzyme systems, these studies 
employed much higher doses compared with dietary intake (Hecht et al. 2002; Kassie et al 2002). 
Liver and lung were selected as the tissues of interest; because the liver is the primary site of the 
detoxification and metabolic activation of procarcinogens, and the lung because it is a major
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target tissue of the chemopreventive effects of isothiocyanate (Conaway et al. 2005; Wattenberg 
1987).
4.2 Methods
Male Wistar albino rats (200g) were acclimatised for 1 week. Diet and water were freely available 
to all rats throughout the experiment. Rats were randomly allocated into 4 groups; each consisting 
of 5 rats. The rats were fed with a rat and mouse expanded diet (BK 0011) supplemented with 
BITC at 0.5, 5 and 50 mg/100 g diet, which is equivalent to daily doses of 0.5, 5, or 50 mg/kg 
body weight (3.3, 33, or 330 pmol/kg) for 2 weeks. Animals were taking care by EBU staff. At 
the end of the treatment period, rats were sacrificed by cervical dislocation. The liver and lungs 
were collected, weighed and homogenised in an ice-cold Tris-HCl buffer (50 mM; pH 7.4). The 
homogenates were centrifuged for 20 minutes at 9000 g and the supernatants were kept at -80° for 
further study.
The methodology for monitoring the expression of Phase I and phase II enzyme activities is 
described in sections 2.2.6 and 2.2.7. Statistical significance was evaluated using the Student’s t- 
test.
4.3 Results
4.3.1 Effects o f BITC on food intake and body weight
The rats tolerated the diet supplemented with BITC well and no significant difference in food 
intake was observed. Rats in every group consumed a daily average of 18.3 g of food per day, and 
body weight gain was not influenced by the BITC treatment (Figure 4.1).
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Figure 4.1 The effect of BITC intake on rat body weight. Rats were allocated in to 4 groups 
and were fed diets containing BITC (0-50 mg/kg BW). Body weights were measured during 
treatment. Data are presented as mean ± SEM (n=5).
4.3.2 Effects o f dietary intake o f BITC on hepatic carcinogenic metabolising enzymes in rat
4.3.2.1 CYP450 enzyme activities in rat liver
The O-deethylation of ethoxyresorufin was elevated by BITC treatment in a dose-dependent 
manner, but significance was only observed at the highest dose (Figure 4.2). The rise in activity 
was accompanied by a marked rise in CYPlAl apoprotein levels (Figure 4.3). The CYP1A2 
mediated O-demethylation of methoxyresorufin was influenced by the treatment with BITC in a 
similar manner, a significant increase was only achieved at the highest dose (Figure 4.2). At the 
apoprotein level, a marked rise of 400% was only evident at the highest dose (Figure 4.3). PROD 
activity was similarly increased by BITC treatment in a dose-dependent manner; significant 
increases were observed at both medium and high doses (Figure 4.2). CYP2B1 apoprotein level 
was elevated by about 100 and 200 % at the medium and high dose, respectively. The 
débenzylation of 7-benzyloxyquinoline (7BQ) was increased following treatment of rats with 
BITC in dose-dependent manner (Figure 4.2). However, at the apoprotein levels, CYP3A was 
only elevated at the highest dose but the effect was marked (300%) (Figure 4.3).
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4.3.2.2 CYP450 enzyme activities in rat lung
In the lung samples, BITC treatment did not lead to any significant effects on the O-deethylation 
of ethoxyresorufin (Figure 4.4) and the débenzylation of 7-benzyloxyquinoline (Figure 4.4) 
activities, and similarly CYPlAl and CYP3A apoprotein levels did not show a marked change 
(Figure 4.5). PROD activity decreased by the same treatment in a dose-dependent manner (Figure 
4.4). This was accompanied with a marked decrease in CYP2B1 apoprotein levels (Figure 4.5).
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Figure 4.2 Effects of BITC on CYP450 activities in rat liver. Hepatic EROD, MROD, PROD, 
and 7-BQ dealkylation were determined in rats fed BITC (0-50 mg/kg BW) for 2 weeks. Results 
are presented as mean ± SEM where n=5, * = P<0.05.
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Figure 4.3 Effects of BITC on CYP450 apoprotein levels in rat liver. Rats were fed with BITC 
(0-50 mg/kg BW) for 2 weeks before sacrifice. The microsomal proteins were separated using gel 
electrophoresis before being transferred to a nitrocellulose membrane. The immunoblot was 
carried out with mouse monoclonal anti-rat CYPlAl antibody; mouse monoclonal anti-rat 
CYP1A2 antibody; goat monoclonal anti-rat CYP2B1 antibody, and rabbit monoclonal anti-rat 
CYP3A antibody, followed by peroxidase labelled anti-mouse IgG (CYPlAl and 1A2), 
peroxidase labelled anti-goat Ig G (CYP2B1), peroxidase labelled anti-rabbit IgG (CYP3A), and 
all lanes were loaded with 20 pg protein. The figures above the immunoblot are percentage values 
that have been calculated using fluorescence software, where fluorescence from the apoprotein 
level of control group has been set at 100%.
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Figure 4.4 Effects of BITC on EROD, PROD and 7-BQ dealkylation activities in rat lung.
EROD, 7-BQ dealkylation and PROD activities in rat lungs were determined in rats fed BITC (0- 
50 mg/kg BW) for 2 weeks. Results are presented as mean ± SEM (n=5), * = P < 0.05.
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Figure 4.5 Effect of BITC on CYP450 apoprotein levels in rat lung. Rats were fed with BITC 
(0-50 mg/kg BW) for 2 weeks before sacrifice. The microsomal proteins were separated using gel 
electrophoresis before being transferred to a nitrocellulose membrane. The immunoblot was 
carried out with mouse monoclonal anti-rat CYPlAl antibody; goat monoclonal anti-rat CYP2B1 
antibody and rabbit monoclonal anti-rat CYP3A antibody, followed by peroxidase labelled anti­
mouse IgG (CYPlAl), peroxidase labelled anti-goat IgG (CYP2B1), and peroxidase labelled anti­
rabbit IgG (CYP3A), and all lanes were loaded with 20 pg protein. The figures above the 
immunoblot are percentage values that have been calculated using fluorescence software, where 
fluorescence from the apoprotein level of control group has been set at 100%.
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4.3.3 Effects of diets supplemented with BITC on Phase II enzyme activities in rat.
4.3.3.1 Phase II  enzyme activities in rat liver
Epoxide hydrolase activity in the liver of rats fed with diets containing BITC was evaluated. 
When monitored using benzo[a]pyrene-4,5-oxide as substrate, there was a significant rise in 
enzyme activity at medium and high doses (Figure 4.6). However, a rise in protein level of 
approximately 100% was detected in all doses (Figure 4.7). The activity of NQOl was determined 
by measuring the rate of MTT reduction. MTT reduction was not influenced by any of the BITC 
treatments (Figure 4.6). In contrast, the level of NQOl protein increased by 136% and 210% at 
the medium and high doses, respectively (Figure 4.7).
Feeding rats with diets supplemented with BITC influenced glutathione ^'-transferase activity, a 
statistically significant increase was achieved at the medium and high doses when using CDNB as 
a substrate (Figure 4.8). However, when DCNB and NDB-Cl were used as substrates, a 
significant increase was exhibited only at the highest dose (Figure 4.8). The rise in activity was 
accompanied by a dose-dependent rise in GST a and GST p protein levels (Figure 4.9). Cytosolic 
glutathione decreased in a dose dependent manner and reached statistical significance only at the 
highest dose (Figure 4.10).
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Figure 4.6 Effects of BITC on Phase II enzyme activities in ra t liver. Epoxide hydrolase and 
NADPH : quinone reductase activities were determined in the liver from rats fed BITC (0-50 
mg/kg BW) for 2 weeks. Results are presented as mean ± SEM (n=5), * =P<0.05.
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Figure 4.7 Effects of BITC on Phase II enzymes protein levels in rat liver. Rats were fed with 
BITC (0-50 mg/kg BW) for 2 weeks before sacrifice. The microsomal (for epoxide hydrolase) and 
cytosolic (for NQOl) proteins were separated using gel electrophoresis before being transferred to 
a nitrocellulose membrane. The immunoblot was carried out with anti-rat epoxide hydrolase 
antibody and anti rat NQOl antibody followed by peroxidase labelled anti-rabbit IgG, and all 
lanes were loaded with 20 pg protein. The figures above the immunoblot are percentage values 
that have been calculated using fluorescence software, where fluorescence from the protein level 
of control group has been set at 100%.
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Figure 4.8 Effects of BITC on glutathione 5-transferase (GST) activities in rat liver. GST
activity was determined in the liver from rats fed with BITC (0-50 mg/kg BW) for 2 weeks. Three 
GST substrates, CDNB, DCNB and NBD-Cl, were employed to determine the activity. Results 
are presented as mean ± SEM (n=5), * = P < 0.05.
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Figure 4.9 Effects of BITC on glutathione 5-transferase protein level in rat liver. Rats were 
fed with BITC (0-50 mg/kg BW) for 2 weeks before sacrifice. The cytosolic proteins were 
separated using gel electrophoresis before being transferred to a nitrocellulose membrane. The 
immunoblot was carried out with anti rat-GST-a antibody and anti rat-GST p antibody followed 
by peroxidase labelled anti-rabbit IgG, and all lanes were loaded with 20 pg protein. The figures 
above the immunoblot are percentage values that have been calculated using fluorescence 
software, where fluorescence from the protein level of control group has been set at 100%.
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Figure 4.10 Effect of BITC on glutathione content in rat liver. Liver from rats fed with BITC 
(0-50 mg/kg BW) for 2 weeks were obtained to measure glutathione content in the cytosolic 
fraction. Results present as mean ± SEM (n=5), * = P < 0.05
93
______________ Chapter 4: In vivo modulation o f CYP450 and Phase II  enzyme activities by BITC
4.3.3.2 Phase II  enzyme activities in rat lung
No change was observed in epoxide hydrolase activity, when using benzo[a]pyrene-4,5-oxide as a 
substrate (Figure 4.11). However, an increase in epoxide hydrolase protein level was evident 
(Figure 4.12). Glutathione 5-transferase, evaluated using CDNB as a substrate, was not altered by 
BITC treatment (Figure 4.11). Protein levels analysed using antibodies recognising GST a  and p 
tended to decrease (Figure 4.12). In contrast, when GST k protein level was determined, a marked 
rise of over 100% was observed at the two higher doses (Figure 4.11). Finally, NADPH:quinone 
oxidoreductase activity was not modulated by the treatment with BITC (Figure 4.11) and, 
similarly, no effect was evident after Western blot analysis (Figure 4.12).
Epoxide liyiJrolase
•i i«Ch
I
Coiifroi Low Medîiïia, High
ClutatMoHe »S?-transferase
Control Low Medittin
NQOl activity
Control Low Medlnta High
Low = 0.5 mg/kg BW, medium = 5mg/kg BW and high = 50 mg/kg Bw.
Figure 4.11 Effects of BITC on Phase II enzyme activities in rat lung. Epoxide hydrolase, 
glutathione 5-transferase and NADPHiquinone reductase were determined in the lungs from rats 
fed with BITC (0-50 mg/kg BW) for 2 weeks. Results are presented as mean ± SEM (n=5)
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Figure 4.12 Effects of BITC on Phase II enzymes protein levels in rat lung. Rats were fed 
with BITC (0-50 mg/kg BW) for 2 weeks before sacrifice. The microsomal (for epoxide 
hydrolase) and cytosolic (for other Phase II enzymes) proteins were separated using gel 
electrophoresis before being transferred to a nitrocellulose membrane. The immunoblot was 
carried out with anti-rat epoxide hydrolase antibody; anti rat-GST-a antibody; anti rat-GST p 
antibody; anti rat GST % antibody; anti rat NQOl antibody followed by peroxidase labelled anti­
rabbit IgG, and all lanes were loaded with 20 pg protein. The figures above the immunoblot are 
percentage values that have been calculated using fluorescence software, where fluorescence from 
the protein level of control group has been set at 100%.
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4.3.4 Effect of BITC treatment on bioactivation of 2-amino-3-methylimidazo[4,5^quinoline
(IQ)
To evaluate the effect of BITC-induced CYPlAl/2 on IQ metabolism, the Ames test employing 
S.typhimurium was performed using BITC-induced CYP 1A 1/2 liver S9 as an activation system. 
The mutagenic response of IQ increased in a dose dependent manner (Figure 4.13), however, no 
difference was observed when using S9 from rats treated with various dose of BITC (0-50 mg/kg 
BW).
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Figure 4.13 The effect of BITC-induced S9 on mutagenic response of IQ in the Ames test.
Mutagenic activity of IQ (0-50 ng/plate) was determined using the Ames test when employing 
S.typhimurium strain YG1024. The activation system was derived from hepatic S9 of rats treated 
with various concentrations of BITC (0-50 mg/kg BW). Data are presented as mean ± SEM of 
triplicate plates. Spontaneous reversion was 30 ± 7. A positive control using Aroclor 1254- 
induced S9, with IQ at the concentration of 5 ng/plate had histidine revertant/plate = 355 ± 32.
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4.4 Discussion
When animal models are employed for clarifying the possible mechanisms whereby natural 
products are beneficial to human health, it is important that the selected compounds are 
administered at dose levels that are equivalent to dietary human consumption. The human intake 
of BITC as glucosinoloate is very difficult to determine because vegetable consumption varies 
widely among socio-economic groups and geographic locations. Generally, human ITC intake is 
based on either food questionnaires or urinary ITC equivalents in a single spot urine specimen, 
neither of which is considered to provide a reliable assessment of long-term human ITC intake.
On the basis of data evaluated from questionnaires, average intake of cruciferous vegetables is 
about 40 g/day in Singapore (Seow et a l, 1998), 19-22 g/day in Japan (Fenwick et a l, 1983), and 
32 g/day in Netherland (Voorrips et al 2000). The level of BITC as glucosinolate in garden cress 
is 49.3 pmol/g or 7.3 mg/g (Vermeulen et al. 2006), and the amount of BITC absorbed after 
consumption was on average 14% of BITC as glucosinolate content present in the vegetable 
(Vermeulen et ah, 2006). For the 70 kg average human BITC exposure can, therefore, be 
estimated to be about 1.1-4.7 pmol/kg/day or 0.2-1.2 mg/kg/day.
Evidence from epidemiological studies suggests an association between consumption of 
cruciferous vegetables and a reduced cancer risk (Voorrips et ah, 2000; Feskanich et ah, 2000; 
Neuhouser et ah, 2003). Pretreatment with garden cress juice, a main source of BITC, or BITC for 
3 days before receiving a single dose of IQ could prevent DNA damage in F344 rats. However, 
the BITC content of garden cress juice was only 28 mg/1 which is three times lower than the 
amount of BITC required to cause Phase II enzyme induction and chemoprotective effects (Kassie 
et a l, 2002). In the present study, BITC was administered to rats at three different doses, namely, 
0.5, 5, and 50 mg/kg which is similar to range of doses reported to have an effect to CYP450 and 
Phase II enzymes (Kassie et a l, 2002; Boysen et a l, 2003). Adverse effect of BITC has been
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demonstrated by Lewerenz and co-workers (1992) who fed rats with diets containing BITC at 
doses of 50, 100 and 200 mg/kg for 4 weeks, and noted that at the high dose of BITC, rats showed 
lower weight gain and food consumption compared with controls. In this thesis, at the higher 
doses of 5 and 50 mg/kg/day which are about 10 and 100 times higher than estimated human daily 
intake, there were not obvious adverse effects.
4.4.1 Effects o f BITC on rat CYP450 activities
Rats fed with a diet containing a high dose BITC demonstrated increased hepatic CYP450 
activities (EROD, MROD, PROD and 7-BQ dealkylation) and CYPlA l, 1A2, 2B1 and 3A 
apoprotein levels. For lung cytochrome P450, only PROD activity was inhibited by dietary 
supplementation with BITC. These results are in agreement with previously report (Huang et al. 
1993).
CYP450 involves both bioactivation and detoxification pathway of carcinogens, induction of 
CYP450 could either promote or prevent carcinogenesis. In case of BITC, it has been reported to 
have dose-dependent chemopreventive effects (Hecht et al. 2002; Kassie et al. 2002; Boysen et al. 
2003). For example, at a low dose (~9 mg/kg) BITC had no effect on DNA and haemoglobin 
adducts, biomarkers of B[a]P metabolic activation (Boysen et al. 2003). Pre-treatment of F344 
rats with BITC (70 mg/kg) for three consecutive days prior to an oral single dose of IQ (90 
mg/kg) significantly reduced DNA damage in colon and liver cells by 75-92% (Kassie et al. 
2002).
The CYPIA subfamily, though it is not a major CYP450 in humans or rodents, is the dominant 
CYP450 in the bioactivation of chemicals. In this thesis, CYP1A2 activity and apoprotein were 
detected only in the liver but not in the lung, while CYPlAl activity and apoprotein were detected 
in both the liver and the lung. This observation is consistent with that reported by Mace and co-
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workers (1998) who demonstrated that CYPlAl but not CYP1A2 mRNA expression could be 
detected in the lung. Induction of CYPIA may either promote or reduce cancer risk. Consumption 
of Brussels sprouts significantly increased human hepatic CYP1A2 activity which subsequently 
resulted in an increase of PhIP excretion (Walters et al. 2004). As Brussels sprouts is a major 
source of ITC, it could be hypothesised that the induction of CYPIA by ITCs favours a 
detoxification pathway rather than a bioactivation pathway, however, more studies are needed to 
understand the underlying mechanism.
In this thesis, BITC increased PROD activity and CYP2B1 apoprotein in the liver but decreased 
both activity and apoprotein levels in the lung. These observations were consistent with a previous 
report by Guo and co-workers (1993) who studied the effect of ITC treatment in rats and mice. 
CYP2B subfamily is responsible for the metabolism of aflatoxin B1 and NNK (tobacco 
carcinogen) (loannides and Lewis 2004). Alteration of CYP2B1 activity could affect 
carcinogenicity/mutagenicity induced by aflatoxin B1 and NNK. Although, BITC decreased NNK 
metabolism in rat lung, it did not alter NNK metabolism in mouse lung. Moreover, treatment with 
BITC did not affect both incidence and multiplicity of NNK-induced lung tumour in mice. This 
implies that more complex mechanisms are involved in the chemopreventive effect of ITCs.
CYP3A subfamily is important in drug metabolism (loannides and Lewis 2004). Induction of 
CYP3A may decrease drug concentration leading to therapeutic insufficiency or failure. In this 
thesis, BITC induced CYP3A activity and apoprotein in the liver but not in the lung, which 
indicated that the effect of BITC on CYP450 is organ specific.
4.4.2 Effects o f BITC treatment on rat Phase II enzymes activities
Phase n  enzymes are important for detoxifying carcinogens through conjugation with acceptor 
molecules such as cellular glutathione, glucuronic acid, and sulphate. Consequently, the effects of
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BITC on hepatic and pulmonary Phase II enzymes were investigated. Hepatic Phase II enzymes: 
epoxide hydrolase and glutathione 5-transferase activities were induced by BITC but there was no 
effect of BITC on NQOl activity. However, a significant change was not achieved at the dietary 
dose. None of the activity was modulated in the lung.
Epoxide hydrolase plays an important role in B[a]P detoxification, since it catalyses conversion of 
the reactive intermediate to dihydrodiol which can be detoxified by conjugation with glucuronide 
and sulphate. However, epoxide hydrolase plays dual roles in B[a]P metabolism, it could also 
produce ^ran^-dihydrodiol which is further oxidised by CYPIA family to dihydrodiol-epoxide, an 
ultimate carcinogen (loannides and Parke 1990). In the present study, BITC increased both 
epoxide hydrolase and GST activity, and showed a tendency to prevent B[a]P-induced 
carcinogenicity/mutagenicity. This hypothesis was supported by a study concerned with the effect 
of BITC on DNA adducts in PAH-treated mice. Sticha et al. (2000) observed that BITC (6.7 
pmol/rat or 1.0 mg/rat), administered 15 minutes before B[a]P to A/J mice, modestly but 
significantly inhibited DNA adduct formation in the lung by 29%.
GSTs are a family of enzymes that catalyse the nucleophilic attack of the sulphur atom of 
glutathione on the electrophilic centres of exogenous and endogenous compounds (Zhang et ah, 
1995). GSTs have been assigned to four major classes: a, p, % and 0 (Mannervik and Danielson,
1988) The liver is the principal site of localisation of GSTAl-1 and GSTMl-1 while GSTPl-1 is 
found principally in extrahepatic tissue, for example lung, kidney etc (Zhang et ah, 1995). Three 
GST substrates were used to study the effect of diet containing BITC on GST activities. CDNB 
was used as broad spectrum GST substrate (Habig et ah, 1974). The p class, Ml/M2-specific, 
activity was evaluated by using DCNB as a substrate (Habig et ah, 1974) while the a and % classes 
were determined by using NBD-Cl as a substrate (Ricci et ah, 1994). BITC was reported as a 
potent inducer of GST in both in vitro and in vivo studies (Guo et al., 1993; Nakamura et ah.
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2000; Zhang, 2000). In this thesis, diet containing BITC increased GST activities in a dose- 
dependent manner and reached statistical significance at the high dose.
GST-Pl is the most abundant isoform in the human lung. It is anticipated to be of particular 
importance in the detoxification of inhaled carcinogens (Anttila et al., 1993). Kolm and 
coworkers (1995) reported that GST-Pl is one of the most efficient isozymes in catalysing ITC 
conjugation with GSH. Although in this present study, the apoprotein level of GST tc in lung 
cytosol was increased by BITC, there was no significant increase observed in GST activities.
Although liver NQOl activity was not induced by BITC, the protein levels determined by 
Western blot showed a 300% increase at the high dose. This implied that BITC may have 
undergone a metabolic process that caused inhibition of NQOl activity. More studies are required 
to understand this mechanism.
4.4.3 Effects o f  BITC-induced hepatic S9 on bioactivation o f  IQ
The presence of mutagenic HA in food was first reported over 20 years ago by Sugimura and co­
workers (1977) following the observation that extracts from cooked meat were mutagenic in the 
Ames/Salmonella assay using the S.typhimurium strains TA98 and TA 100 (Wakabayashi et al.
1992). The mutagenic response of IQ requires a metabolic activation system, and normally 
Aroclor 1254-induced S9 is employed. CYP 450 enzymes in the activation system catalyse the 
conversion of IQ to A-hydroxy IQ, a reactive intermediate. A-hydroxy IQ is converted to O- 
acetyl- or 0-sulfonyl ester by the enzymes acetyltransferase or sulfotransferase to produce the 
mutagenic metabolites. Kamataki and co-workers (1999) reported that the S.typhimurium YG1024 
strain which had 0-acetyltransferase (OAT) over-expression was more efficient in detecting the 
mutagenicity of IQ. In the present study, liver S9 from BITC-treated rats was used as the 
activation system. Since BITC was able to increase the hepatic CYPlAl/2 and other Phase II
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enzymes required in bioactivation of IQ, BITC-induced S9 was expected to increase the 
mutagenic response of IQ in the Ames test. In this thesis, though the number of histidine 
revertants per plate increased in a dose-dependent manner when using various concentrations of 
IQ, BITC treatment had no effect. This indicated that BITC-induced S9 is inefficient in 
modulating the mutagenic response of IQ as determined by the Ames test.
4.5 Conclusion
The effects of BITC-treatment on CYP450 and Phase II enzyme system were organ-dependent. 
While BITC-treatment increased hepatic CYP450 and Phase II enzyme systems in a dose- 
dependent manner, it decreased lung PROD activities and had no effect on other CYP450 and 
Phase II enzyme activities. However, the induction of hepatic enzymes was not sufficient enough 
to modulate the mutagenic response of IQ as determined by the Ames test.
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Chapter 5: Method development
5.1 Introduction
2-Amino-3 methylimidazo[4,5-/|quinoline (IQ) is a member of carcinogens formed in protein-rich 
food during the cooking process and belongs to the class of heterocyclic aromatic amines (HA) 
(Lynch et al. 1995; Sugimura et al. 1977; Turesky et al. 2005). HAs themselves are not 
carcinogenic or mutagenic, but during Phase I and Phase II metabolism they undergo metabolic 
activation, the product of which can lead to DNA adduct formation. (Kato 1986; Snyderwine et al. 
1992; Yamazoe et al. 1983).
5.1.1 Physiochemical properties o f IQ
Physical properties of IQ are shown in Table 5.1. IQ is soluble in methanol, ethanol, and dimethyl 
sulfoxide (DMSO). IQ is stable under moderate acidic and alkaline conditions. IQ is also stable in 
cold aqueous solution protected from light. IQ is easily degraded by diluted hypochlorite (lARC
1993). A solution of IQ in water, DMSO, 95% ethanol, or acetone was reported to be stable for 24 
hours under ambient conditions (lARC 1993).
Table 5.1 Properties of IQ (IARC, 1993)
Property Information
Molecular weight 1982
Color light tan
Physical state crystal
Melting point ("C) >300
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5.1.2 Formation o f IQ
IQ is formed during the heating process of organic products containing nitrogenous compound. It 
is formed at temperatures between 100-300 °C. IQ is generated from creatine, hexose, and amino 
acids through the Maillard reaction and Strecker degradation upon heating. The formation of IQ 
primarily depends on cooking time, temperature, cooking method and type of meat (Ahn and 
Grun 2005a, b). Aeschbacher et al. (1987) reported that creatine and proline heated to 180 ®C will 
produce IQ. IQ is also found in mixtures of creatinine and phenylalanine or creatinine, 
phenylalanine and glucose heated to 200 ®C (lARC, 1993).
5.1.3 Estimated human daily intake
Humans can be exposed to IQ via ingested cooked meat (LARC, 1993) and also from cigarette 
smoke (Yamashita et al. 1986). Turesky (1993) estimated daily IQ exposure of the US population 
based on analysis of various foodstuffs and analysis of HA content, including IQ, is in the range 
from 100 ng to 10 pg per day. When Augustsson et al. (1997) studied the daily IQ intake in an 
elderly population in Stockholm, which was based on the semi-quantitative food survey and 
chemical analysis of HA in cooked food, they estimated the daily IQ intake to be less than 1 
ng/day.
5.1.4 Metabolism o f  IQ
In order to exert its biological effects, IQ requires prior enzyme activation. Oxidation of the 
exocyclic amino group to form the A-hydroxy derivative is mainly catalysed by CYP1A2, and is 
believed to be the initial step in IQ activation (Kato 1986). The A-hydroxy derivative is then 
further activated by O-acetylation or 0-sulfonylation to form A-acetoxy or A-sulfonyloxy species 
that spontaneously break down to release the ultimate carcinogen, believed to be the nitrenium 
ion, resulting in DNA damage and leading to the neoplastic process (loannides and Lewis 2004, 
Turesky 2005).
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IQ is also subject to metabolism through detoxification pathways which include direct 
conjugation of the exocyclic amine group with sulphate, catalysed by sulfotransferases (SULTs) 
or glucuronic acid, catalysed by UDP-glucuronosyltransferases (UGT) (Turesky 2002; Turesky et 
al. 1986). An additional detoxification pathway is the ring oxidation catalysed by CYP1A2 
followed by sulfation or glucuronidation (Turesky et al. 1998). Figure 5.1 shows the principal 
metabolite of IQ.
5.1.5 Analytical techniques fo r the determination o f IQ metabolites
Methods are described in the literature that allows the determination of heterocyclic amines in 
various materials such as cooked food, cigarette condensate, and urine. The procedures consist of 
blue cotton extraction, HPLC, GC/MS and LC/MS (Alexander et al. 1989; Barcelo-Barrachina et 
al. 2004a; Embola et al. 2001; Galceran et al. 1996; Knize et al. 2001; Pais et al. 1997; Santos et 
al. 2004; Snyderwine et al. 1992; Toribio et al. 2000; Turesky et al. 2005; Walters et al. 2004).
5.1.5.1 Sample preparation
IQ and its metabolites are found at trace levels in food or biological fluids, in ng/g level for food 
and pM level in biological fluids (Turesky, 1995). Techniques that selectively concentrate target 
analyte from the complex mixture are required in order to extract IQ and its metabolites from 
complex matrices. Several methods have been applied, for example, liquid-liquid extraction, use 
of Blue cotton, blue rayon, and blue chitin, and tandem extraction etc.
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Figure 5.1 Metabolism of IQ. (loannides and Lewis 2004)
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Liquid-liquid extraction is a method for separating compounds based on their relative solubility in 
two different immiscible liquids, usually water and an organic solvent. The used of liquid-liquid 
extraction to extract IQ and its metabolites was reported by Alexander and co-workers (1989). 
The disadvantage of the method is the requirement of large volumes of solvent, which are 
frequently toxic, and it is also time- and labour- consuming.
Another method employed for extracting of IQ from various types of sample is the use of blue 
cotton, blue rayon and blue chitin. The development of a copper phthalocyanine dye linked to 
supporting material was first reported by Hayatsu and co-workers (1983). The first material 
developed was blue cotton, which is cotton covalently linked to copper phthalocyanine. It can 
selectively absorb aromatic compounds having at least 3 fused rings, such as, HA, polycyclic 
aromatic hydrocarbon and afiatoxin B 1. Blue rayon was subsequently developed. Rayon instead 
of cotton, has the ability to contain two to three times more blue pigment compound. Yoxall et al. 
(2004) studied improved the blue rayon technique for extracting IQ from human urine. They 
reported that blue rayon achieved an extraction of 95% of IQ from human urine, and the amount 
of blue rayon and the nature of the matrix were important for the extraction efficiency. They also 
noted that blue rayon could be washed and re-used without significant loss of efficiency (Yoxall 
et al. 2004). Finally, blue chitin powder column was introduced for extracting HA. This material 
can contain more blue pigment than the previous materials. Moreover, blue chitin column 
required less time. However, with this technique none, or very few, of the two or one ring 
structure compounds could be detected.
SPE has been developed to extract HA and its metabolites from various matrices, for example, 
meat extract, meat juice and urine. Serial steps of SPE have been employed to extract HAs and 
their metabolites by coupling different sorbents. Although this technique requires sample transfer 
and an evaporation step, it achieves high recovery and saves time and solvent volume compared 
to other techniques (Cheng et al., 2006). The SPE cartridges used are mostly 1) strong cation
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exchange; 2) reverse phases or 3) hydrophilic-lipophilic balance (HLB, Oasis cartridge) etc. 
Recovery of the target should be checked to ensure its efficiency and reliability. It could be 
checked by spiking known concentrations of the standard sample.
Tandem extraction is a combination of different sorbents and eluents or coupling of different 
sorbents in tandem, and its advantage is increased selectivity and sensitivity. Gross and Gruter 
(1992) used liquid-liquid extraction on a solid support, followed by a solid-phase extraction with 
cation exchange and Cl 8 column, and this method has been widely used for the extraction of HAs 
from cooked food. Knize et al (2001) also developed a tandem technique to evaluate the 
metabolites profile of HAs in urine. They first applied urine sample through an Oasis HLB 
cartridge in order to remove water and salts from the metabolites. Protein and high molecular 
mass compounds were removed by filtration before being applied through a cation exchange 
column coupled with a Cl 8 column. Using this method, the recovery of metabolites ranged from 
37 -40%.
5.1.5.2 Analytical methods
Several techniques were employed for analysing IQ and its metabolites in biological matrices. 
Most studies used radiolabelled IQ and then characterised IQ metabolites by using enzyme assay, 
then confirmed with NMR or MS. HPLC/Mass spectrometry has been introduced recently in the 
analysis of HAs, and is very useful for characterising complex samples. Moreover, HAs are stable 
during the ionisation process, which make them good candidates for this technique. In order to 
analyse the target molecule by mass spectrometry (MS), it needs to be ionised before transfer into 
the mass analyser, because MS depends on the motion of the gas phase ion in a magnetic electric 
field. One of the ionisation methods that have been used for analysing IQ and its metabolites is 
electrospray ionisation (ESI). ESI is a soft ionisation that can change the target molecule in the 
liquid form to gas phase without requiring heat up (Figure 5.2). ESI is suitable for LC/MS
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because it can be carried out at atmospheric pressure. ESI is not only able to ionise high molecular 
weight molecules (>100 kDa), but it is also suitable for ionised polar compounds, such as, 
glucuronide- or sulphate- conjugates. For the mass analyser, quadrupole mass spectrometer with 
selected ion monitoring mode (SIM) has been frequently used in the last few years. Triple 
quadrupole and ion-trap which provide MS and MS/MS spectra information, have also been used 
and achieve a lower limit of detection. However, the ion trap MS has a limitation for quantitating 
because of the instability of ion vibration caused by repulsion between ions. Recently, quadrupole 
coupled with time of flight (TOF) has been introduced because it provides higher mass accuracy 
which is valuable for quantitating and studying the fragmentation of HAs (Cheng et al., 2006).
C ap illa ry
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Figure 5.2 Schematic of the electrospray ionisation (Mano and Goto, 2003).
5.1.6 Aim o f the study
A major objective of this project was to evaluate whether benzyl isothiocyanate interferes with the 
metabolism of IQ. It was therefore necessary for a sensitive method had to be developed to allow 
the determination of IQ and its metabolites in urine. Several techniques have been employed to 
quantify HAs and metabolites in biological fluids, most of which are not suitable for routine work.
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They require multi step sample preparation and a radioactive marker and were unable to detect the 
metabolites at the low concentrations. The goal of this study was to develop a method to reliably 
quantify IQ metabolites, which could be applied to a large number of samples. The initial step 
was to optimise conditions for LC/MS by using standard IQ solutions, followed by optimisation 
of the extraction procedure using solid phase extraction (SPE) techniques.
5.2 Synthesis of IQ metabolites
To optimise the LC/MS conditions for IQ metabolites, IQ N-glucuronide and N-acetyl IQ were 
synthesised as described below.
5.2.1 Synthesis o f IQ N-glucuronide
An IQ A-glucuronide standard was prepared enzymically by the reaction of IQ (80 mM) with 
uridine 5 ' -diphosphoglucuronic acid ammonium sodium salt (UDGA, 5 mM) in the presence of 
rat liver S9 essentially as described by Luks et al. (1989). Following a 6 -hour incubation at 37 ®C, 
the reaction was terminated by adding ethanol (20 ml.). The precipitated protein was removed by 
filtration and the solution was evaporated in vacuo, and re-dissolved in MilliQ water (5 ml). The 
A-glucuronide was purified by preparative HPLC, under the following conditions; Stationary 
phase (Luna Phenyl-hexyl 5 pm ; 250 x 10 mm; Phenomenex, UK); mobile phase composed of 
20% acetonitrile and 80% ammonium acetate (15 mM); flow rate: 11.1 ml/min. Under these 
conditions, the retention time of IQ A-glucuronide was 2.1 minutes. The collected fractions were 
pooled and freeze-dried. The identity of IQ A-glucuronide was confirmed by infusion into an ion 
trap mass spectrometer (MS/MS with parent ion at m/z [M+H]^ 375 and daughter ion m/z [M+H- 
glu]+ m/z 199) in positive ion electrospray ionisation (ESI) mode.
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5.2.2 Synthesis o f N-acetyl IQ
The A-acetyl IQ standard was prepared chemically by the reaction of IQ in pyridine containing 
20% acetic anhydride at 60®C for 1 hour as described by Turesky et al. (1991). After removal of 
the solvent under reduced pressure, the residue was washed with water and dried in vacuo. The 
identity of A-acetyl IQ was confirmed by ion trap MS in positive ion mode: [M+H]^ at m/z 241.
5.3 Instrument conditions
Two types of MS detectors were employed; LC/TOF-MS and LC/ ion trap MS. Initially, LC/ 
TOF-MS was used, but due to several reasons such as 1) the lack of an IQ-metabolite standard 
solution, 2) very low levels of IQ metabolites generated in the culture media and 3) interference 
compounds present in culture media and urine. LC/ion trap MS was then employed because it 
could be used in both SIM and MS/MS modes.
5.3.1 LC/TOF MS conditions
HPLC was carried out on a Waters Alliance 2695 system (Waters Corporation, Milford, MA, 
USA). The Waters 2695 separation module comprises a binary solvent delivery system, online 
degasser, peltier-cooled autosampler (set at 4°C), controller, and column oven (set at 30°C). This 
system was connected to a Micromass LCT™ Time-of-Flight mass spectrometer (Micromass UK 
Ltd., Manchester, UK) which was operated in positive ion electrospray mode under the following 
optimised conditions: desolvation gas temperature 300°C, source temperature 135°C, capillary 
voltage 4000 V, sample cone voltage 40 V, extraction cone voltage 2 V.
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5.3.2 LC/ion trap MS conditions
LC/MS was carried out on a Surveyor HPLC system (Thermo, Hemel Hempstead, UK), and an 
ion trap mass spectrometer (LCQ DECA Thermo, Hemel Hempstead, UK) equipped with
an electrospray ionisation source (Figure 5.3). Data acquisition was carried out by X-calibur 1.3 
software. Optimised parameters were obtained by tuning on a standard of IQ solution, and 
synthetic IQ A-glucuronide in water. The optimum parameters were as follows: source voltage 2- 
3 kV, capillary voltage 5.00 V, capillary temperature 275 °C, sheath gas 40-70 units, auxiliary 10- 
15 units in positive mode. Source voltage 2.5 kV, capillary voltage -31 V, capillary temperature 
300 °C, sheath gas 65 units, auxiliary 15 units in negative mode. The analysis was carried out 
using both positive and negative ionisation modes. Full scan, single ion monitoring (SIM) and 
selected reaction monitoring (SRM) were applied to establish a suitable technique to identify and 
quantify IQ metabolites.
a
Figure 5.3 LC/MS ion trap machine.
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5.4 HPLC conditions for the determination of 2-amino-3methylimidazo [4,5-/]quinoline (IQ)
5.4.1 UV condition for IQ
The UV spectrum of IQ was obtained using a standard IQ solution and the highest absorbance 
occurs at 255 nm (Figure 5.4). However, the wavelength that was selected for further study was 
280 nm in order to cut off the interference from mobile phase and other artefacts.
5.4.2 Stationary phase
Two types of HPLC column were used, initially experiments were carried out using Synergi Cl 8 
reverse phase column, and this was used to define the HPLC conditions for IQ analysis. This 
column was subsequently replaced with the Gemini Phenyl C6 column, to facilitate the analysis of 
the more polar metabolites of IQ due to its better aromatic selectivity. Conditions were optimised 
for the separation of the ions of N- and 0-glucuronide and sulphamate and 0-sulphate 
metabolites.
5.4.3 Mobile phase conditions
Different mobile phases are described in the literature for the analysis of HAAs and their 
metabolites, including methanol (Embola et al. 2001; Knize et al. 2001), acetonitrile (Wallin et al.
1989), potassium phosphate buffer (Embola et al. 2001; Luks et al. 1989) and ammonium acetate 
buffer (Wallin et al. 1989).
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255.00
Figure 5.4 UV spectrum of IQ in methanol (10 pM).
In this study, the best solvent system for retaining both IQ and its metabolites was a mixture of 
0.5% acetic acid in acetonitrile and ammonium acetate solution (15 mM); ammonium acetate was 
used because of its buffering capacity. Organic solvents such as acetonitrile enable the better 
separation of heterocyclic amines (Barcelo-Barrachina et al. 2004b). However, high concentration 
of ammonium acetate can depress ionisation (Prabhu et al. 2001), consequently to improve the 
ionisation, acetic acid was added to the acetonitrile solution.
5.4.3.1 Concentration o f ammonium acetate
Two different concentrations of ammonium acetate (15 and 30 mM) containing 20% acetonitrile 
were used to determine the optimal aqueous mobile phase conditions. The study was performed 
with 0.1 pg/ml of IQ in methanol using the Synergi CIS column. No differences in IQ retention 
time and detection sensitivity were observed (data not shown). Considering that higher 
concentration of the buffer would decrease the life of the MS detector and cause significant
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problems with ESI (Prabhu et al. 2001), 15 mM ammonium acetate solution was selected for use 
in all subsequent studies.
5.4.3.2 Isocratic vs gradient
Both isocratic and gradient mobile phases at a flow rate of 200 pl/minute were used during 
method development. The isocratic mobile phase consisted of 20% acetonitrile and 80% 15 mM 
aqueous ammonium acetate. The retention time of standard IQ in methanol under this condition 
was 5.4 minutes (Figure 5.5). However, given that the metabolites of IQ are more polar than IQ, 
and therefore would be expected to elute earlier than IQ under standard reverse phase conditions, 
a gradient method was investigated to extend the retention time of IQ. The mobile phase used for 
the gradient comprised of solvent A: 0.5% acetic acid, 99.5% acetonitrile and solvent B: 
ammonium acetate (15 mM). Generally the mobile phase is comprised of an aqueous solution and 
a water-miscible solvent. Acetonitrile, is the most popular organic solvent used in HPLC. 
Ammonium acetate was added into the aqueous solution because it offers better analyte separation 
and ionization. The gradients that were investigated are illustrated in Figure 5.6. Some of the 
gradients were adapted from other publications (Barcelo-Barrachina et al., 2004 a and b) and 
some were adjusted based on HPLC theory. Retention times of IQ from the various gradients are 
shown in Table 5.2. It was apparent that IQ was eluted very fast in the gradients D and E that 
start with 100% acetonitrile as IQ was not retained by the column. The gradient used for the 
study of IQ and its metabolites was a modified gradient H in order to give more time for re­
equilibration of the HPLC column. The protocol of the gradient that was used in subsequence 
studies (Table 5.3) gave a retention time of IQ at 10.7 minutes (Figure 5.7).
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Table 5. 2 The retention time of IQ under different mobile phase gradients. (See Figure 5.6 
for detail of mobile phase composition)
Gradient Retention time (minutes)
A 9.9
B 7.3
C 6.6
D 2.0
E 3.5
F 6.9
G 1.6
H 9.8
Table 5.3 Gradient protocol used for analysing IQ and its metabolites.
Time (minutes) 0. 5% acetic acid in 
Acetonitrile (%)
Ammonium acetate (%)
0 0 100
0.5 5 95
15 20 80
16 100 0
20 0 100
25 0 100
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5.5 Lower limit of detection of standard
The lower limit of detection, based on signal-to-noise ratio of 3:1 (Peters and Maurer 2002), was 
determined by injecting a series of dilutions to the LC/MS. The lower limit of detection of IQ 
solution in water by full scan LC/MS was 2 pmol
5.6 Linearity of standard curve
A standard curve of IQ in water (0-20 jiM) using ion trap LC/MS under the conditions as 
described in section 5.3.2 is shown in Figure 5.8
100i
=  0.7980-
i<0 60-
co
Û
40-i
20-
0 50 100 150 200
IQ (pm ol)
Figure 5.8 Standard curve of standard IQ solution. IQ (0-20 pM) was injected through the LC/ 
ion trap MS. Synergi Hydro Reverse Phase CIS column 150 x 2.1 mm (4pm) was used as 
stationary phase. LC/MS conditions are described in section 5.3.2. Data are individual 
determinations.
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5.7 Sample preparation
In a preliminary study, IQ (50 pM) was incubated with rat liver slices for 24 hour and aliquots of 
media were injected into the LC/MS without any further sample preparation. Only IQ (positive 
ion; m/z 199) and IQ-sulphamate (negative ion; m/z =277) could be detected (data not shown). 
This was thought to be due to a combination of factors, including the possibility that the other 
metabolites had been produced at very low levels below the lower limit of detection, and the salt 
and low molecular weight proteins, which were present in the media, could suppress the 
ionisation of the metabolites. Furthermore, because of a lack of standards for all IQ metabolites, it 
was not possible to optimise the MS conditions for all metabolites. These observations were not 
too surprising, it is documented in the literature that solutions such as culture media, urine and 
other biofluids containing salts and small molecular weight proteins can lead to shorter HPLC 
column life, broadened peaks, suppressed ionisation and increased retention time, commonly 
referred to as matrix effects (Kulp et al. 2000). To try and address as many of these problems as 
possible, it was decided to elean up and eoncentrate the samples.
5.7.1 Liquid-liquid extraction (LLE) o f IQ
This study LLE was performed using a standard of IQ in water and LC/TOF MS (section 5.3.1). 
Ethyl acetate (2 ml) was added to 0.5 ml of IQ solution (0.01 - 0.1 pg/ml) and mixed. Aliquots of 
the ethyl acetate (1.5 ml) fraction were colleeted, dried under oxygen-free nitrogen and re­
dissolved in 0.4 ml of methanol for analysis by LC-MS. The reeovery of IQ using LLE method, 
achieved was only 25%.
5.7.2 Solid phase extraction (SPE) for IQ and its metabolites
SPE is a sample preparation method that uses a solid phase and a liquid phase to isolate the 
eompounds of interest from a solution or complex sample matrix. SPE could solve the problems
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encountered in LLE, which include incomplete phase separation, lower percentage of recovery, 
and the usage of large quantities of organic solvents.
5.7.2.1 Type o f SPE cartridge
Most SPE procedures for the extraction of HAs used a combination of C l8 and cation exchange 
cartridges (Cheng et al. 2006; Knize et al. 2001; Toribio et al. 1999). However, Oasis® HLB 
which is a hydrophilic-lipophilic balance reverse phase sorbent, derived from balance ratio of two 
monomers that provides a special “polar-hook” for enhanced retention of polar analyte, could be 
another option suitable in extracting both IQ and its metabolites. To define the optimal conditions 
for the extraction of IQ, three different SPE cartridges were studied, namely C l8 (Strata C18E, 
Phenomenex), cation exchange (SCX, Phenomenex), and polymer (Oasis® HLB, Waters).
5.7.2.2 Selection o f SPE cartridge
A standard solution of IQ was used to evaluate the extraction potential of each SPE cartridge. 
Three different types of SPE cartridge were selected for use in this study. These were: C l8 
(Strata C18E, Phenomenex), cation exchange (SCX, Phenomenex), and polymer (Oasis® HLB, 
Waters). The five steps involved in the SPE process are illustrated in Figure 5.9, whereas 
conditions are summarised in Table 5.4.
Fractions from each step of the SPE procedure were collected and analysed by LC/MS. In the 
loading step, IQ was detected only when the C l8 cartridge was used. Nothing was detectable from 
SCX cartridge in either the washing or elution step. However, IQ was deteeted from the elution 
step colleeted from C18 and HLB eartridge (Table 5.5). HLB cartridge gave a far better recovery 
and % CV. Reeovery and eoefficient of variation are shown in Table 5.6.
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Table 5. 4 Optimal SPE condition.
CIS Cation exchange Polymer (HLB)
Type of cartridge
(particle size/ pore
size/sorbent
weight)
Strata CIS E
(55uM, 70Â, 
100mg/3ml)
Strata SCX
(55uM, 70À,
100mg/3ml)
Oasis HLB
(30uM, 80À,
60mg/3ml)
Conditioning Methanol (3 ml) 5% Acetic acid in 
Methanol (3 ml)
Methanol (3ml)
Equilibrate Water (3 ml) Water (3 ml) Water (3 ml)
Load lOuM IQ (3 ml) lOuM IQ (3 ml) lOuM IQ (3 ml)
Wash 5% Methanol in water 
(3 ml)
10% Methanol in HCl 
(3 ml)
5% Methanol in water 
(3 ml)
Elute 5% Acetic acid in 
Methanol
Ammonium acetate pH 
8.0
5% Acetic acid in 
Methanol
Table 5.5 Extraction of IQ by various types of SPE cartridge. Three types of cartridge (C l8, 
HLB, and SCX) were evaluated by using IQ (10 pM). Each fraction of solution from steps of SPE 
was collected and analysed by using LC/ ion trap MS.
Cartridge type Loading Washing Elution
CIS 4- - +
HLB - - 4-
SCX -
(-): cannot detect by LC/MS; (+): can detect by LC/MS
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Table 5.6 Comparison of 2 types of SPE cartridge. Percentage recovery and coefficient of 
variation of IQ (10 pM) extraction by using two different types of SPE cartridge (CIS and HLB) 
were determined. Data are presented as mean ± SEM (n= 3)
1 Cartridge type | % Recovery %CV
C18 23.14= 6.0 25.9
HLB 84.94= 8.8 10.3
5.7.2.3 Elution solvent selection
For the optimisation of SPE parameters, culture media from liver slices incubated with a high 
concentration of IQ (50 pM) for 24 hours were used. A number of elution solvents were 
investigated. These were chosen based on their polarity index and acid-basic properties. It was 
noted that the efficiency of extraction of the metabolites fi-om the media was in the following 
order: 5% acetic acid in propan-l-ol > 90% acetonitrile in water >0.1% trifluoroacetic acid (TEA) 
in acetonitrile > acetonitrile > 1% sodium hydroxide in acetonitrile. Under strong acidic 
conditions both IQ-sulphamate and IQ-5-O-sulphate could easily undergo hydrolysis (Knize et al. 
2001; Wallin et al. 1989) and were not detected in the elution solvent containing TFA. However, 
both could be detected in the system containing 5% acetic acid. Under basic conditions, both IQ 
A-glucuronide and IQ-5-O-glucuronide could not be detected in the elution solvent and required 
acidic conditions for maximum recovery (Table 5.7).
5.7.3 Validation o f the method for the determination o f IQ and its metabolites
5.7.3.1 Recovery and precision o f the SPE Assay
From the initial experiments, 5% acetic acid in propan-l-ol achieved the best extraction of 
metabolites of the solvent systems tested. However, additional experiments using samples of 
synthetic A-acetyl IQ and IQ-A-glucuronide indicated that only low recoveries for these
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metabolites could be achieved (20% for N-acetyl IQ and 17% for IQ-N-glucuronide) under these 
conditions. In order to improve the extraction of these polar metabolites, methanol, as a more 
polar solvent, was added to the elution system. The resulting elution mix of 5% acetic acid, 45% 
methanol and 50% propan-l-ol improved the reeoveiy of all of these IQ metabolites (71.1% for 
IQ-N-glucuronide, 74.5% for IQ and 85.3 % for N-acetyl IQ, respectively) (Table 5.8). Standard 
curves after SPE extraction of IQ and N-acetyl IQ were eonstructed (Figure 5.10).
The optimum conditions for SPE of IQ and its metabolites from culture media are presented in 
Table 5.9. 2-Amino-3-trideuteromethyl-3H-imidazo[4,5-/]quinoline (Deuterium IQ; D3 IQ; 5pM) 
was added to each sample before SPE as an internal standard. After SPE, samples were dried 
under nitrogen and re-dissolved in 300 pi of water. Samples were then eentrifuged at 300 g for 10 
minutes before analysis by LC/MS. This protocol was used in all subsequent studies.
An internal standard is usually added to improve precision and accuracy in quantification 
analysis. Ideally, the internal standard should have the same physico-chemieal properties, 
recovery, detector response, and retention time as the analyte. A stable isotope is normally used as 
internal standard for LC/MS because it provides identical structure, recovery and detector 
response as the analyte, but with a sufficient m/z difference. Unfortunately, because of the 
unavailability of a stable isotope for each IQ metabolite, such internal standards could not be used 
in the current studies. Deuterium IQ, which provides the closest structure, was consequently used 
as internal standard for each IQ metabolite. A standard curve for N-acetyl IQ could be 
constructed, as the metabolite was synthesized chemically, and provided good linearity (R^= 0.89; 
Figure 5.1 OB). Interpretation of results using this quantifieation teehnique should take into 
account this limitation.
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Intra- and Inter-day variabilities were determined. In order to evaluate the test of the intra-day 
variability, a standard curve of 5 concentrations, including a blank were determined in 6 
replicates. Three different concentrations of IQ and #-acetyl IQ (2, 5 and 20 pM in media) were 
prepared and stored at -20”C before extraction by SPE on 6 different days to evaluate the inter-day 
variability. The intra- and inter-day assay precision and recovery of SPE extraction for IQ and N- 
acetyl IQ in culture media are summarised in Table 5.10 and 5.11, respectively.
Table 5.8 Percentage recovery of IQ, 7V-acetyl IQ and IQ iV-glucuronide. Data are presented 
as mean ± SEM (n=3).
5% Acetic acid, 
95% methanol
5% Acetic acid, 
95% propan-l-ol
5% Acetic acid, 45% 
methanol, 50% propan-l-ol
IQ 100 ±2.2 40 ± 0.6 74.5 ± 5.7
/V-acetyl IQ 17.5 ±2.8 25 ± 2.5 85.3 ±2.9
IQ A-glucuronide ND 17 ±0.1 71.1 ±2.3
ND ; not detected
100n
0 r 2 = 0.89
40-
20-
150 2001000 50
2.CH
a  1.0-
0.5-
0.0-
2000 50 100 150
IQ (pmol) acetyl IQ (pmol)
Figure 5.10 Standard curve of IQ (A) and iV-acetyl IQ (B) from full scan LC/MS. Serial of 
concentration of IQ (0-20 pM; A) and A-acetyl IQ (0-10 pM; B) were extracted by SPE and 
analysed by LC/MS. Data are individual determinations.
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Table 5.9 SPE protocol for extracted IQ and its metabolite
Type of cartridge
(particle size, pore size, and 
sorbent weight)
Oasis HLB
30uM, 80Â, 60mg/3cc
Conditioning 3 ml of Methanol
Equilibration 3 ml of Water
Loading 5 pM of D3IQ and 3 ml of culture media or 2 ml of urine
Washing 3 ml of 5% methanol in water
Elution 1 ml of 50% methanol, 45% propan-l-ol, 5% acetic acid
Table 5.10 Inter- and intra-day variation in the determination of IQ in culture media. Data 
are presented as mean ± SEM (n=6).
IQ (pM)
Intra-day (n =6) Inter-day (n =6)
Recovery (%) CV (%) Recovery (%) CV (%)
2 76.5 ± 11.6 13.9 82.9± 11.1 10.6
5 62.5 ± 6.7 10.8 69.4 ± 17.6 7.8
20 74.5 ±3.2 3.4 94.4 ±7.1 5.9
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Table 5.11 Inter- and intra-day variation of the determination of the iV-acetyl IQ in culture 
media. Data are presented as mean ± SEM (n=6).
A-acetyl IQ (pM)
Intra-day (n -6) Inter-day (n =6)
Recovery (%) CV (%) Recovery (%) CV (%)
2 75.4 ±2.7 7.8 80.9 ± 7.6 10.5
5 63.7 ±6.1 10.2 63.7 ± 14.9 2fr5
20 8^ 3± 7A 9.4 73.34 ± 11.6 16.6
5.7.3.2 Limit o f detection
Lower limit of detection (LLD) was evaluated based on a signal to noise ratio of 3:1. LLD for the 
SPE technique of IQ and A-acetyl IQ were 2 and 10 pmol, respectively. The lower limit of 
quantification (LLQ) was evaluated based on a signal to noise ratio greater than 10 (Peters and 
Maurer 2002). LLQ for the SPE technique of IQ and A-acetyl IQ was 20 pmol for both 
compounds.
5.8 Mass spectrometric detection of IQ and its Metabolites
Because of the complexity of the culture media following incubation of the parent compound with 
rat liver slices and very low levels of metabolites generated, HPLC detection with UV failed to 
detect any of the IQ metabolites. Metabolites of IQ extracted from culture media using the 
optimised SPE extraction technique were detected using ion trap mass spectrometry on the LCQ 
DECA XP' ’^“® using condition described in section 5.3.2.
Full scan mode was employed to detect IQ and deuterium IQ (internal standard) as the 
concentrations of IQ and deuterium IQ in the study were higher than the lower limit of 
quantification. However, full scan mass spectrometry failed to separate signals from IQ 
metabolites from background noise. In order to address IQ metabolism, in the first instance
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MS/MS was used to target the specific m/z of each of the individual metabolites and provide 
fragmentation information to confirm their identity (Figure 5.11 and Table 5.12). Daughter ions 
found were compared to those reported in the literature (Alexander et al. 1989; Luks et al. 1989; 
Snyderwineetal. 1992).
Once the retention times of each of the metabolites was ascertained, SIM was used to increase 
sensitivity, except for IQ J-O-glucuronide, which has m/z similar to the plasticiser {m/z = 391). In 
this case MS/MS of the selected parent m/z (SRM) was used. The data were collected from area 
under peak of daughter ion. IQ, A-acetyl IQ and both IQ-iV- and IQ-5-O-glucuronide could be 
detected in the positive ion mode, whereas IQ-J-O-sulphate and IQ-sulphamate could be detected 
only in the negative ion mode. As a result, each sample had to be analysed in both positive and 
negative ion modes. Figure 5.11 represents the mass chromatograms from culture media of liver 
slices incubated with IQ (50 pM) for 24 hours and extracted by SPE; IQ and its metabolites were 
clearly detected.
5.9 Metabolism of IQ by rat liver slices
5.9.1 Time-dependent disappearance o f IQ from culture media
Precision-cut rat liver slices were prepared as described in the Chapter 2 (section 2.2.2) before 
being incubated with IQ (lOpM) in culture media for various time periods (0-24 hours). At the 
end of each period, slices were removed and the culture media filtered through 2.2 pm ministar® 
filters. Aliquots of culture media were spiked with 50 pi of internal standard (5 pM deuterium IQ 
in DMSO). LC/MS was carried out using LC/TOF under the conditions described in section 5,3.1. 
Approximately 50% of IQ remained unmetabolised in the media after 24-hours incubation (Figure 
5.12) indicating the metabolism of the heterocyclic amine in this system. Further studies to 
include metabolite identification and quantification were conducted.
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Figure 5.12 Metabolism of IQ by rat liver slices. Precision-cut rat liver slices were incubated 
with IQ (50 irM) for various time periods (0-24 hours). Media were collected at the end of each 
period and extracted by SPE teclmique and analysed by LC/MS. Data are presented as mean 
±SEM, each analysis was performed in triplicate.
5.9.2 Time-dependent generation o f IQ-metabolites
Two preliminary studies were conducted to evaluate the time-dependent generation of IQ 
metabolites. In the first study, liver slices were incubated at various concentrations of IQ (0-50 
pM) for 24 hours. Culture media were then collected and the levels of IQ and its metabolites were 
determined by SPE/ESI/LC/MS. IQ and five metabolites namely iV-acetyl IQ, IQ-A^-glucuronide, 
IQ-5-O-glucuronide, IQ-5-O-sulphate, and IQ-sulphamate were generated in a concentration- 
dependent manner (Figure 5.13). The major metabolites were TV-acetyl IQ and IQ-sulphamate. 
Similar findings have also been reported in rat hepatocyte and in rat in vivo studies (Alexander et 
al. 1989; Inamasu et al. 1989; Luks et al. 1989). In order to evaluate the effect of pre-treatment 
with BITC on IQ metabolism, the second study was carried out by pre-incubating rat liver slices 
for 24 hours before being incubated with IQ. Liver slices were incubated in culture media for 24 
hours before being transferred into media containing various concentrations of IQ (0-50 pM) and 
incubated for another 24 hours. The level of unchanged IQ was higher compared with the first 
study without an initial 24-hour pre-incubation, hi the case of IQ metabolites, only N-acetyl IQ 
and IQ-sulphamate were detected (Figure 5.13). Since liver slices are not sufficiently viable to 
carry out IQ metabolism after 24-hour pre-incubation no further studies were undertaken with this 
protocol.
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Figure 5.13 Concentration-dependent metabolism of IQ by precision-cnt rat liver slices.
Liver slices were incubated with various concentrations of IQ (0-50 gM) for 24 hours. The 
culture media were collected for SPE extraction and metabolites identified and quantified using 
the LC/MS procedure. Results are presented as mean ± SEM (n=4). ■ ■ = 3 0  minutes
preincubation and " *  ' = 24 hours preincubation.
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5.9.3 Metabolism o f IQ by liver slices from p-naphthoflavone-induced rats
In order to study the validity of this system to assess the metabolism of IQ, male Wistar albino 
rats (200g; n=4) were treated with a single daily intraperitoneal injection of P-naphthoflavone (25 
mg/kg) for 3 days. The animals were killed 24 hours after the last administration. Liver slices 
were prepared as described in section 2.2.2. Slices were then incubated in media containing IQ 
(20 gM) for various time periods (0-24 hours). When slices from ^-naphthoflavone-treated rats 
were used, the rate of disappearance of unchanged IQ was enhanced (Figure 5.14). /V-acetyl IQ 
and IQ-sulphamate were the major metabolites when slices from non-induced rats were used, 
while the conjugates of 5-hydroxy IQ, i.e. IQ-5-O-glucuronide and IQ-5-O-suphate were 
dominant in p-naphthoflavone-treated rats. The production of IQ-A^-glucuronide was unaltered by 
the treatment with P-naphthoflavone.
5.10 Application of the SPE/LC/MS method to study the in vivo metaholism of IQ in rats
5.10.1 Precision and accuracy
Synthetic IQ, W-acetyl IQ and IQ-W-glucuronide were used to study the reproducibility of 
recovery of IQ metabolites from rat urine extracted with SPE. The reproducibility was assessed 
using 6 replicates of a standard mixture (O-lOOgg/ml). Standard curves of SPE extraction of IQ 
and iV-acetyl IQ were determined (Figure 5.15). The percentage recovery of IQ iV-glucuronide 
from SPE extraction using urine as a matrix is 83.8%.
The intra- and inter- day assay validations for low, medium and high concentrations of IQ and N- 
acetyl IQ concentration in rat urine are summarised in Table 5.13 and 5.14, respectively.
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Figure 5.14 Metabolism of IQ by precision-cut liver slices from rats induced with fi- 
naphthoflavone. Precision-cut rat liver slices from control ( — ) and p-naphthoflavone-treated 
rats ( — ) were incubated with media containing IQ (20 pM) for various time periods (0-24 
hours). The culture media were collected for SPE extraction and metabolites identified and 
quantified using an LC/MS procedure. Results are presented as mean ± SEM (n-3)
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Figure 5.15 Standard curve of IQ (A) and 7V-acetyl IQ (B) using full scan LC/MS. Data are 
individual determinations.
Table 5.13 Inter- and intra-day variation in the determination of IQ in rat urine
IQ in urine (juig/ml)
In tra day (n =6) In ter day (n =6)
Recovery (%) CV (%) Recovery (%) CV (%)
1 87.1 ± 5.6 6.4 73.5 ±26.7 15.7
10 106.9 ±3.4 3.2 77.0 ± 10.8 21.6
100 133.4 ±6.3 4.7 125.5 ±5.3 11.9
Table 5.14 Inter- and intra-day variation of determination of A-acetyl IQ in urine
V-acetyl IQ in urine (^g/ml)
In tra  day (n =6) In ter day (n =6)
Recovery (%) CV (%) Recovery (%) C V (% )
1 127.6 ± 12.7 20.9 121.04 ± 17.2 21.2
10 75.6 ± 16.5 14.3 72.74 ± 19.1 22.5
100 89.9 ± 16.3 5.9 71.54 ±27.9 36.9
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5.10.2 Limit o f detection
The lower limit of detection of the SPE technique for IQ and V-acetyl IQ, based on a signal to 
noise ratio of 3:1, was 0.1|iig/ml and 0.5|ig/ml respectively. The lower limit of quantification, 
based on a signal to noise ratio of 10:1, of IQ and V-acetyl IQ was Ipg/ml for both compounds.
5.10.3 In vivo metabolism o f  IQ by rats
The SPE methodology used for determining IQ and its metabolites in culture media was also 
applied to the determination of the compound in rat urine. LC/MS/MS was necessary for the 
analysis of IQ metabolites since urinary compounds co-eluted and interfered with quantification. 
IQ metabolite profile was similar to that reported in the literature.(Armbrecht et al. 2007; Embola 
et al. 2001; Kestell et al. 2004; Luks et al. 1989).
Initially, IQ-metabolite profile in urine was studied following a single oral administration of IQ by 
gavage (0-20 mg/ kg). Urine samples were collected every 24 hours for 72 hours. IQ and its 
metabolites were generated in a concentration-dependent manner. Five major metabolites of IQ 
were observed in the first 24-hr urine sample at all doses (Figure 5.16). After 72 hours, IQ and its 
metabolites were found only in urine from rats treated with the highest dose of IQ (20 mg/kg 
BW). To evaluate the effect of CYP450 on IQ metabolism, y^-naphthoflavone-induced rats were 
used. It was noted that the levels of IQ, V-acetyl IQ and IQ -sulphamate in the urine from the 
induced rats were lower but no statistical significance was achieved due to the wide variation 
(Figure 5.17). IQ-5-O-glucuronide and IQ-5-O-sulphate excretion showed a slight increase in rats 
treated with y^-naphthoflavone, however, it did not show a statistical singnificance. These 
observations are consistent with those reported by Armbrecht et al (2007) who studied the 
metabolism of IQ in young and old rats. However, they found that y5-naphthoflavone treatment 
significantly increased IQ-5-O-glucuronide and IQ-5-O-sulphate in both age groups.
141
Chapter 5: Method development
"4"(N
IQ
20-
15-
10-
5-
0.5 1.0 5.0 10.0
IQ dose (mg/kg)
20.0
(U
I 3.5^
<N 2.5- 
*3  20-  
1.5-
1.0-
0.5-
0.0
iV-acetyl IQ
T------- 1----- “ T---
0.5 1.0 5.0 10.0
IQ dose (mg/kg)
BiI
20.0
OJ
I
Tj-
CN
0.29-
0.24*
0.19.
0.14.
0.09.
0.04.
c/3 0.015-1*
15I
p
0.010.
0.005.
0.000.
IQ-7V-glucuronide
5.0 10.0
IQ dose (mg/kg)
20.0
Ü
I 0.40-
035-
030-
025-020-
015-
010- 1-
006- p
005-
004-
003-
002-
001-
ooo-L-
IQ-5“0-glucuromde
T -
0.5 1.0
r-
10.0
‘T -
20.0
IQ dose (mg/kg)
IQ-sulphamate
(N
5.0-
2 5 -
0.5 1.0
IQ dose (mg/kg)
20.05.0 10.0
CN
IQ dose (mg/kg)
Figure 5.16 Urinary profile of IQ metabolites in rat. IQ and metabolites presented in 24-hour 
(taassa)^ 48-hour ( lê oM ) and 72-hour ») urine samples were collected after treatment with a 
single doses of IQ (0-20 mg/kg). Data are expressed as area/internal standard area/ 24 hr urine 
volume. Bars are the mean ± SEM. (n=3)
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Figure 5.17 Effect of treatment with P-naphthoflavone on the metabohsm of IQ in rat.
Control ( Baaaaaai) and p-naphthoflavone-induced ( t a a a )  rat were treated with a single oral dose 
of IQ (5 mg/kg). Urine samples were collected every 24 hours and wee determined by LC/MS. 
Data are expressed as area/internal standard area/ 24 hr urine volume. Bars represent the mean ± 
SEM (n=3).
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5.11 Discussion
The SPE/LC/MS method was developed in order to evaluate IQ and its metabolites in biological 
matrix. The method used in the present study is not a fully quantified method due to the lack of 
standard of each of the IQ metabolites. Identification of the IQ metabolites in this study was based 
only on the m/z and retention times of each metabolite and the quantification based on the relative 
change of peak area and the assumption that all metabolites response to the MS in the same way, 
despite IQ 5-0-sulfate and IQ-sulphamate responds in the negative mode while the other responds 
in the positive mode. However, this method was able to show the pattern of IQ metabolism in 
both in vitro and in vivo model and the change of IQ metabolism pattern response to induction of 
CYP450. To validate this method, the accuracy and precision of this SPE/LC/MS method was 
evaluated at 4 concentrations including blank, both inter- and intra-day. The %CV was calculated 
and most of them were within 20%, which is the requirement of Journal of Chromatography B 
(Peters and Maurer 2002). This procedure could be made more reliable, but requires more work, 
includeing the use of radiolabeled IQ and an enzyme assay (Armbrecht et al. 2007; Inamasu et al. 
1989; Luks et al. 1989)
5.12 Conclusion
An LC/MS method was developed and validated for the determination of IQ and its metabolites in 
culture media and rat urine. IQ was metabolised in a concentration- and time dependent manner 
by both liver slices and rats. The metabolism of IQ was stimulated in rats treated with the CYPIA 
inducer, y5-naphthoflavone, by increasing the levels of IQ-5-O-glucuronide and IQ-5-O-sulphate. 
The development procedure could be applied in studies to assess the effect of potential 
chemopreventive compound in the metabolism of IQ.
144
Chapter 6:
Modulation of 2-amino-3- 
methylimidazo [4,5-/I quinoline (IQ) 
metabolism by isothiocyanates
Chapter 6: Modulation o f  IQ metabolism by ITCs
6.1 Introduction
Food is a complex matrix that includes nutrients, phytochemicals and carcinogenic/genotoxic 
compounds such as heterocyclic amines (HA). One member of HA, 2-amino-3methylimidazo[4,5- 
/Iquinoline (IQ), is reported to be a potent carcinogen in rodents and non-human primates 
(Adamson et al. 1990; Turesky 2005). IQ is a promutagen and requires bioactivation to exert its 
mutagenicity/carcinogenicity. The metabolism of IQ has been extensively studied and involves 
both cytochrome P450 and Phase II enzymes (Turesky 2005; Uhl et al. 2004).
More than 600 complex mixtures and individual compounds present in human diet have been 
studied for possible chemoprotective activity towards HA (Humblot et al. 2004; Knize et al. 2002; 
Walters et al. 2004). Among them, cruciferous vegetables have been reported to prevent IQ- 
induced genotoxicity and formation of preneoplastic lesions (Humblot et al. 2004; Kassie et al. 
2002; Uhl et al. 2004). Humbolt et al (2004) demonstrated in rats that brassica vegetable 
consumption protected against the induction of preneoplastic lesion by IQ in liver and colon. Uhl 
et al. (2004) reported that F344 rats treated with juice of different cruciferous vegetables in the 
drinking water displayed pronounced reduction in IQ-induced preneoplastic lesions, and it was 
believed that isothiocyanates were responsible for this chemopreventive effect. It was 
hypothesised that ITC prevents carcinogenesis by altering cytochrome P450 and Phase II enzyme 
activities, thus modulating the bioactivation and detoxification of IQ.
The aim of this study was to explore the effectiveness of ITC in enhancing detoxification 
pathways of IQ in rats. To achieve this objective, two approaches were utilised. An in vitro study 
was carried out employing precision-cut liver slices where IQ metabolites secreted in the medium 
in the presence and absence of BITC were determined by SPE LC/MS. In a second approach, 
urinary excretion of mutagens and promutagens was assayed in animals treated with ITCs and a 
single dose of IQ. Urinary excretion of mutagens was assessed using the Ames test and employing
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S.typhimurium strain YG1024. Moreover, IQ and metabolic profile in urine were similarly 
determined using SPE LC/MS.
6.2 Methods
6.2.1 Effect o f  BITC on the mutagenicity o f  IQ
6.2.1.1 Preliminary study
Male Wistar albino rats (200-250 g) were kept individually in metabolic cages. Urine was 
collected 24 hours before the administration of a single dose of IQ (0.5-50 mg/kg) by gavage. 
After the IQ administration, urine was collected every 24 hours up to 72 hours. Urine samples 
were centrifuged at 1000 g for 15 minutes in order to remove solid material, and the supernatant 
was collected and filter-sterilised (0.2 pm Ministar filters, performed in a class 2 safety cabinet). 
Urine samples were tested for mutagenicity at a range of volumes (0-200 pi) using S.typhimurium 
strain YG 1024 in the presence of an activation system (10%, v/v) as described in the section 
2 .2 . 10.
6.2.1.2 Experimental study
Male Wistar albino rats (200-250 g) were acclimatised to their surroundings for about 1 week. 
Diet and water were freely available to all rats throughout the experiment. Rats were randomly 
allocated into 4 groups, each consisting of 4 animals. Rats were fed with rat and mouse expanded 
diet (BK 0011) for 2 weeks. The diet of three groups was supplemented with BITC at 0.5, 5 and 
50 mg/100 g diet respectively, which is equivalent to daily doses of 0.5, 5, or 50 mg/kg/day, 
whereas the last group served as a control. After 2 weeks, rats were individually kept in 
metabolism cages and urine was collected for 24 hours before rats were treated with a single dose 
of IQ (5 mg/kg) by gavage. Urine collection was continued every 24 hours up to 72 hours 
following the IQ intake. Urine samples were centrifuged at 1000 g for 15 minutes, then filter- 
sterilised into sterile tubes and stored at -20°C until use.
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6.2.2 Effect o f  BITC on IQ metabolism in liver slices
Liver slices were prepared as described in section 2.2.1. The effect of BITC (0-25 pM) on 2- 
amino-3-methylimidazo[4,5-/|quinoline (IQ) metabolism (20pM) was investigated following 
incubation with rat liver slices for 24 hours. At the end of incubation, culture media samples were 
collected, centrifuged and filtered (0.2 pm. Ministar) before being kept at -20 ®C for further study.
6.2.3 Effect o f  ITC on the metabolism o f IQ in rats
6.2.3.1 Effect o f long term-ITC treatment on IQ metabolism
Rats (200g) were randomly allocated into 4 groups; each group consisted of 4 rats. Group 1 
served as control. Groups 2, 3 and 4 were assigned to be fed with diets supplemeted with BITC at 
0.5, 5 and 50 mg/100 g respectively, which is equivalent to daily doses of 0.5, 5, and 50 mg/kg 
(3.3, 33, and 330 pmol/kg) for 2 weeks. At the end of this period, rats were individually kept in 
metabolism cages and urine was collected for 24 hours. After 24 hours, rats were treated with a 
single dose of IQ (5 mg/kg) by gavage and urine samples were collected every 24 hours up to 48 
hours.
In the second experiment, 4 groups of 4 rats each were similarly used. Group 1 served as control 
whereas groups 2, 3 and 4 were maintained for 2 weeks on PEITC at 1.1, 11 and 110 mg/ lOOg 
diet respectively, which corresponds to 0.1, 1.1, and 11 mg/kg/day (0.6, 6, and 60 pmol/kg/day). 
At the end of this period, all rats received a single oral dose of IQ (5 mg/kg) by gavage, and 24- 
hour urines were collected before, and 48 hours after, IQ administration. Urine samples from 
both studies were centrifuged at 1000 g for 15 minutes, filter-sterilised into sterile tubes and 
stored at -20”C until use. In this experiment, animal treatment was carried out by Nattaya Konsue.
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6.2.3.2 Effect o f short-term ITC treatment on IQ metabolism
To evaluate the short-term effect of ITC treatment on IQ metabolism, three experimental studies 
were conducted. In experiment 1, two groups of four animals were used, the first group served as 
a control and a second group was treated with BITC (50 mg/kg/day). In experiment 2, two groups 
of four animals were similarly used, the first group served as a control whereas a second group 
was treated with PEITC (11 mg/kg/day). In this experiment, the animals were treated hy Nattaya 
Konsue. In experiment 3, rats were allocated into 3 groups, which consisted of a control, a 
sulforaphane-treated group (150 mg/1 in drinking water, equivalent to 12 mg/kg/day or 70 
pmol/kg/day) and an erucin-treated group (150 mg/1 in drinking water, equivalent to 12 
mg/kg/day or 70 pmol/kg/day). In all studies, ITC treatment commenced 24 hours prior to IQ 
administration (5 mg/kg) and maintained for the whole experiment. Twenty-four-hour urine 
samples were collected before and 48 hours after IQ gavage. Urine samples from all studies were 
centrifuged at 1000 g for 15 minutes, filter-sterilised into sterile tubes and stored at -20®C until 
use.
6.2.4 Sample preparation and analysis
IQ and its metabolites in culture media and urine samples were extracted by SPE (Table 5.9) and 
semi-quantified by LC/MS (Section 5.3.2).
6.2.5 Statistical analysis
Data was calculated as percentage of total IQ excreted in urine (for IQ) and percentage of total 
metabolites (for IQ metabolites). Student’s t test was used for statistical comparison.
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6.3 Results
6.3.1 Effect o f  BITC on the mutagenicity o f IQ
6.3.1.1 Preliminary study
The objective of this preliminary study was to monitor the pattern of IQ-induced mutagen 
excretion. In the absence of an activation system, the mutagenic response was very poor, and no 
dose-dependent relationship could be established (data not shown). In the presence of an 
activation system, urine from rats treated with a single dose of IQ (0.5-20 mg/kg) induced 
mutagenic response in a dose dependent manner. Most of the mutagenicity was excreted during 
the first 24 hours after IQ administration (Figure 6.1). On the basis of these results, an IQ dose of 
5 mg/kg and a urine volume (100 pi) was used in all subsequent mutagenicity studies as they give 
a good mutagenic response (Figure 6.2).
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Figure 6.1 The Preliminary pattern of excretion of urinary promutagens in rats treated with
IQ. Mutagenic activity was determined using the Ames test, employing S. typhimurium strain YG 
1024 in the presence of an activation system (10% v/v) derived from rats treated with Aroclor 
1254. Rats were treated with a single dose of IQ (0.5-20 mg/kg) by gavage. Urine was collected 
every 24 hours up to 72 hours following administration of IQ. Data are presented as histidine 
revertants per 24 hours urine ± SEM. Each analysis was performed in triplicate. The spontaneous 
reversion rate of 13 ± 1 has already been subtracted.
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6.3.1.2 Effect o f BITC on the urinary excretion ofpromutagens in rats treated with IQ
In the presence of an activation system, a marked mutagenic response was seen in the urine 
following IQ treatment (Figure 6.3). Most of the mutagenic activity was presented within the first 
24 hours. Lower but detectable levels were present in the 48-hour and 72-hour samples. At the 
higher doses (equivalent to 5 and 50 mg/kg/day)^ BITC treatment caused a modest increase in 
mutagenic response which was not statistically significant (Figure 6.3).
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Figure 6.2 Preliminary study to determine promutagen excretion in rats treated with IQ.
The 24-hour urine samples were collected from rats treated with a single oral dose of IQ (5-20 
mg/kg). Urine samples were tested over a range of volumes (0-100 pi), all made up to 100 pi with 
water. Mutagenic activity was determined using the Ames test, employing S.typhimurium strain 
YG1024 in the presence of an activation system derived from rats treated with Aroclor 1254. Data 
are presented as mean ± SEM of triplicate plates.
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Figure 6.3 The effect of dietary BITC on the excretion of promutagen in the urine of rats 
treated with IQ. Rats were fed with diet containing BITC (0-50 mg/kg BW) for 2 weeks before 
being treated with a single oral dose of IQ (5 mg/kg). Urine samples were collected eveiy 24 
hours up to 72 hours following administration of IQ. Mutagenic activity in all samples was 
determined using the Ames test, employing S.typhimurium strain YG 1024 in the presence of an 
activation system (10% v/v) derived from rats treated with Aroclor 1254. Data are presented as 
mean ± SEM. Each analysis was performed in triplicate. The spontaneous reversion rate of 14 ± 3 
has already been subtracted.
6.3.2 Effect o f  BITC on IQ metabolism by liver slices
In order to evaluate the effect of BITC on IQ metabolism by rat liver slices, IQ and its metabolites 
were assumed to give the same response to the LC/MS. There were only 5 metabolites of IQ 
detected in the culture media. Major metabolites were W-acetyl IQ and IQ-sulphamate. The minor 
metabolites were IQ W-glucuronide, IQ 5-O-glucuronide and IQ 5-O-sulphate. BITC (0-25 pM) 
did not show any significant effect on IQ metabolism by rat liver slices (Figure 6.4).
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Figure 6.4 Effect of BITC on IQ metabolism by liver slices. Liver slices were incubated with 
IQ (20 pM) and various concentration of BITC (0-25 pM) for 24 hours. Culture media samples 
were collected (4 slices per concentration) for SPE extraction and metabolite identification and 
semi-quantification by LC/MS was performed in duplicate. Data are expressed as mean ± SEM 
(n=l 0 rats), the measurements were done in triplicate.
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6.3.3 The effect o f  ITC on the metabolism o f IQ in rats
6.3.3.1 Effect o f  long-term BITC treatment on IQ metabolism in rats
Results from Chapter 4 demonstrated that treatment of rats with BITC induced CYP450 and 
Phase II enzyme activities. To explore whether the changes in these enzyme activities had the 
potential to modulate the metabolism of carcinogens, the same BITC treatment protocol was 
applied before gavaging rats with the pro-carcinogen, IQ (5 mg/kg). Urinary excretion of IQ and 
its metabolites was monitored by LC/MS analysis. No IQ or metabolites were detected in urine 
collected 24 hours before IQ administration (data not shown). Most of IQ excretion was presented 
within the first 24 hours and only very low levels were found in the 48-hour sample. There was no 
significant difference in urinary IQ excretion in all groups in the first 24 hours, hr the 48-hour 
urine samples, rats treated with the low dose of BITC (0.5 mg/kg/day) excreted more 
unmetabolised IQ. However, there was no statistical significant difference in the IQ excretion of 
total IQ (Figure 6.5).
The major metabolites found in the control group were jV-acetyl IQ, IQ J-O-glucutonide and IQ- 
sulphamate. Most of the metabolites were excreted in the first 24 hours, and only very low levels 
were detected in the 48-hour urine. The patterns of metabolite excretion in 24-, 48-hour urine and 
in total amount are presented in Figures 6.6-6.8. In the 24-hour urine samples, a significant 
increase in IQ J-O-glucuronide and IQ 5-0-sulphate levels was noted at the highest BITC dose 
(50 mg/kg/day). IQ-sulphamate excretion significantly decreased in rats treated with medium and 
high doses of BITC. Total metabolite excretion (Figure 6.8), indicated a statistical significant rise 
in IQ 5-O-glucuronide and IQ 5-O-sulphate excretion, whereas the decreased IQ-sulphamate 
excretion did not attain any significance.
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Figure 6.5 Effect of long-term BITC treatment on urinary IQ excretion. Rats were treated 
with BITC-supplemented diet for 2 weeks prior to IQ (5 mg/kg) administration. IQ was 
determined in the urine of rats by LC/MS. Data are presented as mean ± SEM (n=4), * = P< 0.05.
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Figure 6.6 The effect of long-term BITC treatment on 24-hour urinary IQ metabolite 
excretion. Rats were treated with BITC (0-50 mg/kg BW) for 2 weeks before IQ (5 mg/kg) 
administration. Urine samples were collected 24 hours after a single IQ treatment and were 
analysed by LC/MS. Data are presented as mean ± SEM (n=4), * = P< 0.05.
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Figure 6.7 The effect of long-term BITC treatment on 48-hour urinary IQ metabolite 
excretion. Rats were treated with BITC (0-50 mg/kg BW) for 2 weeks before IQ (5 mg/kg) 
administration. Urine samples were collected from 24-48 hours after a single oral dose of IQ and 
were analysed by LC/MS. Data are presented as mean ± SEM (n=4).
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Figure 6.8 The effect of long-term BITC treatment on total urinary IQ metabolite excretion.
Rats were treated with BITC (0-50 mg/kg BW) for 2 weeks before IQ (5 mg/kg) administration. 
Urine samples were collected 0-48 hour after a single IQ treatment and were analysed by LC/MS. 
Data are presented as mean ± SEM (n=4), * = P< 0.05.
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6.33.2 Effect o f long term PEITC treatment on IQ metabolism in rats
Long-term treatment with PEITC showed decreased IQ excretion at the highest dose (Figure 6.9). 
In the 24-hour urine, the highest dose of PEITC significantly increased /V-acetyl IQ. Decreased IQ 
N  -glucuronide and IQ-sulphamate excretion were also evident at the same dose, however, only in 
the later case was statistical significance achieved (Figure 6.10). In the 48-hour urine (Figure 
6.11), A^-acetyl IQ excretion was below the lower limit of detection. Rats treated with the medium 
and high doses of PEITC showed marked increase IQ 5-O-glucuronide and IQ 5-0-sulphate 
excretion. IQ-sulphamate was not detected in the 48-hour urines of the rats treated with the same 
dose (Figure 6.11). When the total excretion of each metabolite was calculated, only the increase 
in A -^acetyl IQ excretion and decrease in IQ-sulphamate excretion were statistically significant 
(Figure 6.12).
6.3.3.3 Effect o f short-term BITC treatment on IQ metabolism in rats
Feeding rats with a diet containing BITC (50 mg/kg/day) 24 hours prior to IQ (5 mg/kg) 
administration caused reduction in urinary IQ excretion, but statistical significance was not 
achieved due to a wide variation and a small sample group (Figure 6.13). In the 24-hour urine, 
BITC caused a marked and significant increase in IQ 5-0-glucuronide excretion. IQ J-O-sulphate 
excretion also showed a marked increase, but statistical significance was not attained because of a 
wide variation. IQ-sulphamate excretion decreased significantly in rats treated with BITC (Figure 
6.14).
In the 48-hour urine, W-acetyl IQ and IQ 5-0-sulphate could not be detected. IQ 5-O-glucuronide 
showed significantly increased excretion in rats treated with BITC but IQ-sulphamate excretion 
significantly decreased (Figure 6.15). When calculating the total excretion of each metabolite, it 
was clear that short-term exposure to BITC increased IQ 5-O-glucuronide and decreased IQ- 
sulphamate excretion (Figure 6.16).
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Figure 6.9 The effect of long-term PEITC treatment on urinary IQ excretion. Rats were 
treated with PEITC (0-110 mg/kg BW) for 2 weeks before IQ (5 mg/kg) administration. Urine 
samples were analysed by LC/MS. Data are presented as mean ± SEM (n=4), * = P< 0.05.
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Figure 6.10 The effect of long-term PEITC treatment on 24-hour urinary IQ metabolite 
excretion. Rats were treated with PEITC (0-110 mg/kg BW) for 2 weeks before IQ (5 mg/kg) 
administration. Urine samples were collected 24 hour after a single IQ treatment and were 
analysed by LC/MS. Data are presented as mean ± SEM (n=4), * = P< 0.05, ** =P<0.01.
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Figure 6.11 The effect of long-term PEITC treatment on 48-hour urinary IQ metabolite 
excretion. Rats were treated with PEITC (0-110 mg/kg BW) for 2 weeks before IQ (5 mg/kg) 
administration. Urine samples were collected from 24-48 hour after a single IQ treatment and 
were analysed by LC/MS. Data are presented as percentage of total metabolites excretion, mean ± 
SEM(n=4), * = ?<0.05.
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Figure 6.12 The effect of long-term PEITC treatment on total urinary IQ metabolite 
excretion. Rats were treated with PEITC (0-110 mg/kg BW) for 2 weeks before IQ (5 mg/kg) 
administration. Urine samples were collected from 0-48 hours after a single IQ treatment and 
were analysed by LC/MS. Data are presented as percentage of total metabolites excretion, mean ± 
SEM (n=4), * = ?<0.05, ** = P< 0.01.
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Figure 6.13 The effect of short-term BITC treatment on urinary IQ excretion. Rats were 
treated with BITC (50 mg/kg BW) 24 hours before IQ (5 mg/kg) administration. Urine samples 
were analysed by LC/MS. Data are presented as mean ± SEM (n=4).
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Figure 6.14 Effect of short-term BITC treatment on 24-hour urinary IQ metabolite 
excretion. Rats were treated with BITC (50 mg/kg BW) 24 hours before IQ (5 mg/kg) 
administration. Urine samples were collected from 24 hours after a single IQ treatment and were 
analysed by LC/MS. Data are presented as mean ± SEM (n=4), ** = P< 0.01.
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Figure 6.15 Effect of short-term BITC treatment on 48-hour urinary IQ metabolite 
excretion. Rats were treated with BITC (50 mg/kg BW) 24 hours before IQ (5 mg/kg) 
administration. Urine samples were collected from 24-48 hour after a single IQ administration and 
were analysed by LC/MS. Data are presented as percentage of total metabolites excretion, mean ± 
SEM(n=4), **=P<0.01.
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Figure 6.16 Effect of short-term BITC treatment on total urinary IQ metabolite excretion.
Rats were treated with BITC (50 mg/kg BW) 24 hours before IQ (5 mg/kg) administration. Urine 
samples were collected from 0-48 hours after a single IQ treatment and were analysed by LC/MS. 
Data are presented as mean ± SEM (n=4), ** = P< 0.01.
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6.3.3.4 Effect o f  short-term PEITC treatment on IQ metabolism in rats
Short-term exposure to PEITC had no significant effect on total urinary IQ excretion (Figure 
6.17). But the same treatment with PEITC elevated IQ 5-O-sulphate excretion significantly 
(Figure 6.18). Although an increase in IQ 5-O-glucuronide was also noted, statistical significance 
was not attained. In the 48-hour urine samples, neither A-acetyl IQ nor IQ 5-O-sulphate was 
detected in the urine of either control or PEITC-treated animals. In the same urine sample, PEITC 
significantly increased IQ-sulphamate excretion. Finally, IQ A-glucuronide excretion was below 
the lower limited of detection in the 48-hours sample in the animals treated with PEITC (Figure 
6.19). When total excretion is considered, however, PEITC significantly increased IQ 5-0- 
sulphate and decreased IQ W-glucuronide level in the urine (Figure 6.20).
6.3.3.5 Effect o f  short-term sulforaphane and erucin treatment on IQ metabolism in rats
Neither sulforaphane nor erucin influenced significantly IQ metabolism. There was no change in 
urinary IQ excretion (Figure 6.21), and no statistically significant changes in the levels of IQ 
metabolites (Figure 6.22- 6.24).
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Figure 6.17 The effect of short-term PEITC treatment urinary IQ excretion. Rats were 
treated with PEITC (110 mg/kg BW) 24 hours before IQ (5 mg/kg) administration. Urine samples 
were analysed by LC/MS. Data are presented as mean ± SEM (n=4).
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Figure 6.18 The effect of short-term PEITC treatment on 24-hour urinary IQ metabolite 
excretion. Rats were treated with PEITC (110 mg/kg BW) for 24 hours before IQ (5 mg/kg) 
administration. Urine samples were collected from 24 hours after a single IQ dose and were 
analysed by LC/MS. Data are presented as mean ± SEM (n=4), ** = P<0.01.
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Figure 6.19 Effect of short-term PEITC treatment on 48-hour urinary IQ metabolites 
excretion. Rats were treated with PEITC (110 mg/kg BW) 24 hours before IQ (5 mg/kg) 
administration. Urine samples were collected from 24-48 hours after a single IQ administration 
and were analysed by LC/MS. Data are presented as percentage of total metabolites excretion, 
mean ± SEM (n=4), * = P<0.05.
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Figure 6.20 Effect of short-term PEITC treatment on total urinary IQ metabolite excretion.
Rats were treated with PEITC (110 mg/kg BW) 24 hours before IQ (5 mg/kg) administration. 
Urine samples were collected from 0-48 hours after single oral dose of IQ and were analysed by 
LC/MS. Data are presented as mean ± SEM (n=4), * = P<0.05, ** = P< 0.01.
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Figure 6.21 Effect of short-term sulforaphane and erucin treatment on urinary IQ 
excretion. Rats were treated with sulforaphane (150 mg/1) or erucin (150 mg/1) 24 hours before 
IQ (5 mg/kg) administration. Urine samples were analysed by LC/MS. Data are presented as 
mean ± SEM (n=4).
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Figure 6.22 Effect of short term sulforaphane and erucin treatment on 24- hour urinary IQ 
metabolites excretion. Rats were treated with sulforaphane (150 mg/1) or erucin (150 mg/1) 24 
hours before IQ (5 mg/kg) administration. Urine samples were collected 24 hours after single oral 
dose of IQ and were analysed by LC/MS. Data are presented as mean ± SEM (n=4).
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Figure 6.23 The effect of short-term sulforaphane and erucin treatment on 48- hour urinary 
IQ metabolite excretion. Rats were treated with sulforaphane (150 mg/1) or erucin (150 mg/1) for 
24 hours before IQ (5 mg/kg) administration. Urine samples were collected from 24-48 hours 
after a single IQ treatment and were analysed by LC/MS. Data are presented mean ± SEM (n=4).
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Figure 6.24 The effect of short-term Sulforaphane and erucin treatment on total urinary IQ 
metabolite excretion. Rats were treated with sulforaphane (150 mg/1) or erucin (150 mg/1) 24 
hours before IQ (5 mg/kg) administration. Urine samples were collected from 0-48 hours after 
single oral dose of IQ and were analysed by LC/MS. Data are presented as percentage of total 
metabolites excretion, mean ± SEM (n=4).
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6.4 Discussion
IQ was chosen as the model carcinogen in this study because; 1) it is a potent carcinogen in 
rodents and non human primates (lARC 1993), 2) it is present in normal human diet (Sugimura et 
al. 1977), 3) its bioactivation and detoxification pathways have been established and involve both 
CYP450 and Phase II enzymes that could potentially be modulated by ITC (Turesky 2005), and 4) 
there is evidence that ITCs have a chemopreventive effect on IQ-induced carcinogenesis (Kassie 
et al. 2002). Although the dose of IQ (5 mg/kg) used in the present studies was higher than the 
average daily human exposure (ranging from 100 ng to 10 pg per day; Turesky, 1993), it was 
selected bearing in mind the limit of detection of the analytical method.
The selected model ITCs were BITC, PEITC, sulforaphane and erucin, representing both aromatic 
and aliphatic compounds. They were chosen because; 1) they are major ITCs found in cruciferous 
vegetable (lARC 2004), 2) previous studies indicated the potential of these ITCs to influence 
CYP450 and Phase II enzyme activities (Misiewicz et al. 2004; Nakamura et al. 2000; von 
Weymam et al. 2007), 3) there is evidence that these ITCs can prevent carcinogenicity and/or 
mutagenicity induced by chemical carcinogens (Talalay and Zhang 1996; Yang et al. 2002), and 
4) they are currently investigated in more detail in our laboratory.
6.4.1 Effects o f BITC on urinary mutagen and promutagen excretion in rats treated with IQ
IQ has been reported to be a potent mutagen in the Ames test when employing S.typhimurium 
strain TA98 (Spingran and Weisburger, 1979). However, in the present study S.typhimurium 
strain YG1024 was selected because it over-expresses 0-acetyltransferase, which is an important 
enzyme in the bioactivation of IQ, an therefore more sensitive to heterocyclic amines (Oda et al. 
2001).
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The results from the present study indicate that treatment of rats with IQ increased the urinary 
excretion of promutagens in a dose-dependent manner, however, the excretion of direct mutagens 
was poor. Although the same protocol for BITC treatment caused induction of both hepatic 
EROD and MROD activity (Chapter 4), it failed to modulate the urinary promutagen excretion.
The presence of urine mutagens activity after IQ administration has been observed for many years 
(Barnes and Weisburger 1985; McArdle et al. 1999; Peleran et al. 1987; Yoxall et al. 2004). 
Banes and Weisburger (1985) reported that the major mutagen, analysed by HPLC, is the 
unchanged IQ, but minor mutagenic activity may correspond to A-acetyl or 3 -A-demethylated 
metabolite. Incubation of urine with ^-glucuronidase or aryl suphatase did not increase the 
mutagenic response either in the presence or absence of an activation system, and this implied that 
5-0-hydroxy IQ is not mutagenic and moreover, can not be converted to mutagens (McArdle et 
al. 1999). IQ-sulphamate was also reported to be non-mutagenic in the Ames test, with or without 
an activation system (Turesky et al. 1986).
Direct mutagenic response could possibly be due to W-hydroxy IQ or nitro-IQ (an oxidised N- 
hydroxy IQ). McArdle and co-workers (1999) suggested that there is a possibility that W-hydroxy 
IQ, a reactive intermediate, underwent W-glucuronidation and was transported to the urinary 
bladder, where it was broken down to release W-hydroxy IQ which can mediate the mutagenic 
response itself. However, there was no difference of the mutagenic response in the Ames test 
when employing S.typhimurium strain YG 1024 after treatment with various doses of IQ in the 
absence of an activation system (Chapter 6, section 6.3.1). This indicated that W-hydroxy IQ or 
nitro-IQ make little or no contribution to urinary mutagenicity.
Metabolism of IQ involves the CYPlAl/2 enzymes, therefore induction of CYPlAl/2 was 
expected to decrease urinary IQ excretion. However, studies of the urinary IQ excretion in
178
Chapter 6: Modulation o f  IQ metabolism by ITCs
CYPlA-induced animals showed inconsistent results (Armbrecht et al. 2007; Dashwood and Xu 
2003; Yoxall et al, 2004). Yoxall and co-workers (2004) noted that the urinary mutagenic 
response in the Ames test employing S.typhimurium was decreased in rats treated with tea, while 
increased CYPlAl/2 activities were observed. Dashwood and co-workers (2003) observed that 
urinary IQ excretion increased in rats treated with indole-3-carbinol, a compound found in 
cruciferous vegetable which induced both the ÇYP450 and Phase II enzyme systems (Xu et al. 
1996). In this study, there was no significant change in urinary mutagenic response following 
treatment with BITC.
6.4.2 Detoxification pathways o f  IQ
The detoxification pathways of IQ have been well studied (Turesky 2005). One pathway involves 
ring oxidation at the 5-position catalysed by CYP450, followed by conjugation with sulphate or 
glucuronide (Luks et al. 1989). An alternative pathway is direct conjugation to the exocyclic 
amino group through A^-glucuronidation and sulphamate formation (Turesky et al. 1986; Luks et 
al. 1989). Normally, IQ and its metabolites excreted in urine accounted for about 55% of the 
administered dose (Armbrecht et al. 2007), and the major metabolite is IQ-sulphamate. IQ and its 
metabolites can also be found in the faeces, and Kestell et al. (1999) reported that faecal excretion 
following a single oral dose of [^ '‘CJ-IQ to rats (50mg/kg), accounted for 27.1 ± 16.7 % of the 
administered dose. Urinary IQ metabolites which represent detoxification pathway have been 
evaluated using LC/MS technique and will be discussed later in this Chapter.
6.4.3 Effects o f  BITC on IQ metabolism in precision-cut liver slice model
As discussed in the Chapter 3, BITC inhibited EROD and MROD and increased Phase II enzyme 
activities in a concentration-dependent manner in rat precision-cut liver slices, alteration of IQ 
metabolism was anticipated. However, in the present study, slices treated with BITC and IQ 
displayed similar metabolite profile as in the absence of the TTC. It may be that the decrease of
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CYP450 activity (MROD decreased by 29 %; Chapter 3, section 3.3.2) and increase of Phase II 
enzyme activities (Chapter 3, section 3.3.5) were not sufficient to modulate IQ metabolism. In 
addition, higher doses of BITC also showed toxicity (Chapter 3, section 3.3.6.) which could 
influence effects of BITC on metabolism of IQ.
6.4.4 Effects o f  long-term treatment with ITCs on IQ metabolism in rats
In humans, vegetables are generally consumed everyday, so that exposure to ITCs may occur 
almost daily. The objective of this study was to establish whether long-term intake of ITCs, 
especially at dietary doses could influence the metabolism of IQ, as determined by urinary IQ 
metabolite pattern. Fourteen days of exposure was selected because there was evidence that 
induction of Phase II activity reached a plateau phase after 15 days of daily exposure (Munday 
and Munday, 2002)
BITC modulated IQ metabolism in rats, in a dose dependent-manner. Rats fed BITC did not 
influence significantly the excretion of unconjugated IQ (Figure 6.25), in agreement with the 
mutagenicity study where no change in mutagenic response was observed (section 6.2.2.2). 
However, when presented as a percentage of total IQ excretion (Figure 6.5), BITC decreased 24- 
hour IQ excretion, implying increased IQ metabolism.
As shown in Chapter 4, diets containing high levels of BITC induced FROD and MROD 
activities in rat liver, as a consequence, increased P450-mediated pathway metabolism (through 
ring-oxidation then conjugation with glucuronic acid and sulphate) would be expected. Lideed, 
urinary IQ 5-0-glucuronide and 5-0-sulphate excretion were elevated whereas urinary IQ- 
sulphamate excretion was decreased. A similar pattern was noted when rats were treated with the 
well established CYPlAl/2 inducer, y^-naphthoflavone (Chapter 5; Alexander et al., 1989; 
Ambrecht et al., 2007).
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Treatment with the highest dose of PEITC for 2 weeks decreased both urinary mutagen excretion 
(Figure 6.26) and the percentage of IQ excreted in urine. The urinary metabolites pattern was 
similar to that found in rats treated with BITC, though the increase in IQ 5-O-glucuronide and IQ 
5-0-sulphate did not reach statistical significance due to the wide variation. These findings are 
consistent with increased hepatic MROD activity observed in rats treated by the same protocol 
(Figure 6.27; N. Konsue personal communication)
control low med high
Low = 0.5 mg/kg BW; medium = 5.0 mg/kg BW; high = 50.0 mg/kg BW
Figure 6.25 Urinary IQ excretion from ra t fed with BITC. Rats were treated with BITC (0-50 
mg/kg BW) for 2 weeks before receiving a single dose of IQ (5 mg/kg). Urine samples were 
collected from 24 hours after a single IQ treatment and were analysed by LC/MS. Data are 
presented as ratio of area under peak of IQ to area under peak of internal standard, mean ± SEM 
(n=4).
Modulation of IQ metabolism by BITC or PEITC is believed to involve not only CYP450 
enzymes but also Phase II enzyme systems. Unfortunately, in the present study neither UGT nor 
SULT activities was determined in rat exposed to the ITCs. However, Kassie et al (2002) 
demonstrated that garden cress (a rich source of BITC) significantly induced hepatic UGT2A 
activity, whilst BITC (70 mg/kg) caused a slight increase. They observed that extent of protection 
of garden cress juice against IQ-induced DNA damage was paralleled by an increase in UGT2A
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activity. They concluded that induction of UGT2A activity by the juice may have been 
responsible for the chemopreventive effect of ITC. However, there is no published work as to 
which UGT isoform that contributes to the metabolism of IQ, the UGT isoform responsible for 
the metabolism of PhIP, another member of HA, belongs to the lA  family and catalysed N^- and 
A^-glucuronidation of A-hydroxy-PhlP (Turesky et al., 2005).
6.4.5 Effects o f  short-term treatment o f  ITCs on IQ metabolism in rats
From the long-term studies, it was demonstrated that dietary doses of BITC or PEITC failed to 
modulate IQ metabolism. In the long-term study, enzyme systems may be modulated by both 
induction and inhibition. However, following only a single dose exposure, only inhibition may be 
manifested as there is no sufficient time for induction to occur. Moreover, people do not eat 
cruciferous vegetables on a daily basis. For this reason, short-term studies were conducted to 
ascertain whether ITCs impact on IQ metabolism.
The effect of short-term ITC exposure to IQ metabolism was studied by feeding rats with BITC 
(50 mg/kg/day) or PEITC (11 mg/kg/day) in diet or sulforaphane (12 mg/kg/day) or erucin (12 
mg/kg/day) in drinking water for 24 hours before IQ administration. As observed in the long 
term-study, rats fed with either BITC or PEITC showed similar effect on IQ metabolism. As 
discussed earlier, the change of urinary IQ and its metabolites excretion was a consequence of 
induction of CYP450 and Phase II activities by ITC. However, rats treated with sulforaphane and 
erucin in drinking water did not show any change in urinary IQ metabolites excretion, although 
there was a tendency for increased IQ 5-O-glucuronide and IQ 5-O-sulphate excretion and a 
decrease in A-acetyl IQ and IQ-sulphamate excretion.
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Figure 6.26 Effect of dietary PEITC on the excretion of promutagen in the urine of rats 
treated with IQ. Rats were fed with diet containing PEITC (0-110 mg/kg BW) for 2 weeks 
before being treated with single oral dose of IQ (5 mg/kg). Urine sample were collected every 24 
hours up to 72 hours following administration of IQ. Mutagenic activity in all samples was 
determined using the Ames test employing S.typhimurium strain YG 1024 in the presence of an 
activation system (10% v/v) derived from rats treated with Aroclor 1254. Data are presented as 
mean ± SEM. Each analysis was performed in triplicate. The spontaneous reversion rate of 14 ± 3 
has already been subtracted. * = P<0.05; ***= P< 0.005. (N.Konsue 2008)
The effect of sulforaphane on rat hepatic CYP450 activities was studied by Yoxall et al. (2005) 
who treated rats with sulforaphane (3 and 12 mg/kg/day) for 10 days. They reported that 
sulforaphane which was stable in the drinking water, at room temperature, for at least 5 days as 
determined by LC/MS, slightly decreased MROD and EROD activities, although the CYPIA 
expression, determined by Western blot, was markedly increased. The authors suggested that 
CYP450 was induced by sulforaphane but was catalytically inactive due to the presence of bound 
metabolites on sulforaphane. A similar phenomenon was also observed in rats treated with low 
doses of PEITC, but at the high doses, significant increase in EROD activity was seen (N. Konsue 
personal communication). Though it is possible that at a higher dose (>12 mg/kg/day).
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sulforaphane and/or erucin may modulate urinary IQ metabolites excretion and CYP450 activity, 
it may not be palatable to the animal because of its strong odour may therefore result in decreased 
water intake leading to homeostatic imbalance.
control low medium high
Low =1.1 mg/kg BW; medium =11 mg/kg BW; high =110 mg/kg BW.
Figure 6.27 Effect of PEITC on MROD activity in rat liver. Hepatic MROD was determined 
in rats fed PEITC (0.1-110 mg/ kg BW) for 2 weeks. Results are presented as mean ± SEM (n=5), 
* = P<0.05. (N. Konsue 2008)
6.5 Conclusion
In summary, the present findings show that ITCs have potential to alter the metabolism of food 
carcinogens such as IQ, but this is unlikely to occur at dietary dose of ITCs as glucosinolate.
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1 Discussion
The consumption of cruciferous vegetables displays an inverse relationship with cancer risk (Tang 
et al. 2008; Thomson et al. 2007). Isothiocyanates are believed to be, at least partly, responsible 
for this chemopreventive effect. A large number of ITCs have been described, but only six occur 
frequently in the diet (lARC, 2004), one of which is BITC, the subject of this thesis. The term 
“chemoprevention” could be divided into two main categories, “blocking” and “suppressing”. 
This study focussed exclusively on the “blocking” property of the ITCs, which involves the 
CYP450 and Phase II enzyme systems. In order to study whether the effect of ITCs on CYP450 
and the Phase II system could modulate the metabolism of carcinogens, IQ, a food carcinogen 
formed in cooked meat and fish, was used as a model.
7.1 Effect of BITC on CYP450 and Phase II  enzyme systems
The effect of ITC on the CYP450 enzyme systems is isoform-specific. In rat precision-cut liver 
slices, BITC inhibited CYPlAl/2 in a concentration-dependent manner, but in contrast, it induced 
apoprotein levels determined immunologically. The inhibition of CYPIA 1/2 required a pre­
incubation of BITC with NADPH, from which it may be concluded that BITC is a mechanism- 
based inactivator of CYPIA. The CYPl family plays a major role in the bioactivation of chemical 
carcinogens, such as the heterocyclic amines, PAHs and oestrogens (loannides and Lewis 2004). 
Consequently, inactivation of CYPlAl/2 may contribute to the chemopreventive activity of BITC 
by suppressing the bioactivation pathway.
However, it is important to extend the in vitro finding to the in vivo situation in the whole animal. 
An in vivo experiment was carried out by exposing rats to BITC. The results showed that BITC 
increased CYPlAl/2 and 2B1 activities in a dose-dependent manner (Chapter 4, section 4.3.2). 
The contrast of the effects of ITCs on CYP450 activities between in vitro and in vivo studies was 
also observed with PEITC. Goosen and co-workers (2000) reported that PEITC inactivated
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purified rat CYP2B1, but Smith and co-workers (1993) noted that PEITC induced PROD, a 
marker activity of CYP2B, in fats fed a diet containing PEITC. The reason why the effects of 
ITCs on CYP450 in an in vitro model are not consistent with those in an in vivo is not well 
established. There are three possible explanations for this. Firstly, body fluids such as serum, 
saliva and gastric juice could attenuate the effectiveness of BITC. Although there are no reports 
on the effect of body fluid on the chemopreventive effect of BITC, there is evidence that some 
ITCs, such as PEITC, are not stable at the low pH of the stomach (Negrusz et al. 1998). Secondly, 
most of the mechanism-based inactivation studies were carried out using purified CYP450 
enzyme or microsomal suspensions which do not contain Phase II enzymes, while in vivo both 
CYP450 and Phase II enzyme systems are active. Phase II enzymes will further catalyse ITCs to 
their detoxification metabolites and facilitate their excretion from the body. Moreover, the 
conjugated forms of ITCs (GSH-conjugate, cysteine-conjugate, and A-acetylcysteine-conjugate) 
have been reported to have less inhibitory potency (Conaway et al. 1996). Finally, there is 
evidence that ITCs activate CYP450 gene transcription, which could lead to increased CYP450 
synthesis (Gross-Steinmeyer et al. 2004). Although BITC up-regulation may not result in 
increased CYP450 activity in liver slices, the results in this thesis showed that BITC increased 
CYPlAl/2 and CYP 2B1 apoprotein levels in both liver slices and in vivo, hiduction of CYPIA 
could either block or promote carcinogenesis. It can promote carcinogenesis by increasing the 
generation of reactive intermediates, which can bind to macromolecules such as DNA, RNA and 
proteins (loannides and Lewis 2004). Induction of CYPIA can also block carcinogenesis by 
increasing the production of detoxified metabolites (Armbrecht et al. 2007; Walters et al. 2004).
The Phase II enzyme systems are important for the detoxification of xenobiotics. In both liver 
slices and in vivo studies, BITC induced epoxide hydrolase and GST activity, as well as enzyme 
protein expression. The effect of ITCs on CYP450 and Phase II enzyme activity was organ- 
specific. In this thesis, BITC increased Phase II enzymes in liver but not in lung tissues. Munday 
and Munday (2004) also noted that five naturally-occurring ITCs significantly increased enzyme
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activity in some rat tissues but had no effect in others. Induction of Phase II enzymes such as 
epoxide hydrolase, GST and NQOl by ITCs, although blocking carcinogen-induced 
tumorigenesis by catalysing the detoxification of metabolites, could also help to promote 
mutagen/carcinogen bioactivation (Turesky 2002). For example, epoxide hydrolase catalyses 
benzo[a]pyrene 4,5-epoxide to dihydrodiols which are further oxidised by the CYPIA family to 
dihydrodiol epoxides, the ultimate carcinogens (loannides and Parke 1990).
In addition to the enzymes studied in this thesis, ITCs have been reported to alter other CYP450 
and Phase II enzymes activities, including UGT and CYP2E1 both in vitro and in vivo (Barcelo et 
al. 1996; Kassie et al. 2002; Moreno et al. 1999). In humans there were no reported effects of ITC 
on CYP450 or Phase II enzyme systems, although the consumption of watercress has been 
reported to decrease chlorzoxazone {in vivo probe for CYP2E1) metabolism (Leclercq et al. 
1998), and increase caffeine {in vivo probe for CYP1A2) metabolism (Lampe et al. 2000) in adult 
volunteers. However, data on the effect of ITCs on CYP450 expression and Phase II enzymes in 
humans are limited and further studies are merited.
7.2 Effect of BITC on carcinogen metabolism
Since CYP450 and the Phase II enzyme system play an important role in the bioactivation and 
detoxification pathways of many xenobiotics, BITC, which can modulate favourably these 
enzyme systems, has the potential to be an effective chemopreventive candidate. In order to 
elucidate the effect of BITC on carcinogen metabolism, the Ames test and LC/MS were used to 
evaluate the metabolism of IQ. BITC treatment did not alter the urinary promutagen excretion in 
IQ-treated rats but did increase urinary IQ 5-O-glucuronide and IQ 5-0-sulphate excretion, 
implying an increase in the detoxification pathways.
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Bioactivation of IQ requires the CYPl family, especially CYP1A2. Induction of CYPlAl/2 leads 
to enhanced ring hydroxylation and A-hydroxylation. Increasing A-hydroxylation, the proximate 
carcinogen, favours IQ-DNA adduct formation (Xu et al. 1996). Alternatively, induction of 
CYPIA enhances ring hydroxylation and resulted in increased IQ 5-O-glucutonide and IQ 5-0- 
sulphate excretion (Alexander et al. 1989; Armbrecht et al. 2007; Dashwood and Xu 2003). The 
studies described in Chapter 6 provided evidence that ITCs have the potential to alter the 
metabolism of food carcinogens such as IQ. This study illustrated that the effect of ITCs on IQ 
metabolism depends on the type and dose of ITC. There was evidence that the excretion of IQ 5- 
0-glucuronide and IQ 5-O-sulphate increased in a dose-dependent manner in rats treated with 
either BITC or PEITC. Short term treatment of sulforaphane and erucin did not alter the urinary 
IQ metabolite excretion. This implied that each ITC may work via a different mechanism.
It was demonstrated in the current studies that BITC and PEITC can increase the detoxification 
products of IQ in rats. It would be interesting to extrapolate the effect of these two ITCs to human 
IQ metabolism and to other potential carcinogens. An important difference between humans and 
rats is that the ring-hydroxylation appears not to occur in humans (Gooderham et al. 2001). 
However, consumption of cruciferous vegetables has been noted to increase the detoxification 
metabolites of NNK, nicotine, and PhIP in human volunteers (Hecht et al. 1999; Hecht et al. 
1995; Murray et al. 2001; Walters et al. 2004).
7.3 Are ITCs responsible for the chemopreventive effects of cruciferous vegetables?
As already discussed, consumption of cruciferous vegetables has the potential to prevent human 
cancer (Kensler et al. 2005; Lin et al. 1998; Tang et al. 2008). In experiments, both in vitro and in 
vivo, cruciferous vegetables, glucosinolates, and ITCs showed chemopreventive activity (Chung 
et al. 2000; Hecht et al. 2000; Kassie et al. 2002; Kuroiwa et al. 2006). There is no doubt that in 
rodents treated with ITC, the carcinogenic or mutagenic activity of a specific carcinogen may be
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suppressed (Chung et al. 2000; Conaway et al. 2005; Hecht et al. 2002; Okazaki et al. 2002). 
However, the doses used in most experiments were much higher than dietary doses. Song et al. 
(2005) determined the concentration of glucosinolates and ITC in human plasma after 
consumption of broccoli by using LC/MS. They reported that after intake of 200 g of raw 
broccoli, containing approximately 67 pmol/100 g fresh weight of total glucosinolates, total ITCs 
in the plasma was detected 549 ±115 nM. ITC concentration in plasma after eating broccoli was 
more than 1000 times lower than the concentration used in liver slices studies (0-25 pM; Chapter 
3) as well as in other in vitro studies (Hasten et al. 2002; Kassie et al. 2003). Moreover, when 
considering the doses used in the in vivo study, BITC modulates CYP450 and the Phase II enzyme 
systems only at the highest dose, one hundred times greater than the dietary level (Chapter 4). 
Similarly, Kassie and co-workers (2002) studied the chemopreventive effect of garden cress juice 
and BITC in rats. They reported that the BITC content in garden cress juice (28 mg/1) was much 
lower than the BITC concentration (70 mg/kg) that caused UGT-2 enzyme induction in the same 
experiment. This further implies that either other compounds in cruciferous vegetables may be 
responsible for the observed chemopreventive effect or that ITCs act through alternative 
mechanisms.
Since the dietary dose of ITCs failed to modulate CYP450 and Phase II enzyme systems, it is 
possible that ITCs may only be partly responsible, and other compounds found in cruciferous 
vegetables may also play a role, or may have a synergistic effect with ITC. Glucosinolates, the 
ITC precursors, have been reported to inhibit CYP450 activity in mice but also possessed 
genotoxic activities (Canistro et al. 2004). Indole, a plant alkaloid which is also found in 
cruciferous vegetables as a glucosinolate, has been demonstrated to prevent the appearance of 
tumours in laboratory animals (Plate and Gallaher 2006; Xu et al. 2001) and induced both 
CYP450 and Phase II enzyme systems (Vang et al 1990 and 1991). However, the 
chemopreventive effect of indole is organ-specific, reducing cancer in the colon but having no 
effect on mammary gland tumorigenesis (Stoner et al. 2002). These data implied that
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glucosinolates or indoles alone may not be responsible for the chemopreventive effect of 
cruciferous vegetables.
Humans cook and combine food sources in each meal, so that one possible hypothesis to explain 
the chemopreventive effect of cruciferous vegetables is the presence of chemical compounds in 
another food source, with which it may interact. For example, the synergistic effect of vitamin C, 
from fruits and vegetables, with ITCs and/or indoles. Garcia and co-workers (2008) noted that 
although PEITC had a weakly protective effect on NDBA- and NPIP-induced DNA damage in the 
human cell line HepG2, this effect was more potent when PEITC was combined with vitamin C.
Another factor that influences the chemopreventive effect of ITCs is the presence of genetic 
polymorphisms, particularly the GST null phenotype. An individual with the GST null phenotype 
(GSTMl and T l) will have a slower metabolic rate for ITCs, and therefore longer tissue 
accumulation, thus providing greater protective effects (Seow et al. 2002; Spitz et al. 2000; Zhao 
et al. 2001). Epidemiological studies support this hypothesis by showing that subjects who have 
the GST null phenotype display the greatest protective effect following cruciferous vegetable 
consumption (Fowke et al. 2003; Lin et al. 1998; London et al. 2000; Seow et al. 2005; Seow et 
al. 2002). The evidence for this GST-ITC-cancer prevention relationship is limited and more 
studies are required, although it does indicate that the chemopreventive effect of cruciferous 
vegetables and/or ITCs may not apply to all, but does have a genetic component.
7.4 Can ITCs be used as dietary supplements?
The use of ITCs as dietary supplements is controversial. Although there is sufficient evidence to 
demonstrate the chemopreventive effects of ITCs on experimental animals (Chung et al. 2000; 
Conaway et al. 2005; Hecht et al. 2002; Okazaki et al. 2002), there are limitations to their use. 
These include the narrow range of chemopreventive doses (Kassie et al. 1999b), and organ- and
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carcinogen-specificities. In addition, we should also be aware of possible interactions with other 
xenobiotics, including medicinal drugs, as well as of the adverse effects of long term exposure to 
ITCs. It is of interest that at high concentrations, BITC in the present studies displayed toxicity in 
rat liver slices most likely as a result of glutathione depletion.
The chemopreventive effect of ITC was reported in both in vitro and in vivo studies. Sulforaphane 
has been reported to reduce the PhlP-induced DNA adduct in the human liver cell line HepG2 
(Bacon et al. 2003). Hecht and co-workers (2002) reported that BITC decreased B[a]P-induced 
lung tumour multiplicity in mice. However, as discussed earlier, the doses required to cause 
chemopreventive effects are much higher than by dietary consumption. Moreover, the 
chemopreventive doses of ITC are near to toxic doses. As discussed in the Chapter 3, at the 
concentration of 5-10 pM, BITC increased Phase II enzyme activities in rat liver slices, but at the 
concentration of 25 pM BITC increased LDH leakage which indicates cytotoxicity. In an in vivo 
study, at 70 mg/kg, BITC was reported to reduce IQ-induced liver and colon DNA damage in rats 
(Kassie et al. 2002), however at 220 mg/kg, BITC caused rat gastric and colon mucosa DNA 
damage (Kassie et al. 1999).
In addition to the narrow range of chemopreventive doses, the effect of ITCs is also organ- 
specific. As discussed in Chapter 4, BITC induced CYP450 and GST activity in rat liver but not 
in the lung. Similarly, Munday and Munday (2004) noted that, naturally-occurring ITCs increased 
Phase n  enzyme activity only in some organs of rats. Moreover, each ITC has different spectrum 
of effect on carcinogen-metabolising enzyme systems. Induction of GST and NQOl activity, 
depends largely on the rate of intracellular accumulation of each ITC (Zhang and Talalay 1998) 
and the inhibition of CYP450 activity is related to the length of the alkyl chain of arylalkyl ITC 
(Conaway et al. 1996). Each ITC not only shows different CYP450 and Phase II enzyme 
modulation potency but its chemopreventive effects also apply to different carcinogens. For 
example, neither BITC nor 4-phenybutyl-ITC affected tumour incidence and had little effect on
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multiplicity, but PEITC and 3-phenyl-propyl-ITC strongly reduced both the incidence and 
multiplicity of NNK-induced tumorigenesis in rats (Stoner and Morse 1997). In contrast, BITC 
had a strong inhibitory effect on B[a]P-induced lung tumours in mice (Hecht et al. 2002), while 
PEITC had no effect (Lin et al. 1993). This raises the question as to which ITC could be used as a 
supplement, and if one ITC is not chemopreventive, will a mixture of ITCs be so?
There are few studies evaluating the chemopreventive effect of a ITCs mixture. Hecht et al (2000) 
noted that a mixture of PEITC and BITC showed a stronger inhibitory effect on mice lung 
tumorigenesis, induced by a mixture of B[a]P and NNK, than either PEITC or BITC alone. A 
mixture of PEITC and BITC was also reported to reduce DNA adducts induced by a mixture of 
B[a]P and NNK (Sticha et al. 2002) and increase urinary NNK metabolite excretion in mice 
(Boysen et al. 2003). However, the effect was more likely to be the result of the effects of PEITC 
on NNK metabolism only (Boysen et al. 2003). Further investigations into the interaction of ITCs 
are required in view of the consumption of ITC mixtures in vegetable as well as a supplement.
Literactions with xenobiotics and other chemopreventive compounds in food should also be 
considered. As discussed earlier, the alteration of CYP450 and Phase II enzymes is a double- 
edged sword, modulating the metabolism of carcinogens and also affecting the metabolism of 
therapeutic drugs. The inhibition of certain CYP450 and/or Phase II enzymes could result in the 
accumulation of xenobiotics leading to toxicity. Induction of the CYP450 and/or Phase II enzyme 
would lead to increased metabolism of xenobiotics and therapeutic failure of drugs deactivated by 
metabolism and having a narrow therapeutic index. Nevertheless, in the human diet, there are 
many compounds that could also affect the CYP450 and Phase II enzyme systems. These include 
the isoflavones, vitamin C and flavonoids (Steinmetz and Potter 1996; Yoxall et al. 2004), 
however, there are few studies looking at the interaction of ITCs with other chemopreventive 
compounds.
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The adverse effects of ITCs should also not be ignored. The toxic effects of ITCs have been 
investigated in experimental animals. Long-term exposure to high doses can cause weight loss in 
rats (Hecht et al. 2000; Lewerenz et al. 1992; Lewerenz et al. 1988). ITCs have also been reported 
to have genotoxic effects in the human liver cell line HepG2 (Kassie and Knasmuller 2000). High 
exposure to BITC was observed to enhance A-butyl-A-(4-hydroxybutyl)nitrosamine-induced 
urinary bladder cancer, although a lower dose had a chemopreventive effect (Okazaki et al. 2003; 
Okazaki et al. 2002).
So far, there is more evidence of the beneficial effects of ITCs rather than the adverse effects. 
However, the results from both epidemiological and experimental studies are not sufficient to 
conclude that ITCs should be included as a diet supplement. Cruciferous vegetable consumption 
is recommended, although the chemopreventive activity is still controversial (Knasmuller et al. 
2002; Sapone et al. 2007).
7.5 Can ITCs be used as drug?
Several studies have demonstrated the chemopreventive effect o f high doses of ITCs against many 
carcinogens, including B[a]P, IQ, and NNK (Boysen et al. 2003; Conaway et al. 2005; Uhl et al. 
2004), ITCs could be good candidates for novel anti-cancer drugs, however there remains some 
concern regarding their efficiency and toxicity.
In addition to the effect on CYP450 and the Phase II enzyme systems, ITC-induced apoptosis and 
cell cycle arrest have also been reported (Yang et al. 2002; Yang et al. 2005; Zhang et al. 2006). 
Three stages of carcinogenesis have been defined, namely initiation, promotion, and progression. 
Induction of cell cycle arrest and apoptosis by ITCs attenuates the stages of promotion and 
progression of carcinogenesis, making ITCs a promising candidate for anti-cancer therapy.
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The use of ITCs as a systemic drug requires more information, such as the efficiency after a single 
treatment and with following chronic treatment, any potential side-effects on long-term treatment, 
the pharmacodynamic properties of ITCs, their systemic distribution, their interactions with other 
xenobiotics and dietary compounds, and their clinical safety. Since the chemopreventive effects of 
ITCs requires a high dosage that could be toxic, a local application may be an alternative method 
to minimise the risk of potential side-effects. Dinkova-Kostova and co-workers (2007) reported 
that topical application of broccoli extracts induced NQOl activity and expression in the skin of 
mice and humans. This observation encourages the development of ITCs as a topical anti-cancer 
drug.
Apart from their anti-cancer effects, ITCs have been reported to provide other beneficial effects. 
ITCs were reported to protect against light-induced retinal damage (Tanito et al. 2005), have a 
potent anti-bacterial effect against Helicobacter pylori (Fahey et al. 2002; Haristoy et al. 2005), 
have anti-fungal activity (Johansson et al. 2008) and induce gene and protein expression which 
could protect against heart and vascular diseases such as thioredoxin super family, thiredoxin 
reductase and peroxiredoxin. Although the mechanisms of action are not well established one 
possible pathway is through Keapl-Nrf2 redox sensitive pathway resulting in expression of gene 
containing ARE (Comelis et al. 2007; Mukheijee et al. 2008; Qian et al. 2006). Since, the anti­
cancer effect of ITCs is still controversial, other beneficial effects could contribute to the 
protective effects of these compounds.
7.6 Conclusion
The present study illustrates that BITC can modulate CYP450 and the Phase II enzyme systems in 
both rat precision-cut liver slices, as well as in vivo. The induction of enzymes after BITC 
administration can modulate the metabolism of food carcinogens, such as IQ. However, these 
effects are unlikely to occur at dietary doses of BITC. Further assessment of the chronic use of
195
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BITC through dietary supplementation requires more comprehensive studies into the effects of 
BITC after long-term exposure, the chemopreventive effect of BITC in individuals with increased 
cancer risk, the importance of genetic polymorphism and the interactions of BITC with other 
chemicals present in food.
196
Bibliography
_____________________ Bibliography
Bibliography
Adamson, R.H., Thorgeirsson, U.P., Snyderwine, E.G., Thorgeirsson, S.S., Reeves, J., 
Dalgard, D.W., Takayama, S. and Sugimura, T. (1990) Carcinogenicity of 2-amino-3- 
methylimidazo[4,5-f]quinoline in nonhuman primates: induction of tumors in three macaques. 
Japanese Journal of Cancer Reasearch 81, 10-14.
Aeschbacher, H.U., Turesky, R.J., Wolleb, U., Wurzner, H.P. and Tannenbaum, S.R. (1987) 
Comparision of the mutagenic activity of various brands of food grade beef extacts. Cancer 
Letters 38, 87-93.
Ahn, J. and Grun, I.U. (2005a) Heterocyclic amines: 1. Kinetics of formation of polar and 
nonpolar heterocyclic amines as a function of time and temperature. Journal of Food Science 
70, C173-C179.
Ahn, J. and Grun, I.U. (2005b) Heterocyclic amines: 2. Inhibitory effects of natural extracts 
on the formation of polar and nonpolar heterocyclic amines in cooked beef. Journal of Food 
Science 70, C263-C268.
Akerboom, T.P.M., Sies, H. and William, B.J. (1981) [48] Assay of glutathione, glutathione 
disulfide, and glutathione mixed disulfides in biological samples. Methods in Enzymology, 
Academic Press, pp. 373-382.
Alexander, J., Holme, J.A., Wallin, H. and Becher, G. (1989) Characterization of Metabolites 
of the Food Mutagens 2-Amino-3- Methylimidazo[4,5-F]Quinoline and 2-Amino-3,4- 
Dimethylimidazo[4,5-F]Quinoline Formed After Incubation with Isolated Rat-Liver Cells. 
Chemico-Biological Interactions 72, 125-142.
198
________________ Bibliography
Ambrosone, C.B., McCann, S.E., Freudenheim, J.L., Marshall, J.R., Zhang, Y.S. and Shields, 
P.O. (2004) Breast cancer risk in premenopausal women is inversely associated with 
consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype. 
Journal of Nutrition 134,1134-1138.
Anttila, S., Hirvonen, A., Vainio, H., Husgafvelpursiainen, K., Hayes, J.D. and Ketterer, B. 
(1993) Immunohistochemical localization of glutathione S-transferase in human lung. Cancer 
Research 53, 5643-5648.
Armbrecht, H.J., Lakshmi, V.M., Wickstra, J., Hsu, F.F. and Zenser, T.V. (2007) Metabolism 
of a heterocyclic amine colon carcinogen in young and old rats. Drug Metabolism and 
Disposition 35, 633-639.
Augustsson, K., Skog, K., Jagerstad, M. and Steineck, G. (1997) Assessment of the human 
exposure to heterocyclic amines. Carcinogenesis 18, 1931-1935.
Bacon, J.R., Williamson, G., Gamer, R.C., Lappin, G., Langouet, S. and Bao, Y.P. (2003) 
Sulforaphane and quercetin modulate PhlP-DNA adduct formation in human HepG2 cells and 
hepatocytes. Carcinogenesis 24,1903-1911.
Barcelo, S; Gardiner, JM; Gescher, A, et al. (1996) CYP2E1-mediated mechanism of anti- 
genotoxicity of the broccoli constituent sulforaphane. Carcinogenesis 17 (2), 277-282.
Barcelo-Barrachina, E., Moyano, E. and Galceran, M.T. (2004a) Determination of 
heterocyclic amines by liquid chromatography-quadmpole time-of-flight mass spectrometry. 
Journal of Chromatography A 1054,409-418.
199
________ Bibliography
Barcelo-Barrachina, E., Moyano, E., Puignou, L. and Galceran, M.T. (2004b) Evaluation of 
different liquid chromatography-electrospray mass spectrometry systems for the analysis of 
heterocyclic amines. Journal of Chromatography A 1023, 67-78.
Barnes, W.S. and Weisburger, J.H. (1985) Fate of the food mutagen 2-amino-3- 
methylimidazo[4,5-f]quinoline (IQ) in sprague-dawley rats. 1. mutagens in the urine. 
Mutation Research 156, 83-91.
Basten, G.P., Bao, Y.P. and Williamson, G. (2002) Sulforaphane and its glutathione conjugate 
but not sulforaphane nitrile induce UDP-glucuronosyl transferase (UGTlAl) and glutathione 
transferase (GSTAl) in cultured cells. Carcinogenesis 23, 1399-1404.
Berthou, F., Ratanasavanh, D., Riche, C., Picart, D., Voirin, T. and Guillouzo, A. (1989) 
Comparison of caffeine metabolism by slices, microsomes and hepatocyte cultures from adult 
human-liver. Xenobiotica 19,401-417.
Bheemreddy, R.M. and Jeffery, E.H. (2007) The metabolic fate of purified glucoraphanin in 
F344 rats. Journal of Agricultural and Food Chemistry 55, 2861-2866.
Bosetti, C., Negri, E., Kolonel, L., Ron, E., Franceschi, S., Preston-Martin, S., McTieman, A., 
Dal Maso, L., Mark, S.D., Mabuchi, K., Land, C., Jin, F., Wingren, G., Galanti, M.R., 
Hallquist, A., Glattre, E., Lund, E., Levi, F., Linos, D. and La Vecchia, C. (2002) A pooled 
analysis of case-control studies of thyroid cancer. VII. Cruciferous and other vegetables 
(International). Cancer Causes & Control 13, 765-775.
Boysen, G., Kenney, P.M.J., Upadhyaya, P., Wang, M.Y. and Hecht, S.S. (2003) Effects of 
benzyl isothiocyanate and 2-phenethyl isothiocyanate on benzo[a]pyrene and 4-
200
 ___________________ •  Bibliography
(methylnitrosamino)-l-(3-pyridyl)-l-butanone metabolism in F-344 rats. Carcinogenesis 24, 
517-525.
Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 
72, 248-254.
Brown, L.M., Swanson, C.A., Gridley, G., Swanson, G.M., Schoenberg, J.B., Greenberg, 
R.S., Silverman, D.T., Pottem, L.M., Hayes, R.B., Schwartz, A.G., Liff, J.M., Fraumeni, J.F. 
and Hoover, R.N. (1995) Adenocarcinoma of the esophagus-role of obesity and diet. Journal 
of the National Cancer Institute 87, 104-109.
Bueno de Mesquita, H.B., Maisonneuve, P., Runia, S. and Moerman, C.J. (1991) Intake of 
foods and nutrients and cancer of the exocrine pancreas: a population-based case-control 
study in The Netherlands. International Journal of Cancer 48, 540-549.
Burke, M.D. and Mayer, R.T. (1974) Ethoxyresorufin-direct fluorimetric assay of a O- 
dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metabolism 
and Disposition 2, 583-588.
Burke, M.D., Thompson, S., Weaver, R.J., Wolf, C.R. and Mayers, R.T. (1994) Cytochrome 
P450 specificities of alkoxyresorufin 0-dealkylation in human and rat liver. Biochemical 
Pharmacology 48, 923-936.
Canistro, D., Della Croce, C., lori, R., Barillari, J., Bronzetti, G., Poi, G., Cini, M., 
Caltavuturo, L., Perocco, P. and Paolini, M. (2004) Genetic and metabolic effects of 
gluconasturtiin, a glucosinolate derived from cruciferae. Mutation Research-Fundamental 
and Molecular Mechanisms of Mutagenesis 545, 23-35.
201
 ________________________________   Bibliography
Chen, Y.-R., Wang, W., Kong, A.N.T. and Tan, T.-H. (1998) Molecular Mechanisms of c-Jun 
N-terminal Kinase-mediated Apoptosis Induced by Anticarcinogenic Isothiocyanates. 
Journal of Biological Chemistry 273,1769-1775.
Cheng, K.W., Chen, F. and Wang, M.F. (2006) Heterocyclic amines: Chemistry and health. 
Molecular Nutrition & Food Research 50,1150-1170.
Chiu, B.C.H., Ji, B.T., Dai, Q., Gridley, G., McLaughlin, J.K., Gao, Y.T., Fraumeni, J.F. and 
Chow, W.H. (2003) Dietary factors and risk of colon cancer in Shanghai, China. Cancer 
Epidemiology Biomarkers & Prevention 12, 201-208.
Chung, F.L., Jiao, D., Getahun, S.M. and Yu, M.C. (1998) A urinary biomarker for uptake of 
dietary isothiocyanates in humans. Cancer Epidemiology Biomarkers & Prevention 7, 103- 
108.
Chung, F.L., Conaway, C.C., Rao, C.V. and Reddy, B.S. (2000) Chemoprevention of colonic 
aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. 
Carcinogenesis 21, 2287-2291.
Conaway, C.C., Jiao, D. and Chung, F.L. (1996) Inhibition of rat liver cytochrome P450 
isozymes by isothiocyanates and their conjugates: A structure-activity relationship study. 
Carcinogenesis 17,2423-2427.
Conaway, C.C., Yang, Y.M. and Chung, F.L. (2002) Isothiocyanates as cancer 
chemopreventive agents: Their biological activities and metabolism in rodents and humans. 
Current Drug Metabolism 3, 233-255.
202
___________________ Bibliography
Conaway, C.C., Wang, C.X., Pittman, B., Yang, Y.M., Schwartz, J.E., Tian, D.F., Mclntee, 
E.J., Hecht, S.S. and Chung, F.L. (2005) Phenethyl isothiocyanate and sulforaphane and their 
N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by 
tobacco carcinogens in A/J mice. Cancer Research 65, 8548-8557.
Comelis, M.C., El-Sohemy, A. and Campos, H. (2007) GSTTl genotype modifies the 
association between cmciferous vegetable intake and the risk of myocardial infarction. 
American Journal of Clinical Nutrition 86, 752-758.
Cui, X., Thomas, A., Han, Y., Palamanda, J., Montgomery, D., White, R.E., Morrison, R.A. 
and Cheng, K.C. (2005) Quantitative PCR assay for cytochromes P4502B and 3A induction 
in rat precision-cut liver slices: Correlation study with induction in vivo. Journal of 
Pharmacological and Toxicological Methods 52,234-243.
Dansette, P.M., Dubois, G.C. and Jerina, D.M. (1979) Continuous fluorometric assay of 
epoxide hydrolase acitivity. Analytical Biochemistry 97, 340-345.
Dashwood, R.H. and Xu, M. (2003) The disposition and metabolism of 2-amino-3- 
methylimidazo-[4,5-f]quinoline in the F344 rat at high versus low doses of indole-3-carbinol. 
Food and Chemical Toxicology 41, 1185-1192.
de Vogel, J., Jonker-Termont, D.S.M.L., van Lieshout, E.M.M., Katan, M.B. and van der 
Meer, R. (2005) Green vegetables, red meat and colon cancer: chlorophyll prevents the 
cytotoxic and hyperproliferative effects ofhaem in rat colon. Carcinogenesis 26, 387-393.
203
____________________________________________  Bibliography
Decker, T. and Lohmann-Matthes, M.-L. (1988) A quiek and simple method for the 
quantitation of laetate dehydrogenase release in measurements of cellular eytotoxieity and 
tumor necrosis factor (TNF) activity. Journal of Immunological Methods 115, 61-69.
Deng, X.S., Tuo, J.S., Poulsen, H.E. and Loft, S. (1998) Prevention of oxidative DNA 
damage in rats by Brussels sprouts. Free Radical Research 28, 323-333.
Dinkova-Kostova, A.T., Jenkins, S.N., Fahey, J.W., Ye, L., Wehage, S.L., Liby, K.T., 
Stephenson, K.K., Wade, K.L. and Talalay, P. (2006) Protection against UV-light-induced 
skin carcinogenesis in SKH-1 high-risk mice by sulforaphane-eontaining broceoli sprout 
extracts. Cancer Letters 240, 243-252.
Drahushuk, A.T., McGarrigle, B.P., Tai, H.L., Kitareewan, S., Goldstein, J.A. and Olson, J.R. 
(1996) Validation of preeision-cut liver sliees in dynamie organ eulture as an in vitro model 
for studying CYPlAl and CYP1A2 induction. Toxicology and Applied Pharmacology 140, 
393-403.
Elmore, S. (2007) Apoptosis: A review of programmed eell death. Toxicologic Pathology 35, 
495-516.
Embola, C.W., Weisburger, J.H. and Weisburger, M.C. (2001) Urinary excretion of N-OH-2- 
amino-3-methylimidazo[4,5- f]quinoline-N-glueuronide in F344 rats is enhanced by green 
tea. Carcinogenesis 22, 1095-1098.
Fahey, J.W., Haristoy, X., Dolan, P.M., Kensler, T.W., Scholtus, I., Stephenson, K.K., 
Talalay, P. and Lozniewski, A. (2002) Sulforaphane inhibits extracellular, intracellular, and 
antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced
204
_________________ Bibliography
stomach tumors. Proceedings of the National Academy of Sciences of the United States of 
America 99, 7610-7615.
Favreau, L.V. and Pickett, C.B. (1995) The Rat Quinone Reductase Antioxidant Response 
Element. Journal of Biological Chemistry 270, 24468-24474.
Fenwick, G.R. and Heaney, R.K. (1983) Glucosinolates and their breakdown products in 
cruciferous crops, food and feedingstuffs. Food Chemistry 11,249-271.
Feskanieh, D., Ziegler, R.G., Michaud, D.S., Giovannucei, E.L., Speizer, F.E., Willett, W.C. 
and Colditz, G.A. (2000) Prospective study of fruit and vegetable consumption and risk of 
lung cancer among men and women. Journal of the National Cancer Institute 92, 1812- 
1823.
Fisher, R.L., Hasal, S.J., Sanuik, J.T., Gandolfi, A.J. and Brendel, K. (1995) Determination of 
Optimal Incubation Media and Suitable Slice Diameters in Precision-Cut Liver Slices - 
Optimization of Tissue Slice Culture .2. Toxicology Methods 5, 115-130.
Fowke, J.H., Fahey, J.W., Stephenson, K.K. and Hebert, J.R. (2001) Using isothiocyanate 
excretion as a biological marker of Brassica vegetable consumption in epidemiological 
studies: evaluating the sources of variability. Public Health Nutrition 4, 837-846.
Fowke, J.H., Shu, X.O., Dai, Q., Shintani, A., Conaway, C.C., Chung, F.L., Cai, Q.Y., Gao, 
Y.T. and Zheng, W. (2003) Urinary isothiocyanate excretion, Brassica consumption, and gene 
polymorphisms among women living in Shanghai, China. Cancer Epidemiology 
Biomarkers & Prevention 12, 1536-1539.
205
____________  Bibliography
Galceran, M.T., Moyano, E., Puignou, L. and Pais, P. (1996) Determination of heteroeyclic 
amines by pneumatically assisted eleetrospray liquid ehromatography-mass spectrometry. 
Journal of Chromatography A 730, 185-194.
Gamet-Payrastre, L., Li, P., Lumeau, S., Cassar, G., Dupont, M.-A., Chevolleau, S., Gasc, N., 
Tulliez, J. and Terce, F. (2000) Sulforaphane, a Naturally Occurring Isothiocyanate, Induces 
Cell Cycle Arrest and Apoptosis in HT29 Human Colon Cancer Cells. Cancer Research 60, 
1426-1433.
Garcia, A., Haza, A.I., Arranz, N., Rafter, J. and Morales, P. (2008) Protective effects of 
isothiocyanates alone or in combination with vitamin C towards N-nitrosodibutylamine or N- 
nitrosopiperidine-induced oxidative DNA damage in the single-cell gel electrophoresis 
(SCGE)/HepG2 assay. Journal of Applied Toxicology 28, 196-204.
Getahun, S.M. and Chung, F.-L. (1999) Conversion of Glucosinolates to Isothiocyanates in 
Humans after Ingestion of Cooked Watercress. Cancer Epidemiol Biomarkers & 
Prevention 8,447-451.
Gibson G. and Skett P. (2001) Introduction to drug metabolism, 3rd edition. Cheltenham: 
Nelson Thornes Publishers.
Gooderham, N.J., Murray, S., Lynch, A.M., Yadollahi-Farsani, M., Zhao, K., Boobis, A.R. 
and Davies, D.S. (2001) Food-derived heterocyclic amine mutagens: Variable metabolism 
and significance to humans. Drug Metabolism and Disposition 29, 529-534.
Goosen, T.C., Kent, U.M., Brand, L. and Hollenberg, P.F. (2000) Inactivation of cytochrome 
P450 2B1 by benzyl isothiocyanate, a ehemopreventative agent from cruciferous vegetables. 
Chemical Research in Toxicology 13,1349-1359.
206
________________________________________________________  Bibliography
Goosen, T.C., Mills, D.E. and Hollenberg, P.F. (2001) Effects of benzyl isothiocyanate on rat 
and human cytochromes P450: Identification of metabolites formed by P4502B1. Journal of 
Pharmacology and Experimental Therapeutics 296 ,198-206.
Gross, G.A. and Gruter, A. (1992) Quantitation of mutagenic earcinogenie heterocyclic 
aromatic-amines if  food-products. Journal of Chromatography 592,271-278.
Gross-Steinmeyer, K., Stapleton, P.L., Liu, F., Tracy, J.H., Bammler, T.K., Quigley, S.D., 
Farin, F.M., Buhler, D.R., Safe, S.H., Strom, S.C. and Eaton, D.L. (2004) Phytochemieal- 
indueed changes in gene expression of eareinogen-metabolizing enzymes in cultured human 
primary hepatocytes. Xenobiotica 34, 619-632.
Guo, Z., Smith, T.J., Wang, E., Eklind, K.L, Chung, F.-L. and Yang, C.S. (1993) Strueture- 
aetivity relationships of arylalkyl isothiocyanates for the inhibition of 4-(methylnitrosamino)- 
1 -(3 -pyridyl)-1 -butanone metabolism and the modulation of xenobiotic-metabolizing 
enzymes in rats and mice. Carcinogenesis 14, 1167-1173.
Habig, W.H., Pabst, M.J. and Jakoby, W.B. (1974) Glutathione S-transferase-first enzymatic 
step in mercapturic acid formation. Journal of Biological Chemistry 249, 7130-7139.
Haristoy, X., Fahey, J.W., Scholtus, I. and Lozniewski, A. (2005) Evaluation of the 
antimicrobial effects of several isothiocyanates on Helicobacter pylori. Planta Medica 71, 
326-330.
207
_____________________________  Bibliography
Hashemi, E., Dobrota, M., Till, C. and loannides, C. (1999a) Structural and functional 
integrity of precision-cut liver slices in xenobiotie metabolism: a comparison of the dynamic 
organ and multi well plate culture procedures. Xenobiotica 29, 11-25.
Hashemi, E., Till, C. and loannides, C. (1999b) Stability of Phase II conjugation systems in 
cultured preeision-cut rat hepatic slices. Toxicology in Vitro 13,459-466.
Hashemi, E., Till, C. and loannides, C. (2000) Stability of cytochrome P450 proteins in 
cultured preeision-cut rat liver slices. Toxicology 149, 51-61.
Hayatsu, H., Oka, T., Wakata, A., Ohara, Y., Hayatsu, T., Kobayashi, H. and Arimoto, S. 
(1983) Adsorption of mutagens to cotton bearing covalently bound trisulfo-eopper- 
phthaloeyanine. M utation Research 119, 233-238.
Hecht, S.S., Chung, F.L., Richie, J.P., Akerkar, S.A., Borukhova, A., Skowronski, L. and 
Carmella, S.G. (1995) Effects of waterererss consumption on metabolism of a tobacco- 
specific lung carcinogen in smorkers. Cancer Epidemiology Biomarkers & Prevention 4, 
877-884
Hecht, S.S., Carmella, S.G. and Murphy, S.E. (1999) Effects of watercress consumption on 
urinary metabolites of nicotine in smokers. Cancer Epidemiology Biomarkers & 
Prevention 8, 907-913.
Hecht, S.S., Kenney, P.M.J., Wang, M., Trushin, N. and Upadhyaya, P. (2000) Effects of 
phenethyl isothiocyanate and benzyl isothiocyanate, individually and in combination, on lung 
tumorigenesis induced in A/J mice by benzo[a]pyrene and 4-(methylnitrosamino)-l-(3- 
pyridyl)-1 -butanone. Cancer Letters 150,49-56.
208
___________ Bibliography
Hecht, S.S., Kenney, P.MJ., Wang, M. and Upadhyaya, P. (2002) Benzyl isothioeyanate: an 
effective inhibitor of polycyelie aromatic hydrocarbon tumorigenesis in A/J mouse lung. 
Cancer Letters 187, 87-94.
Hollenberg, P.P., Kent, U.M., Bumpus, N., xe and N. (2008) Mechanism-Based Inactivation 
of Human Cytochromes P450s: Experimental Characterization, Reactive Intermediates, and 
Clinical Implications. Chemical Research in Toxicology 21, 189-205.
Huang, C.S., Ma, W.Y., Li, J.X., Hecht, S.S. and Dong, Z.G. (1998) Essential role of p53 in 
phenethyl isothiocyanate-indueed apoptosis. Cancer Research 58, 4102-4106.
Huang, Q., Lawson, T.A., Chung, F.-L., Morris, C.R. and Mervish, S.S. (1993) Inhibition by 
phenylethyl and phenylhexylisothiocyanate of metabolism of and DNA méthylation by N- 
nitrosomethylamylamine in rats. Carcinogenesis 14, 749-754.
Huggins, C. and Fukunish.R. (1964) Induced protection of adrenal cortex against 7,12- 
dimethylbenz[a]anthraeene-ingluence of ethionine induction of menadione reductase 
incorporation of thymidine-H3. Journal of Experimental Medicine 119, 923-&.
Humblot, C., Lhoste, E., Knasmuller, S., Gloux, K., Bruneau, A., Bensaada, M., Durao, J., 
Rabot, S., Andrieux, C. and Kassie, F. (2004) Protective effects of Brussels sprouts, 
oligosaccharides and fermented milk towards 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)- 
indueed genotoxicity in the human flora associated F344 rat: role of xenobiotie metabolising 
enzymes and intestinal microflora. Journal of Chromatography B-Analytical Technologies 
in the Biomedical and Life Sciences 802, 231-237.
209
____________ Bibliography
lARC (1985) Tobacco habits other than smoking; Betel Quid and Areca-nut chewing; and 
some related nitrosamined. In: lARC monographs volume 37: the evaluation of the 
carcinogen risk of chemical to human. Lyon: lARC press.
lARC (1993) IQ (2-amino-3-methylimidazo[4,5-f]quinoline). In: lARC monographs volume 
56: some naturally occuring substances: food items and constituents, heterocyclic 
aromatic amines and mycotoxin. Lyon: lARC press.
lARC (2004) lARC handbook of cancer prevention volume 9:cruciferous vegetables, 
isothiocyanate and indoles. Lyon:IARC press.
Inamasu, T., Luks, H.J. and Weisburger, J.H. (1988) Comparison of XAD-2 column and blue 
cotton batch techniques for isolation of metabolites of 2-amino-3-methylimidazo[4,5- 
f]quinoline. Japanese Journal of Cancer Research 79,42-48.
Inamasu, T., Luks, H., Vavrek, M.T. and Weisburger, J.H. (1989) Metabolism of 2-Amino-3- 
Methylimidazo[4,5-F]Quinoline in the Male-Rat. Food and Chemical Toxicology 27, 369- 
376.
loannides, C. and Lewis, D.F. (2004) Cytochromes P450 in the bioactivation of chemicals. 
Current Topic in Medicinal Chemistry 4, 1767-1788.
loannides, C. and Parke, D.V. (1990) The eytochrome-P450-I gene family of microsomal 
hemoproteins and their role in the metabolic-activation of chemicals. Drug Metabolism 
Reviews 22, 1-85.
210
_______ Bibliography
Ishizaki, H., Brady, J.F., Ning, S.M. and Yang, C.S. (1990) Effect of phenethyl isothiocyanate 
on microsomal N-nitrosodimethylamine metabolism and other monooxygenase acitivities. 
Xenobiotica 20, 255-264.
Ito, N., Hasegawa, R., Sano, M., Tamano, S., Esumi, H., Takayama, S. and Sugimura, T. 
(1991) A new colon and mammary carcinogen in cooked food, 2-amino-1 -methyl-6- 
phenylimidazo[4,5-bjpyridine (PhEP). Carcinogenesis 12, 1503-1506.
Ji, B.T., Chow, W.H., Yang, G., McLaughlin, J.K., Zheng, W., Shu, X.O., Jin, F., Gao, R.N., 
Gao, Y.T. and Fraumeni, J.F. (1998) Dietary habits and stomach cancer in Shanghai, China. 
International Journal of Cancer 76, 659-664.
Jiao, D., Yu, M.C., Hankin, J.H., Low, S.H. and Chung, F.L. (1998) Total isothioeyanate 
contents in cooked vegetables frequently consumed in Singapore. Journal of Agricultural 
and Food Chemistry 46, 1055-1058.
Johansson, N.L., Pavia, C.S. and Chiao, J.W. (2008) Growth inhibition of a spectrum of 
bacterial and fungal pathogens by sulforaphane, an isothiocyanate product found in broccoli 
and other cruciferous vegetables. Planta Medica 74, 747-750.
Joseph, M.A., Moysich, K.B., Freudenheim, J.L., Shields, P.G., Bowman, E.D., Zhang, Y.S., 
Marshall, J.R. and Ambrosone, C.B. (2004) Cruciferous vegetables, genetic polymorphisms 
in glutathione S-transferases M l and T l, and prostate cancer risk. Nutrition and Cancer-an 
International Journal 50,206-213.
Kamataki, T., Suzuki, A., Kushida, H., Iwata, H., Watanabe, M., Nohmi, T. and Fujita, K.
(1999) Establishment of a Salmonella tester strain highly sensitive to mutagenic heteroeyclic 
amines. Cancer Letters 143, 113-116.
211
_____________________________________________________________ Bibliography
Kasai, H., Nishimura, S., Wakabayashi, K., Nagao, M. and Sugimura, T. (1980) Chemical 
synthesis of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), a potent mutagen isolated from 
broiled fish. Proceedings of the Japan Academy Series B-Physical and Biological 
Sciences 56, 382-384.
Kassahun, K., Davis, M., Hu, P., Martin, B. and Baillie, T. (1997) Biotransformation of the 
naturally occurring isothiocyanate sulforaphane in the rat: Identification of phase I 
metabolites and glutathione conjugates. Chemical Research in Toxicology 10, 1228-1233.
Kassie, P., Pool-Zobel, B., Parzefall, W. and Knasmuller, S. (1999a) Genotoxie effects of 
benzyl isothioeyanate, a natural chemopreventive agent. Mutagenesis 14, 595-604.
Kassie, P., Qin, H.M., Rabot, S. and Knasmuller, S. (1999b) Protection of organ specific 
genotoxie effects of 2-amino-3-methylimidazo[4,5-F] quinoline (Iq) by benzyl isothiocyanate 
(Bite), glueotropaeolin (Gt) and garden cress juice in in vivo single eell gel electrophoresis 
(Scge) assay with primary rat hepatocytes and eolonocytes. Neoplasma 46,41-43.
Kassie, F. and Knasmuller, S. (2000) Genotoxie effects of allyl isothioeyanate (AITC) and 
phenethyl isothiocyanate (PEITC). Chemico-Biological Interactions 127,163-180.
Kassie, P., Rabot, S., Uhl, M., Huber, W., Qin, H.M., Helma, C., Sehulte-Hermann, R. and 
Knasmuller, S. (2002) Chemoproteetive effects of garden cress (Lepidium sativum) and its 
constituents towards 2-amino-3-methyl-imidazo[4,5- I]quinoline (IQ)-indueed genotoxie 
effects and colonic preneoplastic lesions. Carcinogenesis 23,1155-1161.
Kassie, P., Laky, B., Gminski, R., Merseh-Sundermann, V., Scharf, G., Lhoste, E. and 
Kansmuller, S. (2003) Effects of garden and water cress juices and their constituents, benzyl
212
______________________________________  Bibliography
and phenethyl isothioeyanates, towards benzo(a)pyrene-indueed DNA damage; a model study 
with the single cell gel electrophoresis/Hep G2 assay. Chemieo-Biologieal Interactions 142, 
285-296.
Kato, R. (1986) Metabolic activation of mutagenic heterocyclic aromatic amines from protein 
pyrolysates. Critical Review in Toxicology 16, 307-348.
Kato, T., Migita, H., Ohgaki, H., Sato, S., Takayama, S. and Sugimura, T. (1989) Induction of 
tumors in the Zymbal gland, oral cavity, colon, skin and mammary gland of F344 rats by a 
mutagenic compound, 2-amino-3,4-dimethylimidazo[4,5-f]quinoline. Carcinogenesis 10, 
601-603.
Kensler, T.W., Chen, J.G., Egner, P.A., Fahey, J.W., Jacobson, L.P., Stephenson, K.K., Ye, 
L.X., Coady, J.L., Wang, J.B., Wu, Y., Sun, Y., Zhang, Q.N., Zhang, B.C., Zhu, Y.R., Qian, 
G.S., Carmella, S.G., Hecht, S.S., Benning, L., Gange, S.J., Groopman, J.D. and Talalay, P.
(2005) Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA 
adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, 
People's Republic of China. Cancer Epidemiology Biomarkers & Prevention 14, 2605- 
2613.
Kestell, P., Zhao, L.L., Zhu, S.T., Harris, P.J. and Ferguson, L.R. (1999) Studies on the 
mechanism of cancer protection by wheat bran: effects on the absorption, metabolism and 
excretion of the food carcinogen 2-amino-3-methylimidazo [4,5-f]quinoline (IQ). 
Carcinogenesis 20,2253-2260.
Kestell, P., Zhu, S. and Ferguson, L.R. (2004) Mechanisms by which resistant starches and 
non-starch polysaccharide sources affect the metabolism and disposition of the food
213
_____________________________________  Bibliography
carcinogen, 2-amino-3-methylimidazo[4,5-f]quinoline. Journal of Chromatography B 802, 
201- 210 .
Kirlin, W.G., Cai, J.Y., DeLong, M.J., Patten, E.J. and Jones, D.P. (1999) Dietary compounds 
that induce cancer preventive phase 2 enzymes activate apoptosis at comparable doses in 
HT29 colon carcinoma cells. Journal of Nutrition 129,1827.
Knasmuller, S., Steinkellner, H., Majer, B.J., Nobis, E.C., Scharf, G. and Kassie, F. (2002) 
Search for dietary antimutagens and anticarcinogens: methodological aspects and 
extrapolation problems. Food and Chemical Toxicology 40,1051-1062.
Knize, M.G., Kulp, K.S., Malfatti, M.A., Salmon, C.P. and Felton, J.S. (2001) Liquid 
ehromatography-tandem mass spectrometry method of urine analysis for determining human 
variation in carcinogen metabolism. Journal of Chromatography A 914, 95-103.
Knize, M.G., Kulp, K.S. and Felton, J.S. (2002) The effect of dietary soy protein on the 
metabolism of PhIP in humans. Cancer Epidemiology Biomarkers & Prevention 11, 
1189S-1189S.
Knize, M.G. and Felton, J.S. (2005) Formation and human risk of carcinogenic heterocyclic 
amines formed from natural precursors in meat. Nutrition Reviews 63, 158-165.
Konsue N. 2008 Pesonal communication
Krumdieck, C.L., Dossantos, J.E. and Ho, K.J. (1980) A new instrument for the rapid 
preparation of tissue-sliees. Analytical Biochemistry 104, 118-123.
214
_____________________________________________________________ Bibliography
Kulp, K.S., Knize, M.G., Malfatti, M.A., Salmon, C.P. and Felton, J.S. (2000) Identification 
of urine metabolites of 2-amino-1-methyl-6- phenylimidazo [4,5-b]pyridine following 
consumption of a single cooked chicken meal in humans. Carcinogenesis 21,2065-2072.
Kuroiwa, Y., Nishikawa, A., Kitamura, Y., Kanki, K., Ishii, Y., Umemura, T. and Hirose, M.
(2006) Protective effects of benzyl isothioeyanate and sulforaphane but not resveratrol against 
initiation of pancreatic carcinogenesis in hamsters. Cancer Letters 241, 275-280.
Lampe, J.W., King, I.B., Li, S., Grate, M.T., Barale, K.V., Chen, C., Feng, Z. and Potter, J.D. 
(2000) Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 
activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable 
diets. Carcinogenesis 21, 1157-1162.
Leclercq, I., Desager, J.P. and Horsmans, Y. (1998) Inhibition of chlorzoxazone metabolism, 
a clinical probe for CYP2E1, by a single ingestion of watercress. Clinical Pharmacology & 
Therapeutics 64, 144-149.
Lerche-Langrand, C. and Toutain, H.J. (2000) Precision-cut liver slices: eharacteristies and 
use for in vitro pharmaco-toxicology. Toxicology 153, 221-253.
Lewerenz, H.J., Plass, R., Bleyl, D.W.R. and Macholz, R. (1988) Short-term toxicity study of 
allyl isothiocyanate in rats. Nahrung-Food 32, 723-728.
Lewerenz, H.J., Bleyl, D.W.R. and Plass, R. (1992) Subacute ora; toxicity study of benzyl 
isothiocyanate in rats. Nahrung-Food 36, 190-198.
Lhoste, E.F., Gloux, K., De Waziers, L, Garrido, S., Lory, S., Philippe, C., Rabot, S. and 
Knasmuller, S. (2004) The activities of several detoxication enzymes are differentially
215
_______________   Bibliography
induced by juices of garden cress, water cress and mustard in human HepG2 cells. Chemico- 
Biological Interactions 150, 211-219.
Lin, J.-M., Amin, S., Trushin, N. and Hecht, S.S. (1993) Effects of isothiocyanates on 
tumorigenesis by benzo[a]pyrene in murine tumor models. Cancer Letters 74, 151-159.
Lin, H.J., Probst-Hensch, N.M., Louie, A., Kau, I.H., Witte, J.S., Ingles, S.A., Frankl, H.D., 
Lee, E.R. and Haile, R.W. (1998) Glutathione transferase null genotype, broccoli, and lower 
prevalence of colorectal adenomas. Cancer Epidemiology Biomarkers & Prevention 7, 
647-652.
London, S.J., Yuan, J.M., Chung, F.L., Gao, Y.T., Coetzee, G.A., Ross, R.K. and Yu, M.C.
(2000) Isothiocyanates, glutathione S-transferase M l and T l polymorphisms, and lung-eaneer 
risk: a prospective study of men in Shanghai, China. Lancet 356, 724-729.
Lopez, M. and Mazzanti, L. (1955) Experimental investigations on alpha-naphthyl-iso- 
thiocyanate s a hyperplastic agent of the biliary ducts in the rat. Journal of Pathology and 
Bacteriology 69, 243-250.
Luks, H.J., Spratt, T.E., Vavrek, M.T., Roland, S.F. and Weisburger, J.H. (1989) 
Identification of Sulfate and Glueuronie-Acid Conjugates of the 5-Hydroxy Derivative As 
Major Metabolites of 2-Amino-3- Methylimidazo[4,5-F]Quinoline in Rats. Cancer Research 
49,4407-4411.
Lupp, A., Danz, M. and Muller, D. (2001) Morphology and cytochrome P450 isoforms 
expression in preeision-cut rat liver slices. Toxicology 161, 53-66.
216
_________________________________ Bibliography
Lynch, A.M., Murray, S., Gooderham, N.J. and Boobis, A.R. (1995) Exposure to and 
activation of dietary heterocyclic amines in humans. Critical Reviews in 
Oncology/Hematology 21, 19-31.
Mace, K., Bowman, E.D., Vautravers, P., Shields, P.G., Harris, C.C. and Pfeifer, A.M.A. 
(1998) Characterisation of xenobiotic-metabolising enzyme expression in human bronchial 
mucosa and peripheral lung tissues. European Journal of Cancer 34, 914-920.
Maheo, K., Morel, P., Langouet, S., Kramer, H., LeFerree, E., Ketterer, B. and Guillouzo, A.
(1997) Inhibition of cytochromes P-450 and induction of glutathione S-Transferases by 
sulforaphane in primary human and rat hepatocytes. Cancer Research 57, 3649-3652.
Mannervik, B. and Danielson, U.H. (1988) Glutathione transferase-strueture and eatalystie 
activity. Critical Reviews in Biochemistry 23,283-337.
Mano, N. and Goto, J. (2003) Biomedical and biological mass spectrometry. Analytical 
Sciences 19, 3-14.
Maron, D.M. and Ames, B.N. (1983) Revised methods for the Salmonella mutagenicity test. 
Mutation Research/Environmental Mutagenesis and Related Subjects 113,173-215.
McArdle, N.J., Clifford, M.N. and loannides, C. (1999) Consumption of tea modulates the 
urinary excretion of mutagens in rats treated with IQ. Role of caffeine. Mutation Research- 
Genetic Toxicology and Environmental Mutagenesis 441,191-203.
MeCune, J.S., Hawke, R.L., LeCluyse, E.L., Gillenwater, H.H., Hamilton, G., Ritchie, J. and 
Lindley, C. (2000) In vivo and in vitro induction of human cytochrome P4503A4 by 
dexamethasone. Clinical Pharmacology & Therapeutics 68, 356-366.
217
_____________________________________________________________ Bibliography
McNaughton, S.A. and Marks, G.C. (2003) Development of a food composition database for 
the estimation of dietary intakes of glucosinolates, the biologically active constituents of 
cruciferous vegetables. British Journal of Nutrition 90, 687-697.
Memon, A., Varghese, A. and Suresh, A. (2002) Benign thyroid disease and dietary factors in 
thyroid cancer: a case-eontrol study in Kuwait. British Journal of Cancer 86, 1745-1750.
Misiewiez, I., Skupinska, K., Kowalska, E., Lubinski, J. and Kasprzyeka-Guttman, T. (2004) 
Sulforaphane-mediated induction of a phase 2 detoxifying enzyme NAD(P)H: quinone 
reductase and apoptosis, in human lymphoblastoid cells. Acta Biochimica Polonica 51,711- 
721.
Mithen, R.F., Dekker, M., Verkerk, R., Rabot, S. and Johnson, I.T. (2000) The nutritional 
significance, biosynthesis and bioavailability of glucosinolates in human foods. Journal of 
the Science of Food and Agriculture 80, 967-984.
Miyoshi, N., Uehida, K., Osawa, T. and Nakamura, Y. (2004) A link between benzyl 
isothioeyanate-induced cell cycle arrest and apoptosis: Involvement o f mitogen-activated 
protein kinases in the Bel-2 phosphorylation. Cancer Research 64, 2134-2142.
Moore, L.E., Brennan, P., Karami, S., Hung, R.J., Hsu, C., Boffetta, P., Toro, J., Zaridze, D., 
Janout, V., Bencko, V., Navratilova, M., Szeszenia-Dabrowska, N., Mates, D., Mukeria, A., 
Holcatova, I., Welch, R., Chanock, S., Rothman, N. and Chow, W.H. (2007) Glutathione S- 
transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and 
Eastern European kidney cancer study. Carcinogenesis 28, 1960-1964.
218
__________________________________ Bibliography
Moreno, R.L., Kent, U.M., Hodge, K. and Hollenberg, P.F. (1999) Inactivation of cytochrome 
P450 2E1 by benzyl isothioeyanate. Chemical Research in Toxicology 12, 582-587.
Moreno, R.L., Goosen, T., Kent, U.M., Chung, F.L. and Hollenberg, P.F. (2001) Differential 
effects of naturally occurring isothioeyanates on the activities of cytochrome P450 2E1 and 
the mutant P450 2E1 T303A. Archives of Biochemistry and Biophysics 391, 99-110.
Mori, Y., Koide, A., Kobayashi, Y., Morimura, K., Kaneko, M. and Fukushima, S. (2002) 
Effect of ethanol treatment on metabolic activation and detoxification of esophagus 
carcinogenic N-nitrosamines in rat liver. Mutagenesis 17, 251-256.
Mori, Y., Tatematsu, K., Koide, A., Sugie, S., Tanaka, T. and Mori, H. (2006) Modification 
by curcumin of mutagenic activation of earcinogenie N-nitrosamines by extrahepatie 
cytochromes P-4502B1 and 2E1 in rats. Cancer Science 97, 896-904.
Mukheijee, S., Gangopadhyay, H. and Das, D.K. (2008) Broccoli: A unique vegetable that 
protects mammalian hearts through the redox cycling of the thioredoxin superfamily. Journal 
of Agricultural and Food Chemistry 56, 609-617.
Munday, R. and Munday, C.M. (2002) Selective induction of phase II enzymes in the urinary 
bladder of rats by allyl isothiocyanate, a compound derived from Brassica vegetables. 
Nutrition and Cancer-an International Journal 44, 52-59.
Munday, R. and Munday, C.M. (2004) Induction of phase II detoxification enzymes in rats by 
plant-derived isothiocyanates: Comparison of allyl isothiocyanate with sulforaphane and 
related compounds. Journal of Agricultural and Food Chemistry 52,1867-1871.
219
_____________________________________________________________ Bibliography
Murray, S., Lake, B.G., Gray, S., Edwards, A.J., Springall, C., Bowey, E.A., Williamson, G., 
Boobis, A.R. and Gooderham, N.J. (2001) Effect of cruciferous vegetable consumption on 
heterocyclic aromatic amine metabolism in man. Carcinogenesis 22, 1413-1420.
Nagao, M., Honda, M., Seino, Y., Yahagi, T. and Sugimura, T. (1977) Mutagenicities of 
smoke condensates and the charred surface of fish and meat. Cancer Letters 2,221-226.
Nakajima, M., Yoshida, R., Shimada, N., Yamazaki, H. and Yokoi, T. (2001) Inhibition and 
inactivation of human cytochrome P450 isoforms by phenethyl isothioeyanate. Drug 
Metabolism and Disposition 29, 1110-1113.
Nakamura, Y., Morimitsu, Y., Uzu, T., Ohigashi, H., Murakami, A., Naito, Y., Nakagawa, Y., 
Osawa, T. and Uehida, K. (2000) A glutathione S-transferase inducer from papaya, rapid 
screening, identification and strueture-activity relationship of isothiocyanates. Cancer 
Letters 157, 193-200.
Nakamura, Y., Kawakami, M., Yoshihiro, A., Miyoshi, N., Ohigashi, H., Kawai, K., Osawa, 
T. and Uehida, K. (2002) Involvement of the Mitochondrial Death Pathway in 
Chemopreventive Benzyl Isothiocyanate-indueed Apoptosis. Journal of Biological 
Chemistry 277, 8492-8499.
Negrusz, A., Moore, C.M., MeDonagh, N.S., Woods, E.F., Crowell, J.A. and Levine, B.S.
(1998) Determination of phenethylamine, a phenethyl isothioeyanate marker, in dog plasma 
using solid-phase extraction and gas chromatography-mass spectrometry with chemical 
ionization. Journal of Chromatography: Biomedical Applications 718, 193-198.
Neuhouser, M.L., Patterson, R.E., Thomquist, M.D., Omenn, G.S., King, LB. and Goodman, 
G.E. (2003) Fruits and vegetables are associated with lower lung cancer risk only in the
220
 ___________________________________________________  Bibliography
placebo arm of the beta-Carotene and Retinol Efficaey Trial (CARET). Cancer 
Epidemiology Biomarkers & Prevention 12, 350-358.
Nguyen, T., Sherratt, P.J. and Piekett, C.B. (2003) Regulatory mechanisms controlling gene 
expression mediated by the antioxidant response element. Annual Review of Pharmacology 
and Toxicology 43, 233-260.
Oda, Y., Aryal, P., Terashita, T., Gillam, E.M.J., Guengerieh, P.P. and Shimada, T. (2001) 
Metabolic activation of heterocyclic amines and other proearcinogens in Salmonella 
typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, IB l, 2C9, 
2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-aeetyltransferase. 
Mutation Research-Genetic Toxicology and Environmental Mutagenesis 492, 81-90.
Ohgaki, H., Hasegawa, H., Suenaga, M., Kato, T., Sato, S., Takayama, S. and Sugimura, T. 
(1986) Induction of hepatocellular-carcinoma and highly metastatic squamous-cell 
carcinomas in the forestomaeh of mice by feeding 2-amino-3-methyIimidazo[4,5-f]quinoline. 
Carcinogenesis 7, 1889-1893.
Okazaki, K., Yamagishi, M., Son, H.Y., Imazawa, T., Furukawa, F., Nakamura, H., 
Nishikawa, A., Masegi, T. and Hirose, M. (2002) Simultaneous treatment with benzyl 
isothioeyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N- 
butyl-N-(4-hydroxybutyl)nitrosamine. Nutrition and Cancer-an International Journal 42, 
211-216.
Okazaki, K., Umemura, T., Imazawa, T., Nishikawa, A., Masegi, T. and Hirose, M. (2003) 
Enhancement of urinary bladder carcinogenesis by combined treatment with benzyl 
isothiocyanate and N-butyl-N-(4-hydroxybutyl)nitrosamine in rats after initiation. Cancer 
Science 94, 948-952.
221
___________________________________________  Bibliography
Olinga, P., Meijer, D.K.F., Slooff, MJ.H. and Groothuis, G.M.M. (1998) Liver slices in in 
vitro pharmaeotoxicology with special reference to the use of human liver tissue. Toxicology 
in Vitro 12, 77.
Omura, T. and Sato, R. (1964) The Carbon Monoxide-binding Pigment of Liver Mierosomes. 
I. Evidence for its hemoprotein nature. Journal Biological Chemistry 239, 2370-2378.
Pacin, A., Martinez, E., de Portela, M. and Neira, M.S. (1999) Food consumption and intake 
of several nutrients of Lujan University's population (Buenos Aires, Argentina). Archives 
Latinoamericanos De Nutricion 49, 31-39.
Pais, P., Moyano, E., Puignou, L. and Galceran, M.T. (1997) Liquid chromatography- 
electrospray mass spectrometry with in-source fragmentation for the identification and 
quantification of fourteen mutagenic amines in beef extracts. Journal of Chromatography A 
775, 125-136.
Pamaud, G., Li, P.P., Cassar, G., Rouimi, P., Tulliez, J., Combaret, L. and Gamet-Payrastre, 
L. (2004) Mechanism of sulforaphane-induced eell cycle arrest and apoptosis in human colon 
cancer cells. Nutrition and Cancer-an International Journal 48, 198-206.
Parrish, A.R., Gandolfi, A.J. and Brendel, K. (1995) Preeision-cut tissue-slices-applications in 
pharmacology and toxicology. Life Sciences 57,1887-1901.
Peleran, J.C., Rao, D. and Bories, G.F. (1987) Indetification of the cooked food mutagen 2- 
amino-3-methylimidazo[4,5-fjquinoline (IQ) and its N-acetylated and 3-N-demethylated 
metabolites in rat urine. Toxicology 43,193-199.
222
_______________ Bibliography
Peters, F.T. and Maurer, H.H. (2002) Bioanalytical method validation and its implications for 
forensic and clinical toxicology - A review. Accreditation and Quality Assurance 7, 441- 
449.
Pintao, A.M., Pais, M.S.S., Coley, H., Kelland, L.R. and Judson, I.R. (1995) In vitro and in 
vivo antitumor-aetivity of benzyl isothioeyanate- a natural product from propaeolum majus. 
Planta Medica 61, 233-236.
Plate, A.Y.A. and Gallaher, D.D. (2006) Effects of Indole-3-Carbinol and phenethyl 
isothiocyanate on colon carcinogenesis induced by azoxymethane in rats. Carcinogenesis 27, 
287-292.
Prabhu, S., Lee, M.J., Hu, W.Y., Winnik, B., Yang, L, Buckley, B. and Hong, J.Y. (2001) 
Determination of 2-Amino-1 -methyl-6-phenylimidazo [4,5 - bjpyridine (PhIP) and Its 
Metabolite 2-Hydroxyamino-PhIP by Liquid Chromatography/Eleetrospray lonization-Ion 
Trap Mass Spectrometry. Analytical Biochemistry 298, 306-313.
Prestera, T., Zhang, Y.S., Spencer, S.R., Wilezak, C.A. and Talalay, P. (1993) The 
electrophile counterattack response-protectioin against neoplasia and toxicity. Advances in 
Enzyme Regulation 33, 281-296.
Prochaska, H.J. and Santamaria, A.B. (1988) Direct measurement of NAD(P)H -  quinone 
reductase from cells cultured in microtitter wells-a screening assay for antieareinogen enzyme 
inducers. Analytical Biochemistry 169, 328-336.
Pushparajah, D.S., Umachandran, M., Plant, K.E., Plant, N. and loannides, C. (2007) 
Evaluation of the precision-cut liver and lung slice systems for the study of induction of 
CYPl, epoxide hydrolase and glutathione S-transferase activities. Toxicology 231, 68-80.
223
_______________________________________________   Bibliography
Pushparajah, D.S., Umachandran, M., Plant, K.E., Plant, N. and loannides, C. (2008) 
Differential response of human and rat epoxide hydrolase to polycyelie aromatic hydrocarbon 
exposure: Studies using precision-cut tissue slices. Mutation Research/Fundamental and 
Molecular Mechanisms of Mutagenesis 640,153-161.
Qian, Q.W., Babaei-Jadidi, R., Ahmed, N. and Thomalley, P.J. (2006) Reversal of 
biochemical dysfunction in endothelial cells in hyperglycemia by induction of antioxidant 
response element-linked gene expression by sulforaphane. Diabetes 55, A184-A185.
Reen, R.K., Dombkowski, A.A., Kresty, L.A., Cukovic, D., Mele, J.M., Salagrama, S., Nines, 
R. and Stoner, G.D. (2007) Effects of phenylethyl isothioeyanate on early molecular events in 
N-nitrosomethylbenzylamine-induced cytotoxicity in rat esophagus. Cancer Research 67, 
6484-6492.
Rekka, E., Evdokimova, E., Eeckhoudt, S., Labar, G. and Calderon, P.B. (2002) Role of 
temperature on protein and mRNA cytochrome P450 3A (CYP3A) isozymes expression and 
midazolam oxidation by cultured rat precision-cut liver slices. Biochemical Pharmacology 
64, 633-643.
Ricci, G., Caccuri, A.M., Lobello, M., Pastore, A., Piemonte, F. and Federiei, G. (1994) 
colorimetric and fluorometric assays of blutathione transferase based on 7-chloro-4- 
nitrobenzo-2-oxa-l,3-diazole. Analytical Biochemistry 218,463-465.
Rodman, J.E., Soltis, P.S., Soltis, D.E., Sytsma, K.J. and Karol, K.G. (1998) Parallel 
evolution of glucosinolate biosynthesis inferred from congruent nuclear and plastid gene 
phylogénies. American Journal of Botany 85, 997-1006.
224
____________________________________  Bibliography
Santos, F.J., Barcelo-Barrachina, E., Toribio, F., Puignou, L., Galceran, M.T., Persson, E., 
Skog, K., Messner, C., Murkovie, M., Nabinger, U. and Ristie, A. (2004) Analysis of 
heterocyclic amines in food products: interlaboratory studies. Journal of Chromatography 
B 802, 69-78.
Sapone, A., Affatato, A., Canistro, D., Pozzetti, L., Broceoli, M., Barillari, J., lori, R. and 
Paolini, M. (2007) Cruciferous vegetables and lung cancer. Mutation Research-Reviews in 
Mutation Research 635, 146-148.
Sasaki, S. (1963) Inhibitory effects by a-naphthyl-isothioeyanate on liver tumorigenesis in 
rats treated with 3’-methyl-4-dimethyl-aminoazobenzene. Journal of Nara Medical 
Association 14, 101-115.
Satoshi, S., Kumiko, O., Masao, H., Fumitaka, T., Makoto, A. and Tomoyuki, S. (2003) 
Reversibility of proliferative lesions and induction of non-papillary tumors in rat urinary 
bladder treated with phenylethyl isothiocyanate. Carcinogenesis 24, 547-553.
Scow, A., Shi, C.Y., Chung, F.L., Jiao, D., Hankin, J.H., Lee, H.P., Coetzee, G.A. and Yu, 
M.C. (1998) Urinary total isothiocyanate (ITC) in a population-based sample of middle-aged 
and older Chinese in Singapore: relationship with dietary total ITC and glutathione S- 
transferase M l/T l/P l genotypes. Cancer Epidemiology Biomarkers & Prevention 7, 775- 
781.
Scow, A., Yuan, J.M., Sun, C.L., Van den Berg, D., Lee, H.P. and Yu, M.C. (2002) Dietary 
isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the 
Singapore Chinese Health Study. Carcinogenesis 23,2055-2061.
225
_____________ Bibliography
Seow, A., Vainio, H. and Yu, M.C. (2005) Effect of glutathione-S-transferase polymorphisms 
on the cancer preventive potential of isothiocyanates: An epidemiological perspective. 
Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis 592, 58- 
67.
Shannon, J., Thomas, D.B., Ray, R.M., Kestin, M., Koetsawang, A., Koetsawang, S., 
Chitnarong, K., Kiviat, N. and Kuypers, J. (2002) Dietary risk factors for invasive and in-situ 
cervical carcinomas in Bangkok, Thailand. Cancer Causes & Control 13, 691-699.
Shapiro, T.A., Fahey, J.W., Wade, K.L., Stephenson, K.K. and Talalay, P. (1998) Human 
metabolism and excretion of cancer chemoproteetive glucosinolates and isothiocyanates of 
cruciferous vegetables. Cancer Epidemioligy Biomarkers & Prevention 7, 1091-1100.
Sidransk.H, Ito, N. and Vemey, E. (1966) Influence of alpha-naphthyl-isothiocyanate on liver 
tumorigenesis in rats ingesting ethionine and N-2-fluorenylacetamide. Journal of the 
National Cancer Institute 37, 677-&.
Sjodin, P. and Jagerstad, M. (1984) A balanaee study of C-14-labeled 3-H-imidazo[4,5- 
f]quinoline-2-amines (IQ and MelQ) in rats. Food and Chemical Toxicology 22, 207-210.
Smith, P.F., Gandolfi, A.J., Krumdieck, C.L., Putnam, C.W., Zukoski, C.F., Davis, W.M. and 
Brendel, K. (1985) Dynamic organ-culture of precision liver slices for in vitro toxicology. 
Life Sciences 36, 1367-1375.
Smith, T.J., Guo, Z., Li, C., Ning, S.M., Thomas, P.E. and Yang, C.S. (1993) Mechanisms of 
Inhibition of 4-(Methylnitrosamino)-l-(3-pyridyl)-1-butanone Bioactivation in Mouse by 
Dietary Phenethyl Isothiocyanate. Cancer Research 53, 3276-3282.
226
_____________________________________________________________ Bibliography
Snyderwine, E.G., Welti, D.H., Fay, L.B., Wurzner, H.P. and Turesky, R.J. (1992) 
Metabolism of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman 
primates undergoing eareinogen bioassay. Chemical Research Toxicology 5, 843-851.
Sones, K., Heaney, R.K. and Fenwiek, G.R. (1984a) An estimate of the mean daily intake of 
glucosinolates from eruciferous vegetables in the UK. Journal of the Science of Food and 
Agriculture 35, 712-720.
Sones, K., Heaney, R.K. and Fenwick, G.R. (1984b) Glucosinolates in brassiea vegetables- 
analysis of 27 eauliflower cultivars (brassica-oleracea L var botrytis subvar-cauliflora DC). 
Journal of the Science of Food and Agriculture 35, 762-766.
Song, L.J., Morrison, J.J., Dotting, N.P. and Thomalley, P.J. (2005) Analysis of 
glucosinolates, isothiocyanates, and amine degradation products in vegetable extracts and 
blood plasma by LC-MS/MS. Analytical Biochemistry 347, 234-243.
Sorensen, M., Jensen, B.R., Poulsen, H.E., Deng, X.S., Tygstmp, N., Dalhoff, K. and Loft, S.
(2001) Effects of a Bmssels sprouts extract on oxidative DNA damage and metabolising 
enzymes in rat liver. Food and Chemical Toxicology 39, 533-540.
Spamins, V.L., Chuan, J. and Wattenberg, L.W. (1982) Enhancement of glutathione S- 
transferase aetivitity of the esophagus by phenols, lactones, and benzyl isothiocyanate. 
Cancer Research 42, 1205-1207.
Spingam, N.E. and Weisburger, J.H. (1979) Formation of mutagens in cooked foods. 1. Beef. 
Cancer Letters 7,259-264.
227
__________________________________________________  Bibliography
Spitz, M.R., Duphome, C.M., Detry, M.A., Pillow, P.C., Amos, C.I., Lei, L., de Andrade, M., 
Gu, X J., Hong, W.K. and Wu, X.F. (2000) Dietary intake of isothiocyanates: Evidence of a 
joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer 
Epidemiology Biomarkers & Prevention 9,1017-1020.
Staretz, M.E., Koenig, L.A. and Hecht, S.S. (1997) Effects of long term dietary phenethyl 
isothiocyanate on the microsomal metabolism of 4-(methylnitrosamino)-l-(3-pyridyl)-1- 
butanone and 4-(methylnitrosamino)-1 -(3-pyridyl)-1 -butanol in F344 rats. Carcinogenesis 
18, 1715-1722.
Steensma, A., Beamand, J.A., Walters, D.G., Price, R.J. and Lake, B.G. (1994) Metabolism of 
coumarin and 7-ethoxyeoumarin by rat, mouse, guinea-pig, cynomolgus monkey and human 
precision-cut liver sliees. Xenobiotica 24, 893-907.
Steinkellner, H., Rabot, S., Freywald, C., Nobis, E., Scharf, G., Chabicovsky, M., Knasmller, 
S. and Kassie, F. (2001) Effects of cruciferous vegetables and their constituents on drug 
metabolizing enzymes involved in the bioactivation of DNA-reactive dietary carcinogens. 
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 480-481, 
285-297.
Steinmetz, K.A. and Potter, J.D. (1996) Vegetables, fruit, and cancer prevention: A review. 
Journal of the American Dietetic Association 96, 1027-1039.
Sticha, K.R.K., Kenney, P.M.J., Boysen, G., Liang, H., Su, X.J., Wang, M.Y., Upadhyaya, P. 
and Hecht, S.S. (2002) Effects of benzyl isothioeyanate and phenethyl isothiocyanate on 
DNA adduct formation by a mixture of benzo[a]pyrene and 4-(methylnitrosamino)-l-(3- 
pyridyl)-1 -butanone in A/J mouse lung. Carcinogenesis 23,1433-1439.
228
_____________________________________________  Bibliography
Sticha, K.R.K., Staretz, M.E., Wang, M., Liang, H., Kenney, P.M.J. and Hecht, S.S. (2000) 
Effects of benzyl isothiocyanate and phenethyl isothiocyanate on benzo[a]pyrene metabolism 
and DNA adduct formation in the A/J mouse. Carcinogenesis 21,1711-1719.
Stoner, G., Casto, B., Ralston, S., Roebuck, B., Pereira, C. and Bailey, G. (2002) 
Development of a multi-organ rat model for evaluating chemopreventive agents: efficacy of 
indole-3-carbinol. Carcinogenesis 23,265-272.
Stoner, G.D. and Morse, M.A. (1997) Isothiocyanates and plant polyphenols as inhibitors of 
lung and esophageal cancer. Cancer Letters 114, 113-119.
Stresser, D.M., Blanchard, A.P., Turner, S.D., Erve, J.C.L., Dandeneau, A.A., Miller, V.P. 
and Crespi, C.L. (2000) Substrate-dependent modulation of CYP3A4 catalytic activity: 
Analysis of 27 test compounds with four fiuorometric substrates. Drug Metabolism and 
Disposition 28, 1440-1448.
Sugimura, T., Nagao, M., Kawachi, T., Honda, M., Yahagi, T., Seino, Y., Sato, S., 
Matsukura, N., Matsushima, T., Sirai, A., Sawamura, M., Matsumoto, T., Hiatt, H.H., 
Watson, J.D. and Winsten, J.A. (1977) Mutagen-carcinogens in foods, with special reference 
to highly mutagenic pyrolytic products in broiled foods. Origins of Human cancer, 1561- 
1577.
Svehlikova, V., Wang, S., Jakubikova, J., Williamson, G., Mithen, R. and Bao, Y. (2004) 
Interactions between sulforaphane and apigenin in the induction of UGTlAl and GSTAl in 
CaCo-2 cells. Carcinogenesis 25,1629-1637.
229
_____________________________________________________________ Bibliography
Takayama, S., Nakatsuru, Y., Masuda, M., Ohgaki, H., Sato, S. and Sugimura, T. (1984) 
Demonstration of carcinogenicity in F344 rats of 2-amino-3-methyl-imidazo[4,5-f]quinoline 
from broiled sardine, fried beef and beef extract. Gann 75,467-470.
Talalay, P. and Zhang, Y. (1996) Chemoprotection against cancer by isothiocyanates and 
glucosinolates. Biochemical Society Transactions 24, 806-810.
Tang, L., Zirpoli, G.R., Guru, K., Moysich, K.B., Zhang, Y.S., Ambrosone, C.B. and 
McCann, S.E. (2008) Consumption of raw cruciferous vegetables us inversely associated with 
Bladder cancer risk. Cancer Epidemiology Biomarkers & Prevention 17, 938-944.
Tanito, M., Masutani, H., Kim, Y.C., Nishikawa, M., Ohira, A. and Yodoi, J. (2005) 
Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates 
retinal light damage in mice. Investigative Ophthalmology Visual Science 46, 979-987.
Terry, P., Wolk, A., Persson, I. and Magnusson, C. (2001) Brassica vegetables and breast 
cancer risk. Jama-Journal of the American Medical Association 285,2975-2977.
Teny, P., Vainio, H., Wolk, A. and Weiderpass, E. (2002) Dietary factors in relation to 
endometrial cancer: A nationwide case-control study in Sweden. Nutrition and Cancer-an 
International Journal 42,25-32.
Thomson, C.A., Rock, C.L., Caan, B.J., Flatt, S.W., Al-Delaimy, W.A., Newman, V.A., 
Hajek, R.A., Chilton, J.A. and Pierce, J.P. (2007) Increase in cruciferous vegetable intake in 
women previously treated for breast cancer participating in a dietary intervention trial. 
Nutrition and Cancer-an International Journal 57, 11-19.
230
____________________________  Bibliography
Thomalley, P J. (2002) Isothiocyanates: mechanism of cancer chemopreventive action. Anti- 
Cancer Drugs 13, 331-338.
Toribio, P., Puignou, L. and Galceran, M.T. (1999) Evaluation of different clean-up 
procedures for the analysis of heterocyclic aromatic amines in a lyophilized meat extract. 
Journal of Chromatography A 836,223-233.
Toribio, F., Moyano, E., Puignou, L. and Galceran, M.T. (2000) Comparison of different 
commercial solid-phase extraction cartridges used to extract heterocyclic amines from a 
lyophilised meat extract. Journal of Chromatography A 880, 101-112.
Towbin, H., Staehelin, T. and Gordon, J. (1979) Electrophoretic transfer of proteins from 
polyarylamide gels to nitrocellulose sheets-procudure and some applications. Proceedings of 
the National Academy of Sciences of the United States of America 76,4350-4354.
Turesky, R.J., Skipper, P.L., Tannenbaum, S.R., Coles, B. and Ketterer, B. (1986) Sulfamate 
formation is a major route for detoxification of 2-amino-3-methylimidazo[4,5-f]quinoline in 
the rat. Carcinogenesis 7,1483-1485.
Turesky, R.J., Lang, N.P., Butler, M.A., Teitel, C.H. and Kadlubar, F.F. (1991) Metabolic- 
Activation of Carcinogenic Heterocyclic Aromatic- Amines by Human Liver and Colon. 
Carcinogenesis 12, 1839-1845.
Turesky, R.J., Stillwell, W.G.S., Skipper, P.L. and Tannenbaum, S.R. (1993) Metabolism of 
the food-home carcinogens 2-amino-3-mtheylimidazo[4,5-f]quinoline and 2-amino-3,8- 
dimethylimidazo[4,5-f]-quinoxaline in the rat as a model for human biomonitoring. 
Environmental Health Perspective 99,123-128.
231
___________________________________ Bibliography
Turesky, R.J., Fay, L.B. and Welti, D.H. (1995) Metabolism of heterocyclic aromatic amines 
and strategies of human biomonitoring. Princess Takamatsu Symposium 23, 59-68.
Turesky, R.J., Constable, A., Richoz, J., Varga, N., Markovic, J., Martin, M.V. and 
Guengerich, F.F. (1998) Activation of heterocyclic aromatic amines by rat and human liver 
microsomes and by purified rat and human cytochrome P450 1A2. Chemical Research in 
Toxicology 11, 925-936.
Turesky, R.J. (2002) Heterocyclic aromatic amine metabolism, DNA adduct formation, 
mutagenesis, and carcinogenesis. Drug Metabolism Reviews 34, 625-650.
Turesky, R.J. (2005) Interspecies metabolism of heterocyclic aromatic amines and the 
uncertainties in extrapolation of animal toxicity data for human risk assessment. Molecular 
Nutrition & Food Research 49,101-117.
Turesky, R.J., Taylor, J., Schnackenberg, L., Freeman, J.P. and Holland, R.D. (2005) 
Quantitation of carcinogenic heterocyclic aromatic amines and detection o f novel heterocyclic 
aromatic amines in cooked meats and grill scrapings by HPLC/ESI-MS. Journal of 
Agricultural and Food Chemistry 53, 3248-3258.
Uhl, M., Kassie, F., Rabot, S., Grasl-Kraupp, B., Chakraborty, A., Laky, B., Kundi, M. and 
Knasmuller, S. (2004) Effect of common Brassica vegetables (Brussels sprouts and red 
cabbage) on the development of preneoplastic lesions induced by 2-amino-3- 
methylimidazo[4,5-f]quinoline (IQ) in liver and colon of Fischer 344 rats. Journal of 
Chromatography B-Analytical Technologies in the Biomedical and Life Sciences 802, 
225-230.
232
___________________________________________________  Bibliography
Vanetten, C.H., Daxenbichler, M.E., Williams, P.H. and Kwolek, W.F. (1976) Glucosinolates 
and derived products in cruciferous vegetables-analysis of efible part from 22 vaieties of 
cabbage. Journal of Agricultural and Food Chemistry 24,452-455.
Vang, O., Jensen, M.B. and Autrup, H. (1990) Induction of cytochrome P450IA1 in rat colon 
and liver by indole-3-carbinol and 5,6-benzoflavone. Carcinogenesis 11,1259-1263.
Vang, O., Jensen, H. and Autrup, H. (1991) Induction of cytochrome-P-450-IaI, cytochrome- 
P-450IA2, cytochrome-P-45OIIB1, cytochrome-P-450IIB2, and cytochrome-P-45OIIEl by 
broccoli in rat-liver and colon. Chemico-Biological Interactions 78, 85-96.
Vasudevan KM, Gurumurthy S, RangnekarVM. (2004) Suppression of PTEN 
expression by NF-kappa B prevents apoptosis. M olecular and C ellu lar B iology. Feb; 
24 (3):1007-21
Vermeulen, M., van Rooijen, H.J.M. and Vaes, W.H.J. (2003) Analysis of isothiocyanate 
mercapturic acids in urine: A biomarker for cruciferous vegetable intake. Journal of 
Agricultural and Food Chemistry 51, 3554-3559.
Vermeulen, M., Van den Berg, R., Freidig, A.P., Van Bladeren, P.J. and Vaes, W.H.J. (2006) 
Association between consumption of cruciferous vegetables and condiments and excretion in 
urine of isothiocyanate mercapturic acids. Journal of Agricultural and Food Chemistry 54, 
5350-5358.
von Weymam, L.B., Chun, J.A. and Hollenberg, P.F. (2006) Effects of benzyl and phenethyl 
isothiocyanate on P450s 2A6 and 2A13: potential for chemoprevention in smokers. 
Carcinogenesis 27, 782-790.
233
__________________________________________________________  Bibliography
von Weymam, L.B., Chun, J.A., Knudsen, G.A. and Hollenberg, P.F. (2007) Effects of eleven 
isothiocyanates on P450 2A6- and 2A13-catalyzed coumarin 7-hydroxylation. Chemical 
Research in Toxicology 20,1252-1259.
Voorrips, L.E., Goldbohm, R.A., van Poppel, G., Sturmans, F., Hermus, R.J.J. and van den 
Brandt, P.A. (2000) Vegetable and fruit consumption and risks of colon and rectal cancer in a 
prospective cohort study - The Netherlands Cohort Study on Diet and Cancer. American 
Journal of Epidemiology 152, 1081-1092.
Wagner B, Natarajan A, Grunaug S, Kroismayr R, Wagner EF, Sibilia M. (2006) Neuronal 
survival depends on EGFR signalling in cortical but not midbrain astrocytes. The EMBO 
Journal. Feb 22;25(4):752-62.
Wakabayashi, K., Nagao, M., Esumi, H. and Sugimura, T. (1992) Food-Derived Mutagens 
and Carcinogens. Cancer Research 52, S2092-S2098.
Wallin, H., Holme, J.A., Becher, G. and Alexander, J. (1989) Metabolism of the Food 
Carcinogen 2-Amino-3,8- Dimethylimidazo[4,5-F]Quinoxaline in Isolated Rat-Liver Cells. 
Carcinogenesis 10, 1277-1283.
Walters, D.G., Young, P.J., Agus, C., Knize, M.G., Boobis, A.R., Gooderham, N.J. and Lake, 
B.G. (2004) Cruciferous vegetable consumption alters the metabolism of the dietary 
carcinogen 2-amino-1 -methyl-6-phenylimidazo[4,5 - bjpyridine (PhIP) in humans. 
Carcinogenesis 25, 1659-1669.
234
_____________________________________________________________Bibliography
Wattenberg, L.W. (1981) Inhibition of carcinogen-induced nepplasia by sodium cyanate, ter- 
butyl isocyanate, and benzyl isothiocyanate administered subsequent to carcinogen exposure. 
Cancer Research 41,2991-2994.
Wattenberg, L.W. (1987) Inhibitory effects of benzyl isothiocyanate administered shortly 
before diethylnitrosamine or benzo[a]pyrene on pulmonary and forestomach neoplasia in A/J 
mice. Carcinogenesis 8, 1971-1973.
Wauthier, V., Verbeeck, R.K. and Calderon, P.B. (2004) The use of precision-cut liver slices 
from male Wistar rats as a tool to study age related changes in CYP3A induction and in 
formation of paracetamol conjugates. Toxicology in Vitro 18, 879-885.
Woosley, R.L. (1996) Cardiac Actions of Antihistamines. Annual Review of Pharmacology 
and Toxicology 36,233-252.
Xu, M., Bailey, A.C., Hemaez, J.F., Taoka, C.R., Schut, H.A.J. and Dashwood, R.H. (1996) 
Protection by green tea, black tea, and indole-3-carbinol against 2-amino-3- 
methylimidazo[4,5-f]quinoline-induced DNA adducts and colonic aberrant crypts in the F344 
rat. Carcinogenesis 17, 1429-1434.
Xu, M.R., Omer, G.A., Bailey, G.S., Stoner, G.D., Horio, D.T. and Dashwood, R.H. (2001) 
Post-initiation effects of chlorophyllin and indole-3-carbinol in rats given 1,2- 
dimethylhydrazine or 2-amino-3-methylimidazo[4,5-f]quinoline. Carcinogenesis 22, 309- 
314.
Yamaguchi, T. (1980) Mutagenicity of isothiocyanate, isocyanates and thioureas on 
salmonella-typhimurium. Agricultural and Biological Chemistry 44, 3017-3018.
235
________________ Bibliography
Yamashita, M., Wakabayashi, K., Nagao, M., Sato, S., Yamaizumi, Z., Takahashi, M., Kinae, 
N., Tomita, I. and Sugimura, T. (1986) Detection of 2-amino-3-methylimidazo[4,5- 
f]quinoline in cigarette-smoke condensate. Japanese Journal of Cancer Research 77, 419- 
422.
Yamazoe, Y., Shimada, M., Kamataki, T. and Kato, R. (1983) Microsomal activation of 2- 
amino-3-methylimidazo[4,5-f]quinoline, a pyrolysate of sardine and beef extracts, to a 
mutagenic intermediate. Cancer Research. 43, 5768-5774.
Yang, Y.M., Conaway, C.C., Chiao, J.W., Wang, C.X., Amin, S., Whysner, J., Dai, W., 
Reinhardt, J. and Chung, F.L. (2002) hihibition of benzo(a)pyrene-induced lung 
tumorigenesis in A/J mice by dietary N-acetylcysteine conjugates of benzyl and phenethyl 
isothiocyanates during the postinitiation phase is associated with activation of mitogen- 
activated protein kinases and p53 activity and induction of apoptosis. Cancer Research 62, 
2-7.
Yang, Y.M., Jhanwar-Uniyal, M., Schwartz, J., Conaway, C.C., Halicka, H.D., Traganos, F. 
and Chung, F.L. (2005) N-acetylcysteine conjugate of phenethyl isothiocyanate enhances 
apoptosis in growth-stimulated human lung cells. Cancer Research 65, 8538-8547.
Yoxall, V.R., Parker, D.A., Kentish, P.A. and loannides, C. (2004) Short-term black tea 
intake modulates the excretion of urinary mutagens in rats treated with 2-amino-3- 
methylimidazo-[4,5-f]quinoline (IQ): role of CYP1A2 upregulation. Archives of Toxicology 
78,477-482.
Yoxall, V., Kentish, P., Coldham, N., Kuhnert, N., Sauer, M.J. and loannides, C. (2005) 
Modulation of hepatic cytochromes P450 and phase II enzymes by dietary doses of
236
___________ Bibliography
sulforaphane in rats: Implications for its chemopreventive activity. International Journal of 
Cancer 117, 356-362.
Zhang, Y.S., Kensler, T.W., Cho, C.G., Posner, G.H. and Talalay, P. (1994) Anticarcinogenic 
acitivities of sulforaphane and structurally related synthetic norbomyl isothiocyanates. 
Proceedings of the National Academy of Sciences of the United States of America 91, 
3147-3150.
Zhang, Y.S. and Talalay, P. (1994) Anticarcinogenic activities of organic acitivies of organic 
isothiocyanates-chemistry and mechanisms. Cancer Research 54, S I976-81981.
Zhang, Y.S., Kolm, R.H., Mannervik, B. and Talalay, P. (1995) Reversible conjugation of 
isothiocyanates with with glutathione transferases. Biochemical and Biophysical Research 
Communications 206, 748-755.
Zhang, Y.S. and Talalay, P. (1998) Mechanism of differential potencies of isothiocyanates as 
inducers of anticarcinogenic phase 2 enzymes. Cancer Research 58,4632-4639.
Zhang, Y.S. (2000) Role of glutathione in the accumulation of anticarcinogenic 
isothiocyanates and their glutathione conjugates by murine hepatoma cells. Carcinogenesis 
21, 1175-1182.
Zhang, Y.S. (2001) Molecular mechanism of rapid cellular accumulation of anticarcinogenic 
isothiocyanates. Carcinogenesis 22,425-431.
Zhang, R., Loganathan, S., Humphreys, I. and Srivastava, S.K. (2006) Benzyl Isothiocyanate- 
Induced DNA Damage Causes G2/M Cell Cycle Arrest and Apoptosis in Human Pancreatic 
Cancer Cells. Journal of nutrition 136, 2728-2734.
237
_____________________________________________________________ Bibliography
Zhao, B., Seow, A., Lee, E.J.D., Poh, W.T., Teh, M., Eng, P., Wang, Y.T., Tan, W.C., Yu, 
M.C. and Lee, H.P. (2001) Dietary isothiocyanates, glutathione S-transferase-Ml,-Tl 
polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer 
Epidemiology Biomarkers & Prevention 10,1063-1067.
238
Reproduced with permission of copyright owner. Further reproduction prohibited without permission.
